Compounds > verapamil
Page last updated: 2024-10-24

verapamil and Cardiovascular Stroke

verapamil has been researched along with Cardiovascular Stroke in 421 studies

Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.

Research Excerpts

ExcerptRelevanceReference
"The effect of Ca-antagonist, long-acting verapamil and the selective beta-1 blocking bisoprolol were investigated and compared in the secondary prevention after myocardial infarction."10.18[Comparative study of verapamil and bisoprolol in the secondary prevention of myocardial infarction]. ( Bogár, L; Czopf, L; Debreceni, G; Habon, T; Kónyi, A; Mühl, D; Sárosi, I; Schmidt, E; Tekeres, M; Tóth, K; Zámbó, K, 1997)
"CLINICAL TRIALS WITH VERAPAMIL AND TRANDOLAPRIL: In the Danish Verapamil Infarction Trial II, verapamil improved survival in patients without heart failure but had no effect in patients with heart failure who were receiving diuretic treatment."10.18Congestive heart failure and ischaemic heart disease treated with trandolapril and verapamil. DAVIT Study Group. Danish Verapamil Infarction Trial. ( Hansen, JF, 1998)
"An overview of the published studies on the use of verapamil during and after an acute myocardial infarction is presented."10.17Review of postinfarct treatment with verapamil: combined experience of early and late intervention studies with verapamil in patients with acute myocardial infarction. Danish Study Group on Verapamil in Myocardial Infarction. ( Hansen, JF, 1994)
"The effect of verapamil on death and reinfarction after an acute myocardial infarction was studied in two double-blind, randomized, placebo-controlled multicenter trials, the Danish Verapamil Infarction Trials I and II (DAVIT I and II)."10.16Treatment with verapamil during and after an acute myocardial infarction: a review based on the Danish Verapamil Infarction Trials I and II. The Danish Study Group on Verapamil in Myocardial Infarction. ( Hansen, JF, 1991)
"We aimed to investigate the effects of verapamil and adenosine in an adjunct to intravenous tirofiban on management and prognosis of no-reflow phenomenon during primary percutaneous coronary intervention (PPCI) and to compare their efficacies on reversing of no-reflow phenomenon and short and midterm survival."9.19Effects of verapamil and adenosine in an adjunct to tirofiban on resolution and prognosis of noreflow phenomenon in patients with acute myocardial infarction. ( Arif Yalcin, A; Biyik, I; Celik, O; Erturk, M; Faruk Akturk, I; Murat Caglar, I; Oner, E; Sarikamis, C; Turhan Caglar, N; Uzun, F, 2014)
"In INternational VErapamil-trandolapril STudy, 22,576 CAD patients with hypertension (mean age 66 years) were randomized to verapamil-SR or atenolol-based strategies and followed for 2."9.14Pulse pressure and risk of cardiovascular outcomes in patients with hypertension and coronary artery disease: an INternational VErapamil SR-trandolapril STudy (INVEST) analysis. ( Bangalore, S; Champion, A; Franklin, SS; Mancia, G; Messerli, FH; Pepine, CJ, 2009)
"In hypertensive patients with prior MI, a verapamil-SR-based strategy was equivalent to a beta-blocker-based strategy for blood pressure control and prevention of cardiovascular events, with greater subjective feeling of well-being and a trend toward lower incidence of angina pectoris and stroke in the verapamil-SR-based group."9.13Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy. ( Bacher, PH; Bangalore, S; Champion, A; Cohen, JD; Kowey, P; Mancia, G; Messerli, FH; Pepine, CJ; Sleight, P; Zhou, Q, 2008)
"To study the impact of injection of verapamil and adenosine in the coronary arteries on TIMI (Thrombolysis in Myocardial Infarction) frame count (TFC) after percutaneous coronary intervention (PCI) in patients with an acute coronary syndrome (ACS)."9.12Prospective, randomised, controlled trial to study the effect of intracoronary injection of verapamil and adenosine on coronary blood flow during percutaneous coronary intervention in patients with acute coronary syndromes. ( de Belder, MA; Graham, J; Hall, JA; Kunadian, B; Sutton, A; Vijayalakshmi, K; Whittaker, VJ; Wright, RA, 2006)
"The effect of nonsteroid anti-inflammatory drugs (NSAIDs) after acute myocardial infarction was studied in a retrospective study of 88 patients who were receiving regular NSAID treatment at randomization in the Danish Verapamil Infarction Trial II."9.09Nonsteroidal anti-inflammatory drugs after acute myocardial infarction. DAVIT Study Group. Danish Verapamil Infarction Trial. ( Hansen, JF; Mortensen, LS; Sajadieh, A; Wendelboe, O, 1999)
"The VISOR is a double blind, randomized, placebo-controlled study aimed to assess the effects of early and prolonged administration of verapamil on the left ventricular geometry and diastolic function in patients with anterior acute myocardial infarction treated with thrombolysis."9.09The effect of verapamil on left ventricular remodelling and diastolic function after acute myocardial infarction (the Verapamil Infarction Study on Remodelling and Relaxation--VISOR). ( Carelli, M; Celli, P; Di Marcotullio, G; Malinconico, U; Milazzotto, F; Natale, E; Polizzi, CA; Tubaro, M; Vajola, SF, 1999)
"The administration of verapamil during the reperfusion phase of acute myocardial infarction can reduce the extent and severity of microvessel damage and limit myocardial dysfunction."9.09Early administration of verapamil after thrombolysis in acute anterior myocardial infarction. Effect on left ventricular remodeling and clinical outcome. VAMI Study Group. Verapamil Acute Myocardial Infarction. ( Biasco, MG; Boni, L; Brigiani, MS; Iliceto, S; Marangelli, V; Memmola, C; Rizzon, P; Scrutinio, D, 2000)
"The main objective of this retrospective analysis was to evaluate the long-term effect of the heart rate-lowering calcium antagonists verapamil and diltiazem on the incidence of combined cardiac events and all-cause mortality in patients who had experienced a non-Q-wave acute myocardial infarction (AMI), but who did not also have pulmonary congestion."9.09Long-term effects of diltiazem and verapamil on mortality and cardiac events in non-Q-wave acute myocardial infarction without pulmonary congestion: post hoc subset analysis of the multicenter diltiazem postinfarction trial and the second danish verapamil ( Boden, WE; Gibson, RS; Hansen, JF; Messerli, F; Schechtman, KB, 2000)
"A multicenter, double-blind, randomized, placebo-controlled trial was conducted to assess the effects of verapamil on total mortality, cardiac mortality, reinfarction, and angina after an acute myocardial infarction."9.08A controlled trial of verapamil in patients after acute myocardial infarction: results of the calcium antagonist reinfarction Italian study (CRIS) ( Acanfora, D; Bernabei, R; Carbonin, P; Carosella, L; DeCaprio, L; Ferrara, N; Pahor, M; Parlati, S; Rengo, F; Vitale, D, 1996)
", death, repeat infarction, unstable angina pectoris, or repeat admission because of heart failure) was 14% in patients treated with verapamil and trandolapril and 35% in patients treated with trandolapril (p = 0."9.08Treatment with verapamil and trandolapril in patients with congestive heart failure and angina pectoris or myocardial infarction. The DAVIT Study Group. Danish Verapamil Infarction Trial. ( Bjergaard, OP; Hagerup, L; Hansen, JF; Mellemgaard, K; Pedersen, F; Sigurd, B, 1997)
"We assessed the acute effect of intracoronary injection of verapamil on microvascular function after primary percutaneous translumanal coronary angioplasty (PTCA) for acute myocardial infarction (AMI) with myocardial contrast echocardiography (MCE) in relation to functional outcomes."9.08Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction. ( Fujii, K; Higashino, Y; Hori, M; Ito, H; Iwakura, K; Masuyama, T; Minamino, T; Nishikawa, N; Takiuchi, S; Taniyama, Y, 1997)
"Because decreased heart rate variability measured after an acute myocardial infarction (AMI) has been demonstrated to predict subsequent mortality and sudden death, and an efficacy analysis of the Danish Verapamil Infarction Trial II (DAVIT II) demonstrated that long-term postinfarction treatment with verapamil significantly reduced sudden death, the aim of the present substudy was to evaluate the effect of verapamil on heart-rate variability in the time and frequency domain, measured in two 5-minute segments during the day and night."9.08Effect of verapamil on heart rate variability after an acute myocardial infarction. Danish Verapamil Infarction Trial II. ( Rasmussen, V; Vaage-Nilsen, M, 1998)
"The prognostic significance of angina pectoris and the effect of intervention with verapamil on the incidence of angina pectoris were studied in patients recovering from myocardial infarction and included in the Danish Verapamil Infarction Trial II."9.07The prognostic significance of post-infarction angina pectoris and the effect of verapamil on the incidence of angina pectoris and prognosis. The Danish Study Group on Verapamil in Myocardial Infarction. ( Hansen, JF; Jespersen, CM; Mortensen, LS, 1994)
"DAVIT-II is a double-blind, randomized, multicentre, placebo-controlled study of long-term treatment with verapamil 360 mg per day administered to patients who have suffered an acute myocardial infarction (AMI)."9.07Prevalence of transient myocardial ischaemia during the first year after a myocardial infarction. Effect of treatment with verapamil. The Danish Study Group on Verapamil in Myocardial Infarction. ( Hansen, JF; Holländer, NH; Rasmussen, V; Vaage-Nilsen, M, 1992)
"This article is a review of presented subsets of the Danish Verapamil Infarction Trial II (DAVIT II) regarding the effect of verapamil on postinfarction ischemia, ventricular arrhythmias, and heart rate (HR), and the prognostic implications of these findings."9.07Effect of verapamil on ischemia and ventricular arrhythmias after an acute myocardial infarction: prognostic implications. The Danish Verapamil Infarction Trial II Study Group. ( Bjergaard, OP; Hagerup, L; Hansen, JF; Holländer, NH; Mellemgaard, K; Nielsen, I; Rasmussen, V; Sigurd, B; Sørensen, MB; Vaage-Nilsen, M, 1991)
"The effect of verapamil on death and reinfarction in patients with and without exercise-induced myocardial ischemia after acute myocardial infarction was studied in a double-blind, placebo-controlled multicenter study."9.07The effect of verapamil on major events in patients with exercise-induced ischemia recovering from acute myocardial infarction: a review. The Danish Study Group on Verapamil in Myocardial Infarction. ( Jespersen, CM, 1991)
"In a double-blind, randomized, placebo-controlled study comparing verapamil and placebo in late secondary intervention after acute myocardial infarction, the physicians were asked to try to identify the treatment in 100 consecutive patients."9.06Assessment of blindness in the Danish Verapamil Infarction Trial II (DAVIT II). Danish Study Group on Verapamil in Myocardial Infarction. ( Jespersen, CM, 1990)
"Verapamil was administered to 35 patients with acute myocardial infarction during the first 12 h of the disease."9.05[Effect of isoptin (verapamil) on the indicators of central hemodynamics in patients with acute myocardial infarction]. ( Avaliani, ShG; Gratsianskiĭ, NA; Karpov, IuA; Ruda, MIa, 1984)
"The effect of verapamil on plasma lipids and lipoproteins was studied in 64 patients taking part in a double blind controlled trial of verapamil versus placebo in post myocardial infarction."9.05Variation of serum lipoproteins in postmyocardial infarction patients treated with verapamil or placebo. ( Engby, B; Schmidt, E; Strunge, P; Trostmann, AF, 1984)
"We evaluated the effects of intravenous verapamil, a calcium antagonist, on hemodynamics and regional left ventricular (LV) performance in patients with acute myocardial infarction (AMI)."9.05Effects of verapamil in patients with acute myocardial infarction: hemodynamics and function of normal and ischemic left ventricular myocardium. ( Heikkilä, J; Nieminen, MS, 1984)
"The reasons for starting a trial of verapamil in early intervention of acute myocardial infarction (AMI) are reviewed."9.05Verapamil in acute myocardial infarction. The Danish Multicentre Study Group. ( , 1982)
" The influences of training plus placebo and training plus verapamil have been studied in a double-blind randomized trial on 40 patients recovering from actue myocardial infarction."9.04Effects of training and of verapamil on exercise capacity in patients recovering from myocardial infarction. A double-blind study. ( Giordano, A; Minuco, G; Rossi, P; Schiavo, B; Tamiz, A, 1979)
"We found no evidence that adenosine and verapamil as treatments for no-reflow during PPCI can reduce all-cause mortality, non-fatal myocardial infarction or the incidence of angiographic no-reflow (TIMI flow grade < 3 and MBG 0 to1), but there was some evidence of increased adverse events."8.89Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction. ( Aung Naing, K; Li, L; Su, Q; Wu, T, 2013)
"Verapamil is well tolerated in patients with stable and unstable angina pectoris, as well as in patients with threatened infarction."8.80Verapamil in acute myocardial infarction. The rationales of the VAMI and DAVIT III trials. ( Jespersen, CM, 1999)
"Verapamil is well tolerated in patients with stable and unstable angina pectoris, as well as in patients with threatened infarction."8.80Verapamil in acute myocardial infarction. The rationales of the VAMI and DAVIT III trials. ( Jespersen, CM, 2000)
"The present review discusses the prognostic significance of post-infarction angina pectoris, and the significance of post-infarction intervention with verapamil on the prevalence of post-infarction ischaemia and prognosis."8.79Anti-ischaemic intervention with verapamil in patients recovering from acute myocardial infarction. ( Jespersen, CM, 1995)
"EFFECTS OF VERAPAMIL AND TRANDOLAPRIL: Progression of heart failure, sudden death and death from re-infarction are the major cause of the increased mortality in postinfarct patients with congestive heart failure."8.79Treatment with verapamil and trandolapril in patients with congestive heart failure and myocardial infarction. The Danish Verapamil Infarction Trial (DAVIT Study Group). ( Hagerup, L; Hansen, JF; Mellemgaard, K; Pedersen, F; Pedersen-Bjergaard, O; Sigurd, B, 1997)
"The present study evaluated the efficacy of intracoronary administration of verapamil to attenuate the no-reflow phenomenon following the primary percutaneous coronary intervention (PCI) in patients with the ST-segment elevation acute myocardial infarction (STEMI)."7.79Verapamil reverses myocardial no-reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction. ( Fu, Q; Huang, YJ; Jiang, SZ; Lu, W; Wang, HB; Wang, LG; Wang, YJ; Wu, Q, 2013)
"The effect of verapamil therapy in a dosage of 120 thrice daily on the mortality and re-infarction from the time of admission and for the subsequent six months was investigated in a double-blind, randomized, placebo-controlled, multicentre investigation (The Danish Verapamil Infarction Trial (DAVIT I))."7.77[Verapamil therapy improves the prognosis after acute myocardial infarction. A review over the Danish studies of verapamil therapy during and after acute myocardial infarction]. ( Hansen, JF, 1992)
" In this study, we evaluated the ability of HO-4038, an N-hydroxypiperidine derivative of verapamil, on the modulation of myocardial tissue oxygenation (Po(2)), I/R injury, and key signaling molecules involved in cardioprotection in an in vivo rat model of acute myocardial infarction (MI)."7.75Cardioprotection by HO-4038, a novel verapamil derivative, targeted against ischemia and reperfusion-mediated acute myocardial infarction. ( Bognar, B; Carnes, CA; Hideg, K; Kálai, T; Khan, M; Kuppusamy, P; Mohan, IK; Selvendiran, K; Sridhar, A; Wisel, S, 2009)
"5-Fluorouracil, a widely used drug in cancer treatment, is known to have cardiotoxic effects: chest pain with ECG changes, arrhythmias, arterial hypertension or hypotension, myocardial infarction, cardiogenic shock and sudden death have been described in the literature."7.72Management of patients with persistent chest pain and ST-segment elevation during 5-fluorouracil treatment: report about two cases. ( Alberti, A; Corrada, E; Ferrari, S; Mafrici, A; Marenna, B, 2003)
" This retrospective study investigates the efficacy of therapy with intracoronary verapamil to terminate reperfusion-induced ventricular tachyarrhythmias in patients with acute myocardial infarction (AMI)."7.72Intracoronary verapamil rapidly terminates reperfusion tachyarrhythmias in acute myocardial infarction. ( Dote, K; Habara, S; Hasegawa, D; Kato, M; Sasaki, S; Takemoto, H, 2004)
" Male Wistar rats with ligation-induced myocardial infarction were assigned to placebo or treatment with mibefradil (10 mg/kg/day), verapamil (8 mg/kg/day), or amlodipine (4 mg/kg/day) by oral gavage starting 7 days before the induction of myocardial infarction."7.70Differential effects of mibefradil, verapamil, and amlodipine on myocardial function and intracellular Ca(2+) handling in rats with chronic myocardial infarction. ( Meissner, A; Min, JY; Sandmann, S; Simon, R; Unger, T, 1999)
" VAMI is a multicentre, randomized double-blind, placebo-controlled study whose aim is to ascertain the potentiality of verapamil in limiting regional functional damage in patients with acute myocardial infarction and undergoing early thrombolysis."7.69[Myocardial viability in acute myocardial infarction and verapamil]. ( Iliceto, S; Rizzon, P, 1994)
"10 year follow up of all patients with confirmed acute myocardial infarction registered in the database of the Danish verapamil infarction trial in 1979-81."7.69Sex related differences in short and long-term prognosis after acute myocardial infarction: 10 year follow up of 3073 patients in database of first Danish Verapamil Infarction Trial. ( Galatius-Jensen, S; Hansen, JF; Launbjerg, J; Mortensen, LS, 1996)
"The aim of the present study was to investigate the antiarrhythmic potential of verapamil in the late myocardial infarction period in conscious dogs."7.68Efficacy of verapamil against ventricular arrhythmias induced by programmed electrical stimulation in the late myocardial infarction phase in dogs. ( Krejcy, K; Krumpl, G; Raberger, G; Todt, H, 1992)
"We compared the effects of verapamil to high dose procainamide on the rate of inducible and spontaneously occurring ventricular tachycardia (VT) in 10 patients."7.67Verapamil in ventricular tachycardia. ( Gotsman, MS; Hasin, Y; Kriwisky, M, 1984)
"In a patient with ischaemic heart disease chronic atrial flutter reverted to sinus rhythm during treatment with oral Verapamil, given at dosage of 240 mg once a day in order to prevent spontaneous angina."7.67Conversion of longstanding atrial flutter to sinus rhythm and transient complete A-V block following oral administration of verapamil. Report of a case. ( Di Giacomo, M; Di Giacomo, V; Tedeschi, A, 1984)
"Recently, this laboratory has demonstrated an enhanced susceptibility toward the development of lethal ventricular arrhythmias occurring in response to acute posterolateral ischemia in dogs with previous anterior myocardial infarction in the presence of therapeutic serum concentrations of digoxin."7.67Effect of digoxin on the extent of injury and the severity of arrhythmias during acute myocardial ischemia and infarction in the dog. ( Lucchesi, BR; Lynch, JJ, 1988)
"The effectiveness of verapamil in preventing ventricular fibrillation caused by coronary occlusion or reperfusion has been well demonstrated in animal studies, but these experimental data have not yet been confirmed in man."7.67[Efficacy of verapamil in the prevention of ventricular fibrillation in the acute phase of myocardial infarction]. ( Aurier, E; Bonatti, V; Botti, G; Favaro, L; Finardi, A; Rolli, A, 1988)
"We previously showed that combined treatment with allopurinol plus verapamil had a salutary effect on tissue necrosis during 24-h permanent coronary occlusion."7.67Influence of allopurinol plus verapamil treatment on myocardial tissue necrosis during permanent coronary occlusion in canine hearts with small infarcts. ( Denniss, AR; Kingma, JG; Yellon, DM, 1989)
"We tested the hypothesis that preservation of left ventricular function results from treatment with intravenous streptokinase given in the first 2 hours from onset of acute transmural myocardial infarction together with nitroglycerine and verapamil."7.67Myocardial salvage with streptokinase combined with nitroglycerine and verapamil in acute myocardial infarction. ( Goble, AJ; Horowitz, JD; Lee, KJ; McKay, WJ, 1988)
"In a 67-year-old man with multiple myocardial infarctions in the past, the use of oral verapamil for control of angina pectoris was followed by the appearance of two previously undiagnosed abnormalities, namely, a dual-pathway AV node conduction pattern, and paroxysms of AV nodal reentrant tachycardia precipitated by premature ventricular beats (PVB)."7.67Verapamil-mediated atrioventricular nodal reentrant tachycardia and the uncovering of dual-pathway AV nodal conduction. ( Massumi, RA; Udhoji, VN, 1988)
"The haemodynamic effects of the two calcium antagonists, tiapamil and verapamil, were compared in conscious rats with or without myocardial infarction."7.67Haemodynamic effects of tiapamil and verapamil in conscious rats following chronic myocardial infarction. ( Clozel, JP, 1988)
" A long-term, open clinical trial of verapamil therapy was conducted in ninety-three patients with coronary artery disease, selected on the basis of having stable angina pectoris and of being unsuitable for treatment with beta-adrenoceptor blocking drugs."7.66Verapamil in the long-term treatment of angina pectoris. ( Raftos, J, 1982)
"In 8 patients affected with acute myocardial infarction verapamil was highly effective in controlling ventricular extrasystoles."7.66Effects of verapamil in ventricular premature beats of acute myocardial infarction. ( Fazzini, PF; Marchi, F; Pucci, P, 1978)
"In 16 patients, a sustained supraventricular tachyarrhythmia occurring less than 72 hours after the first symptom of an acute myocardial infarction was treated with titrated doses of verapamil."7.66Verapamil in the management of supraventricular tachyarrhythmias occurring after a recent myocardial infarction. ( Hagemeijer, F, 1978)
"In 12 patients affected by acute myocardial infarction complicated only by ventricular extrasystoles, verapamil was highly effective in the control of the arrhythmias."7.65[The antiarrhythmic effects of verapamil in acute myocardial infarction. Considerations on the possible action mechanism (author's transl)]. ( Fazzini, PF; Marchi, F; Pucci, P, 1977)
"In the verapamil group ventricular arrhythmias increased from 25 to 33% (NS)."6.67Ventricular arrhythmias in patients recovering from myocardial infarction: do residual myocardial ischemia and anti-ischemic medical intervention influence the one-month prevalence? The Danish Study Group on Verapamil in Myocardial Infarction. ( Jespersen, CM; Vaage-Nilsen, M, 1993)
"In patients treated for heart failure during the acute phase of myocardial infarction, the lowest 18-month event rate was seen in the verapamil group (21."6.67The effect of verapamil on major events in patients with impaired cardiac function recovering from acute myocardial infarction. The Danish Study Group on Verapamil in Myocardial Infarction. ( Jespersen, CM, 1993)
"Verapamil was administered at the dose of 50 mg in continuous drip."6.65[Behaviour of serum CPK curves in acute myocardial infarction treated with digitalis, verapamil and combined verapamil-digitalis (author's transl)]. ( Allegri, P; Cappelletti, F; Comacchio, G; De Lio, U; Maiolino, P; Morlino, T; Ometto, R; Vincenzi, M; Zanchetta, M, 1981)
"Adenosine as treatment for no-reflow during PPCI could reduce angiographic no-reflow (TIMI flow grade < 3) but was found to increase adverse events."6.52Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction. ( Li, L; Nyi, TS; Su, Q, 2015)
"The effect of Ca-antagonist, long-acting verapamil and the selective beta-1 blocking bisoprolol were investigated and compared in the secondary prevention after myocardial infarction."6.18[Comparative study of verapamil and bisoprolol in the secondary prevention of myocardial infarction]. ( Bogár, L; Czopf, L; Debreceni, G; Habon, T; Kónyi, A; Mühl, D; Sárosi, I; Schmidt, E; Tekeres, M; Tóth, K; Zámbó, K, 1997)
"CLINICAL TRIALS WITH VERAPAMIL AND TRANDOLAPRIL: In the Danish Verapamil Infarction Trial II, verapamil improved survival in patients without heart failure but had no effect in patients with heart failure who were receiving diuretic treatment."6.18Congestive heart failure and ischaemic heart disease treated with trandolapril and verapamil. DAVIT Study Group. Danish Verapamil Infarction Trial. ( Hansen, JF, 1998)
"An overview of the published studies on the use of verapamil during and after an acute myocardial infarction is presented."6.17Review of postinfarct treatment with verapamil: combined experience of early and late intervention studies with verapamil in patients with acute myocardial infarction. Danish Study Group on Verapamil in Myocardial Infarction. ( Hansen, JF, 1994)
"The effect of verapamil on death and reinfarction after an acute myocardial infarction was studied in two double-blind, randomized, placebo-controlled multicenter trials, the Danish Verapamil Infarction Trials I and II (DAVIT I and II)."6.16Treatment with verapamil during and after an acute myocardial infarction: a review based on the Danish Verapamil Infarction Trials I and II. The Danish Study Group on Verapamil in Myocardial Infarction. ( Hansen, JF, 1991)
"Nine randomized trials in patients with acute myocardial infarction have been performed to assess the effect of nifedipine on infarct size, reinfarction and/or survival."6.16Review of calcium antagonist trials in acute myocardial infarction. ( Roberts, R, 1989)
"Verapamil-sensitive fascicular ventricular tachycardia (VT) of right bundle branch block (RBBB) and superior axis pattern is typically seen in young patients with structurally normal hearts and considered "idiopathic"."5.35Verapamil-sensitive left posterior fascicular ventricular tachycardia after myocardial infarction. ( Hart, D; Kantharia, BK; Liu, Z; Mehta, R; Nagra, B, 2008)
"Myocardial infarction is usually induced in small animals by means of invasive procedures: the aim of this study was to cause heart necrosis lesions by non-invasive means."5.32Myocardial infarction non-invasively induced in rabbits by administering isoproterenol and vasopressin: protective effects exerted by verapamil. ( Bertolini, B; Bonacina, E; Brenna, S; Pinelli, A; Tomasoni, L; Trivulzio, S; Vignati, S, 2004)
" Long-term use of verapamil has contributed to better control of clinical symptomatology."5.28Prinzmetal angina. Multifocal ischemia, recurrent AV block, and bradycardia with patent coronary arteries responsive to verapamil. ( Haywood, LJ; Venkataramen, K, 1991)
"Pretreatment with verapamil reduced the size of these subendocardial infarcts from 34 +/- 8 to 8 +/- 3% of the ischemic circumflex vascular bed at risk (identified by postmortem perfusion of the previously occluded and unoccluded arteries with different dyes)."5.27Verapamil in two reperfusion models of myocardial infarction. Temporary protection of severely ischemic myocardium without limitation of ultimate infarct size. ( Jennings, RB; Reimer, KA, 1984)
"This arrhythmia, similar to the more common uniform AIVR, was intermittent, did not cause hemodynamic compromise, and was not related to more serious ventricular arrhythmias."5.27Multiform accelerated idioventricular rhythm in acute myocardial infarction: electrocardiographic characteristics and response to verapamil. ( Agmon, J; Arditi, A; Fuchs, J; Klainman, E; Kracoff, OH; Lewin, RF; Sclarovsky, S; Strasberg, B, 1983)
"Verapamil is an effective and relatively-safe antihypertensive drug."5.27Verapamil withdrawal as a possible cause of myocardial infarction in a hypertensive woman with a normal coronary angiogram. ( Beilin, LJ; Dimmitt, SB; Hockings, BE, 1988)
" Nicardipine given by three different dosing schedules to baboons markedly limited myocardial infarction over a 6 h period of LAD occlusion."5.27Nicardipine in models of myocardial infarction. ( Alps, BJ; Calder, C; Wilson, A, 1985)
"The arrhythmias were prevented by higher doses of the calcium antagonist verapamil which, however, decreased the survival times."5.26Comparative investigation of the effects of metoprolol, propranolol, practolol, and verapamil in the acute phase of experimental myocardial infarction. ( Bernauer, W, 1982)
"Verapamil was given at the dose of 0."5.26[Treatment of acute myocardial infarction with verapamil. Hemodynamic effects and electrical changes studied by body surface maps (author's transl)]. ( Bonatti, V; Botti, G; Favaro, L; Musso, E; Rolli, A; Taccardi, B, 1981)
" Group III animals were given verapamil orally in the dosage of 4 mg/kg, three times a day, 10 days before coronary ligation."5.26Experimental myocardial infarction in rhesus monkeys. Verapamil pretreatment in the reduction of infarct size. ( Anand, IS; Chakravarti, RN; Sharma, PL; Wahi, PL, 1980)
"Reentrant ventricular arrhythmias (RVA) were analyzed in dogs 3--7 days after ligation of the anterior descending coronary artery using averaged "composite" recordings of electrical activity of reentrant pathways (RP) from the epicardial surface of the infarction zone (IZ)."5.26Reentrant ventricular arrhythmias in the late myocardial infarction period. 7. Effect of verapamil and D-600 and the role of the "slow channel". ( El-Sherif, N; Lazzara, R, 1979)
"We aimed to investigate the effects of verapamil and adenosine in an adjunct to intravenous tirofiban on management and prognosis of no-reflow phenomenon during primary percutaneous coronary intervention (PPCI) and to compare their efficacies on reversing of no-reflow phenomenon and short and midterm survival."5.19Effects of verapamil and adenosine in an adjunct to tirofiban on resolution and prognosis of noreflow phenomenon in patients with acute myocardial infarction. ( Arif Yalcin, A; Biyik, I; Celik, O; Erturk, M; Faruk Akturk, I; Murat Caglar, I; Oner, E; Sarikamis, C; Turhan Caglar, N; Uzun, F, 2014)
"Intracoronary infusion of diltiazem or verapamil can reverse no-reflow more effectively than nitroglycerin during primary PCI for acute myocardial infarction."5.16REstoration of COronary flow in patients with no-reflow after primary coronary interVEntion of acute myocaRdial infarction (RECOVER). ( Dong, L; Ge, J; Ge, L; Huang, D; Jin, H; Jin, X; Liu, Z; Ma, J; Qian, J; Wang, X; Yao, K; Zhang, F, 2012)
"In INternational VErapamil-trandolapril STudy, 22,576 CAD patients with hypertension (mean age 66 years) were randomized to verapamil-SR or atenolol-based strategies and followed for 2."5.14Pulse pressure and risk of cardiovascular outcomes in patients with hypertension and coronary artery disease: an INternational VErapamil SR-trandolapril STudy (INVEST) analysis. ( Bangalore, S; Champion, A; Franklin, SS; Mancia, G; Messerli, FH; Pepine, CJ, 2009)
"No previous study has assessed the possible role of dipyridamole for treatment of no-reflow during acute myocardial infarction (AMI)."5.14Dipyridamole versus verapamil for treatment of no-reflow during primary angioplasty. ( Arrivi, A; Greco, C; Mangieri, E; Pasceri, V; Pelliccia, F; Placanica, A; Tanzilli, G, 2010)
"In hypertensive patients with prior MI, a verapamil-SR-based strategy was equivalent to a beta-blocker-based strategy for blood pressure control and prevention of cardiovascular events, with greater subjective feeling of well-being and a trend toward lower incidence of angina pectoris and stroke in the verapamil-SR-based group."5.13Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy. ( Bacher, PH; Bangalore, S; Champion, A; Cohen, JD; Kowey, P; Mancia, G; Messerli, FH; Pepine, CJ; Sleight, P; Zhou, Q, 2008)
"To study the impact of injection of verapamil and adenosine in the coronary arteries on TIMI (Thrombolysis in Myocardial Infarction) frame count (TFC) after percutaneous coronary intervention (PCI) in patients with an acute coronary syndrome (ACS)."5.12Prospective, randomised, controlled trial to study the effect of intracoronary injection of verapamil and adenosine on coronary blood flow during percutaneous coronary intervention in patients with acute coronary syndromes. ( de Belder, MA; Graham, J; Hall, JA; Kunadian, B; Sutton, A; Vijayalakshmi, K; Whittaker, VJ; Wright, RA, 2006)
"Intracoronary verapamil restored myocardial perfusion in patients with angiographic no-reflow after PCI and lead to better functional recovery after acute myocardial infarction."5.12The effect of verapamil on the restoration of myocardial perfusion and functional recovery in patients with angiographic no-reflow after primary percutaneous coronary intervention. ( Baden, M; Fujitaka, K; Iwasaka, T; Nakamura, S; Sugiura, T; Tsuka, Y; Umemura, S; Yoshida, S, 2006)
"The effect of nonsteroid anti-inflammatory drugs (NSAIDs) after acute myocardial infarction was studied in a retrospective study of 88 patients who were receiving regular NSAID treatment at randomization in the Danish Verapamil Infarction Trial II."5.09Nonsteroidal anti-inflammatory drugs after acute myocardial infarction. DAVIT Study Group. Danish Verapamil Infarction Trial. ( Hansen, JF; Mortensen, LS; Sajadieh, A; Wendelboe, O, 1999)
"The VISOR is a double blind, randomized, placebo-controlled study aimed to assess the effects of early and prolonged administration of verapamil on the left ventricular geometry and diastolic function in patients with anterior acute myocardial infarction treated with thrombolysis."5.09The effect of verapamil on left ventricular remodelling and diastolic function after acute myocardial infarction (the Verapamil Infarction Study on Remodelling and Relaxation--VISOR). ( Carelli, M; Celli, P; Di Marcotullio, G; Malinconico, U; Milazzotto, F; Natale, E; Polizzi, CA; Tubaro, M; Vajola, SF, 1999)
"The administration of verapamil during the reperfusion phase of acute myocardial infarction can reduce the extent and severity of microvessel damage and limit myocardial dysfunction."5.09Early administration of verapamil after thrombolysis in acute anterior myocardial infarction. Effect on left ventricular remodeling and clinical outcome. VAMI Study Group. Verapamil Acute Myocardial Infarction. ( Biasco, MG; Boni, L; Brigiani, MS; Iliceto, S; Marangelli, V; Memmola, C; Rizzon, P; Scrutinio, D, 2000)
"The main objective of this retrospective analysis was to evaluate the long-term effect of the heart rate-lowering calcium antagonists verapamil and diltiazem on the incidence of combined cardiac events and all-cause mortality in patients who had experienced a non-Q-wave acute myocardial infarction (AMI), but who did not also have pulmonary congestion."5.09Long-term effects of diltiazem and verapamil on mortality and cardiac events in non-Q-wave acute myocardial infarction without pulmonary congestion: post hoc subset analysis of the multicenter diltiazem postinfarction trial and the second danish verapamil ( Boden, WE; Gibson, RS; Hansen, JF; Messerli, F; Schechtman, KB, 2000)
"In the Angina Prognosis Study in Stockholm (APSIS), 809 patients with stable angina pectoris were studied prospectively during double-blind treatment with verapamil or metoprolol."5.09Prognostic implications of intima-media thickness and plaques in the carotid and femoral arteries in patients with stable angina pectoris. ( Björkander, I; Eriksson, SV; Forslund, L; Held, C; Hjemdahl, P; Rehnqvist, N, 2001)
"The ten-year mortality in patients with suspected myocardial infarction with (AMI) and without (non-AMI) confirmed diagnosis was evaluated in 1897 non-AMI patients and 1401 AMI patients who were consecutively admitted to hospital during The Danish Verapamil Infarction Study."5.08[10-year mortality of patients admitted to coronary units with or without confirmed diagnosis of myocardial infarction. A relation to anamnesis and diagnosis at discharge]. ( Fruergaard, P; Hansen, JF; Launbjerg, J; Madsen, JK; Mortensen, LS, 1995)
"The Danish Verapamil Infarction Trial II (DAVIT II) demonstrated from the second postinfarction week, that long term treatment with verapamil significantly improved reinfarction free survival after an acute myocardial infarction (AMI)."5.08Effect of verapamil on the prognosis of patients with early postinfarction electrical or mechanical complications. The Danish Verapamil Infarction Trial II (DAVIT II). ( Hagerup, L; Hansen, JF; Mellemgaard, K; Sigurd, B; Steinmetz, E; Vaage-Nilsen, M, 1995)
"A multicenter, double-blind, randomized, placebo-controlled trial was conducted to assess the effects of verapamil on total mortality, cardiac mortality, reinfarction, and angina after an acute myocardial infarction."5.08A controlled trial of verapamil in patients after acute myocardial infarction: results of the calcium antagonist reinfarction Italian study (CRIS) ( Acanfora, D; Bernabei, R; Carbonin, P; Carosella, L; DeCaprio, L; Ferrara, N; Pahor, M; Parlati, S; Rengo, F; Vitale, D, 1996)
", death, repeat infarction, unstable angina pectoris, or repeat admission because of heart failure) was 14% in patients treated with verapamil and trandolapril and 35% in patients treated with trandolapril (p = 0."5.08Treatment with verapamil and trandolapril in patients with congestive heart failure and angina pectoris or myocardial infarction. The DAVIT Study Group. Danish Verapamil Infarction Trial. ( Bjergaard, OP; Hagerup, L; Hansen, JF; Mellemgaard, K; Pedersen, F; Sigurd, B, 1997)
"We assessed the acute effect of intracoronary injection of verapamil on microvascular function after primary percutaneous translumanal coronary angioplasty (PTCA) for acute myocardial infarction (AMI) with myocardial contrast echocardiography (MCE) in relation to functional outcomes."5.08Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction. ( Fujii, K; Higashino, Y; Hori, M; Ito, H; Iwakura, K; Masuyama, T; Minamino, T; Nishikawa, N; Takiuchi, S; Taniyama, Y, 1997)
"Because decreased heart rate variability measured after an acute myocardial infarction (AMI) has been demonstrated to predict subsequent mortality and sudden death, and an efficacy analysis of the Danish Verapamil Infarction Trial II (DAVIT II) demonstrated that long-term postinfarction treatment with verapamil significantly reduced sudden death, the aim of the present substudy was to evaluate the effect of verapamil on heart-rate variability in the time and frequency domain, measured in two 5-minute segments during the day and night."5.08Effect of verapamil on heart rate variability after an acute myocardial infarction. Danish Verapamil Infarction Trial II. ( Rasmussen, V; Vaage-Nilsen, M, 1998)
"The purpose of this study was to compare the effects of verapamil on early versus late reinfarction after an index myocardial infarction."5.08Temporal pattern of the effect of verapamil on myocardial reinfarction. DAVIT Study Group. Danish Verapamil Infarction Trial. ( Hansen, JF; Mortensen, LS; Sajadieh, A, 1998)
"The prognostic significance of angina pectoris and the effect of intervention with verapamil on the incidence of angina pectoris were studied in patients recovering from myocardial infarction and included in the Danish Verapamil Infarction Trial II."5.07The prognostic significance of post-infarction angina pectoris and the effect of verapamil on the incidence of angina pectoris and prognosis. The Danish Study Group on Verapamil in Myocardial Infarction. ( Hansen, JF; Jespersen, CM; Mortensen, LS, 1994)
"DAVIT-II is a double-blind, randomized, multicentre, placebo-controlled study of long-term treatment with verapamil 360 mg per day administered to patients who have suffered an acute myocardial infarction (AMI)."5.07Prevalence of transient myocardial ischaemia during the first year after a myocardial infarction. Effect of treatment with verapamil. The Danish Study Group on Verapamil in Myocardial Infarction. ( Hansen, JF; Holländer, NH; Rasmussen, V; Vaage-Nilsen, M, 1992)
"This article is a review of presented subsets of the Danish Verapamil Infarction Trial II (DAVIT II) regarding the effect of verapamil on postinfarction ischemia, ventricular arrhythmias, and heart rate (HR), and the prognostic implications of these findings."5.07Effect of verapamil on ischemia and ventricular arrhythmias after an acute myocardial infarction: prognostic implications. The Danish Verapamil Infarction Trial II Study Group. ( Bjergaard, OP; Hagerup, L; Hansen, JF; Holländer, NH; Mellemgaard, K; Nielsen, I; Rasmussen, V; Sigurd, B; Sørensen, MB; Vaage-Nilsen, M, 1991)
"The effect of verapamil on death and reinfarction in patients with and without exercise-induced myocardial ischemia after acute myocardial infarction was studied in a double-blind, placebo-controlled multicenter study."5.07The effect of verapamil on major events in patients with exercise-induced ischemia recovering from acute myocardial infarction: a review. The Danish Study Group on Verapamil in Myocardial Infarction. ( Jespersen, CM, 1991)
"In a double-blind, randomized, placebo-controlled study comparing verapamil and placebo in late secondary intervention after acute myocardial infarction, the physicians were asked to try to identify the treatment in 100 consecutive patients."5.06Assessment of blindness in the Danish Verapamil Infarction Trial II (DAVIT II). Danish Study Group on Verapamil in Myocardial Infarction. ( Jespersen, CM, 1990)
"This review critically evaluates the recently reported clinical trials involving the administration of nifedipine and verapamil after myocardial infarction and highlights the ongoing trials with diltiazem."5.06Current status of calcium channel blocking drugs after myocardial infarction. ( Moss, AJ, 1986)
"Fasting levels of serum lipids and lipoproteins were measured in survivors of acute myocardial infarction after 6 months of treatment with placebo (n = 19) or verapamil 360 mg daily (n = 13)."5.05Serum lipoproteins after treatment with verapamil for 6 months. ( Faergeman, O; Hansen, JF; Meinertz, H, 1984)
"In 12 male patients with angiographically confirmed coronary heart disease and stable angina the antianginal effects of 50 mg Gallopamil have been studied in comparison with 10 mg Nifedipine and placebo."5.05[Anti-angina effect of gallopamil in comparison with another calcium antagonist and a placebo]. ( Drews, H; Hopf, R; Kaltenbach, M, 1984)
"In a prospective, controlled study, 29 patients were randomly allocated to receive intravenous verapamil, 5 to 10 mg/hour, for 2 days starting at a mean of 8 hours after the onset of myocardial infarction."5.05Reduction of creatine kinase and creatine kinase-MB indexes of infarct size by intravenous verapamil. ( Bussmann, WD; Gruengras, M; Seher, W, 1984)
"Verapamil was administered to 35 patients with acute myocardial infarction during the first 12 h of the disease."5.05[Effect of isoptin (verapamil) on the indicators of central hemodynamics in patients with acute myocardial infarction]. ( Avaliani, ShG; Gratsianskiĭ, NA; Karpov, IuA; Ruda, MIa, 1984)
" verapamil, 5-10 mg/h for two days, at a mean of eight hours after onset of myocardial infarction."5.05[Reduction in CK- and CKMB-measured infarct size by verapamil]. ( Bussmann, WD; Grüngras, M; Seher, W, 1983)
"The effect of verapamil on plasma lipids and lipoproteins was studied in 64 patients taking part in a double blind controlled trial of verapamil versus placebo in post myocardial infarction."5.05Variation of serum lipoproteins in postmyocardial infarction patients treated with verapamil or placebo. ( Engby, B; Schmidt, E; Strunge, P; Trostmann, AF, 1984)
"We evaluated the effects of intravenous verapamil, a calcium antagonist, on hemodynamics and regional left ventricular (LV) performance in patients with acute myocardial infarction (AMI)."5.05Effects of verapamil in patients with acute myocardial infarction: hemodynamics and function of normal and ischemic left ventricular myocardium. ( Heikkilä, J; Nieminen, MS, 1984)
"The reasons for starting a trial of verapamil in early intervention of acute myocardial infarction (AMI) are reviewed."5.05Verapamil in acute myocardial infarction. The Danish Multicentre Study Group. ( , 1982)
"Because verapamil is effective in the treatment of "preinfarction" angina, a single-blind, placebo-controlled trial was performed in 17 patients admitted to the coronary care unit with transmural acute myocardial infarction (AMI) to assess the effects of verapamil on angina and reinfarction after AMI."5.05Effects of verapamil in preventing early postinfarction angina and reinfarction. ( Crea, F; Crean, P; Davies, G; Deanfield, J; Maseri, A; Sharom, M, 1985)
" The influences of training plus placebo and training plus verapamil have been studied in a double-blind randomized trial on 40 patients recovering from actue myocardial infarction."5.04Effects of training and of verapamil on exercise capacity in patients recovering from myocardial infarction. A double-blind study. ( Giordano, A; Minuco, G; Rossi, P; Schiavo, B; Tamiz, A, 1979)
"We found no evidence that adenosine and verapamil as treatments for no-reflow during PPCI can reduce all-cause mortality, non-fatal myocardial infarction or the incidence of angiographic no-reflow (TIMI flow grade < 3 and MBG 0 to1), but there was some evidence of increased adverse events."4.89Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction. ( Aung Naing, K; Li, L; Su, Q; Wu, T, 2013)
" In comparative trials in the management of hypertension, trandolapril 1 to 4 mg/d was statistically indistinguishable from or superior to captopril 100 mg/d, enalapril 10 or 20 mg/d, hydrochlorothiazide (HCTZ) 25 mg/d, nifedipine ER 30 or 40 mg/d, nitrendipine 20 mg/d, perindopril 4 mg/d, and verapamil ER 120 to 240 mg/d."4.82Trandolapril: a newer angiotensin-converting enzyme inhibitor. ( Guay, DR, 2003)
"From three large, randomized, placebo-controlled, secondary prevention trials investigating verapamil or diltiazem (the first and second Danish Verapamil Infarction Trials and the Multicentre Diltiazem Post-Infarction Trial) data from a total of 1,325 hypertensive post-myocardial infarction patients (drugs = 667, placebo = 658) were pooled to assess effect of blinded therapy on mortality and event rates."4.81Heart rate-lowering calcium antagonists in hypertensive post-myocardial infarction patients. ( Boden, WE; Gibson, RS; Hansen, JF; Messerli, FH; Schechtman, KB, 2001)
"Based on over 4,000 person-years of observation, patients with acute myocardial infarction (MI) treated with verapamil had a decreased risk of nonfatal reinfarction compared with placebo (relative risk 0."4.80Verapamil use in patients with cardiovascular disease: an overview of randomized trials. ( Faich, G; Makuch, R; Pepine, CJ, 1998)
"Verapamil is well tolerated in patients with stable and unstable angina pectoris, as well as in patients with threatened infarction."4.80Verapamil in acute myocardial infarction. The rationales of the VAMI and DAVIT III trials. ( Jespersen, CM, 1999)
"Verapamil is well tolerated in patients with stable and unstable angina pectoris, as well as in patients with threatened infarction."4.80Verapamil in acute myocardial infarction. The rationales of the VAMI and DAVIT III trials. ( Jespersen, CM, 2000)
"The present review discusses the prognostic significance of post-infarction angina pectoris, and the significance of post-infarction intervention with verapamil on the prevalence of post-infarction ischaemia and prognosis."4.79Anti-ischaemic intervention with verapamil in patients recovering from acute myocardial infarction. ( Jespersen, CM, 1995)
"EFFECTS OF VERAPAMIL AND TRANDOLAPRIL: Progression of heart failure, sudden death and death from re-infarction are the major cause of the increased mortality in postinfarct patients with congestive heart failure."4.79Treatment with verapamil and trandolapril in patients with congestive heart failure and myocardial infarction. The Danish Verapamil Infarction Trial (DAVIT Study Group). ( Hagerup, L; Hansen, JF; Mellemgaard, K; Pedersen, F; Pedersen-Bjergaard, O; Sigurd, B, 1997)
" Although nifedipine is highly effective against vasospastic angina, its use in threatened myocardial infarction or severe unstable angina is not supported by recent studies, unless combined with a beta-blocker."4.77Calcium channel antagonists. Part II: Use and comparative properties of the three prototypical calcium antagonists in ischemic heart disease, including recommendations based on an analysis of 41 trials. ( Opie, LH, 1988)
"The present study evaluated the efficacy of intracoronary administration of verapamil to attenuate the no-reflow phenomenon following the primary percutaneous coronary intervention (PCI) in patients with the ST-segment elevation acute myocardial infarction (STEMI)."3.79Verapamil reverses myocardial no-reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction. ( Fu, Q; Huang, YJ; Jiang, SZ; Lu, W; Wang, HB; Wang, LG; Wang, YJ; Wu, Q, 2013)
"This was a post hoc analysis from the INternational VErapamil Trandolapril STudy (INVEST), which enrolled patients with hypertension and coronary artery disease."3.77Harmful effects of NSAIDs among patients with hypertension and coronary artery disease. ( Bavry, AA; Cooper-Dehoff, RM; Gong, Y; Handberg, EM; Khaliq, A; Pepine, CJ, 2011)
"The effect of verapamil therapy in a dosage of 120 thrice daily on the mortality and re-infarction from the time of admission and for the subsequent six months was investigated in a double-blind, randomized, placebo-controlled, multicentre investigation (The Danish Verapamil Infarction Trial (DAVIT I))."3.77[Verapamil therapy improves the prognosis after acute myocardial infarction. A review over the Danish studies of verapamil therapy during and after acute myocardial infarction]. ( Hansen, JF, 1992)
" In this study, we evaluated the ability of HO-4038, an N-hydroxypiperidine derivative of verapamil, on the modulation of myocardial tissue oxygenation (Po(2)), I/R injury, and key signaling molecules involved in cardioprotection in an in vivo rat model of acute myocardial infarction (MI)."3.75Cardioprotection by HO-4038, a novel verapamil derivative, targeted against ischemia and reperfusion-mediated acute myocardial infarction. ( Bognar, B; Carnes, CA; Hideg, K; Kálai, T; Khan, M; Kuppusamy, P; Mohan, IK; Selvendiran, K; Sridhar, A; Wisel, S, 2009)
"The incidence of perioperative myocardial events (defined as either low cardiac output syndrome or perioperative myocardial infarction) was significantly reduced in the phenoxybenzamine group (6."3.74Radial artery graft treatment with phenoxybenzamine is clinically safe and may reduce perioperative myocardial injury. ( Bourke, ME; Gunning, D; Kulik, A; Mesana, TG; Rubens, FD; Ruel, M, 2007)
"Inhibition of the multifunctional Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) or depletion of sarcoplasmic reticulum (SR) Ca(2+) stores protects against apoptosis from excessive isoproterenol (Iso) stimulation in cultured ventricular myocytes, suggesting that CaMKII inhibition could be a novel approach to reducing cell death in conditions of increased adrenergic tone, such as myocardial infarction (MI), in vivo."3.73Calmodulin kinase II inhibition protects against myocardial cell apoptosis in vivo. ( Anderson, ME; Eren, M; Gleaves, L; Hou, Y; Joiner, ML; Ni, G; Oddis, CV; Price, EE; Vaughan, DE; Xiao, RP; Yang, J; Yang, Y; Zhang, R; Zhu, WZ, 2006)
"5-Fluorouracil, a widely used drug in cancer treatment, is known to have cardiotoxic effects: chest pain with ECG changes, arrhythmias, arterial hypertension or hypotension, myocardial infarction, cardiogenic shock and sudden death have been described in the literature."3.72Management of patients with persistent chest pain and ST-segment elevation during 5-fluorouracil treatment: report about two cases. ( Alberti, A; Corrada, E; Ferrari, S; Mafrici, A; Marenna, B, 2003)
"Verapamil and amlodipine produced a potent antiischemic effect and reduced the area of myocardial infarction in rats."3.72Oxygen-dependent mechanisms underlying the antiischemic effect of verapamil and amlodipine. ( Gatsura, SV, 2004)
" This retrospective study investigates the efficacy of therapy with intracoronary verapamil to terminate reperfusion-induced ventricular tachyarrhythmias in patients with acute myocardial infarction (AMI)."3.72Intracoronary verapamil rapidly terminates reperfusion tachyarrhythmias in acute myocardial infarction. ( Dote, K; Habara, S; Hasegawa, D; Kato, M; Sasaki, S; Takemoto, H, 2004)
"Calcium channel blockers were widely prescribed at hospital discharge to elderly patients with myocardial infarction between 1994 and 1995 (n = 51,921), the most commonly prescribed being diltiazem (n = 21,175), nifedipine (n = 12,670), amlodipine (n = 11,683), and verapamil (n = 3639)."3.70Calcium channel blockers and mortality in elderly patients with myocardial infarction. ( Cascio, WE; Chowdhury, MK; Crouse, JR; Jollis, JG; Massing, MW; Simpson, RJ; Smith, SC, 1999)
" Male Wistar rats with ligation-induced myocardial infarction were assigned to placebo or treatment with mibefradil (10 mg/kg/day), verapamil (8 mg/kg/day), or amlodipine (4 mg/kg/day) by oral gavage starting 7 days before the induction of myocardial infarction."3.70Differential effects of mibefradil, verapamil, and amlodipine on myocardial function and intracellular Ca(2+) handling in rats with chronic myocardial infarction. ( Meissner, A; Min, JY; Sandmann, S; Simon, R; Unger, T, 1999)
" VAMI is a multicentre, randomized double-blind, placebo-controlled study whose aim is to ascertain the potentiality of verapamil in limiting regional functional damage in patients with acute myocardial infarction and undergoing early thrombolysis."3.69[Myocardial viability in acute myocardial infarction and verapamil]. ( Iliceto, S; Rizzon, P, 1994)
"10 year follow up of all patients with confirmed acute myocardial infarction registered in the database of the Danish verapamil infarction trial in 1979-81."3.69Sex related differences in short and long-term prognosis after acute myocardial infarction: 10 year follow up of 3073 patients in database of first Danish Verapamil Infarction Trial. ( Galatius-Jensen, S; Hansen, JF; Launbjerg, J; Mortensen, LS, 1996)
"The aim of the present study was to investigate the antiarrhythmic potential of verapamil in the late myocardial infarction period in conscious dogs."3.68Efficacy of verapamil against ventricular arrhythmias induced by programmed electrical stimulation in the late myocardial infarction phase in dogs. ( Krejcy, K; Krumpl, G; Raberger, G; Todt, H, 1992)
" The effects of Ro 40-5967 on the susceptibility to ventricular fibrillation were investigated and compared to diltiazem."3.68Ro 40-5967, a novel calcium channel antagonist, protects against ventricular fibrillation. ( Billman, GE, 1992)
"The experiments with models of myocardial infarction established that carnitine chloride reduced the size of an ischemic zone, prevented oxidative metabolism, lowered ATP and creatine phosphate levels, inhibited lactate and free fatty acid accumulation in the ischemic myocardium."3.68[Study of anti-ischemic action of carnitine chloride and its effects on the effectiveness of antianginal agents]. ( Danilovich, MI; Dunaev, VV; Favoritov, VN; Kacharava, VG; Kryzhanovskiĭ, SA; Riabinin, VA; Tishkin, VS, 1990)
"Following multiple myocardial infarctions, a patient was treated with the calcium channel-blocking agent nifedipine."3.67Development of immune complex nephritis during treatment with the calcium channel-blocking agent nifedipine. ( Hall-Craggs, M; Light, PD; Peters, RW, 1984)
"We compared the effects of verapamil to high dose procainamide on the rate of inducible and spontaneously occurring ventricular tachycardia (VT) in 10 patients."3.67Verapamil in ventricular tachycardia. ( Gotsman, MS; Hasin, Y; Kriwisky, M, 1984)
"The ability of the two calcium-antagonists Verapamil and Nifedipine to reduce ventricular electrical instability following acute transient coronary artery occlusion and release and to prevent ventricular arrhythmias, particularly fibrillation, was evaluated on a total of 25 anaesthetized and artificially ventilated dogs."3.67[Comparative studies on the anti-arrhythmic and anti-fibrillatory effectiveness of verapamil and nifedipine following acute coronary artery occlusion and reperfusion]. ( Bender, F; Brisse, B; Gülker, H; Thale, J, 1984)
"In a patient with ischaemic heart disease chronic atrial flutter reverted to sinus rhythm during treatment with oral Verapamil, given at dosage of 240 mg once a day in order to prevent spontaneous angina."3.67Conversion of longstanding atrial flutter to sinus rhythm and transient complete A-V block following oral administration of verapamil. Report of a case. ( Di Giacomo, M; Di Giacomo, V; Tedeschi, A, 1984)
"Recently, this laboratory has demonstrated an enhanced susceptibility toward the development of lethal ventricular arrhythmias occurring in response to acute posterolateral ischemia in dogs with previous anterior myocardial infarction in the presence of therapeutic serum concentrations of digoxin."3.67Effect of digoxin on the extent of injury and the severity of arrhythmias during acute myocardial ischemia and infarction in the dog. ( Lucchesi, BR; Lynch, JJ, 1988)
"The effectiveness of verapamil in preventing ventricular fibrillation caused by coronary occlusion or reperfusion has been well demonstrated in animal studies, but these experimental data have not yet been confirmed in man."3.67[Efficacy of verapamil in the prevention of ventricular fibrillation in the acute phase of myocardial infarction]. ( Aurier, E; Bonatti, V; Botti, G; Favaro, L; Finardi, A; Rolli, A, 1988)
"We previously showed that combined treatment with allopurinol plus verapamil had a salutary effect on tissue necrosis during 24-h permanent coronary occlusion."3.67Influence of allopurinol plus verapamil treatment on myocardial tissue necrosis during permanent coronary occlusion in canine hearts with small infarcts. ( Denniss, AR; Kingma, JG; Yellon, DM, 1989)
"We tested the hypothesis that preservation of left ventricular function results from treatment with intravenous streptokinase given in the first 2 hours from onset of acute transmural myocardial infarction together with nitroglycerine and verapamil."3.67Myocardial salvage with streptokinase combined with nitroglycerine and verapamil in acute myocardial infarction. ( Goble, AJ; Horowitz, JD; Lee, KJ; McKay, WJ, 1988)
" The effects of the calcium blockers bepridil and verapamil on latency time to ventricular fibrillation (VF) and VF incidence were assessed in 109 anesthetized dogs, submitted to coronary occlusion and reperfusion."3.67Effects of calcium blockers on ventricular fibrillation during acute myocardial infarction. ( Da-Luz, PL; Da-Silveira, MC; Murad-Neto, A; Pileggi, F, 1988)
"In a 67-year-old man with multiple myocardial infarctions in the past, the use of oral verapamil for control of angina pectoris was followed by the appearance of two previously undiagnosed abnormalities, namely, a dual-pathway AV node conduction pattern, and paroxysms of AV nodal reentrant tachycardia precipitated by premature ventricular beats (PVB)."3.67Verapamil-mediated atrioventricular nodal reentrant tachycardia and the uncovering of dual-pathway AV nodal conduction. ( Massumi, RA; Udhoji, VN, 1988)
"The haemodynamic effects of the two calcium antagonists, tiapamil and verapamil, were compared in conscious rats with or without myocardial infarction."3.67Haemodynamic effects of tiapamil and verapamil in conscious rats following chronic myocardial infarction. ( Clozel, JP, 1988)
"The effect of an antioxidant dibunol and calcium antagonist verapamil on postperfusion release of myoglobin (Mb) and MB-creatine kinase (MB-CK) has been assessed in 30 dogs with experimental coronary occlusive myocardial infarction."3.67[Effect of dibunol and isoptin on the creatine kinase and myoglobin content of the blood serum in dogs undergoing postischemic coronary reperfusion]. ( Avilova, OA; Berestov, AA; Golikov, AP; Konorev, EA; Polumiskov, VIu, 1987)
"The effect of intracoronary streptokinase administration (31 patients), verapamil treatment (23 patients) and conventional therapy (27 patients) on the size of the affected area was examined in patients with acute myocardial infarction (MI)."3.67[Effect of intracoronary streptokinase infusion and verapamil treatment on the size of the affected area in myocardial infarct patients]. ( Karpov, RS; Kun, VI; Markov, VA; Varvarenko, VI; Vasil'tsev, IaS, 1986)
"The efficacy of verapamil and lidocaine for treating ischemia-induced arrhythmias was determined in a conscious canine model with a previous myocardial infarction remote from the ischemic area."3.67Effects of verapamil and lidocaine in a canine model of sudden coronary death. ( Hoffman, BF; Legenza, M; Southworth, SR; Temesy-Armos, PN, 1985)
" A long-term, open clinical trial of verapamil therapy was conducted in ninety-three patients with coronary artery disease, selected on the basis of having stable angina pectoris and of being unsuitable for treatment with beta-adrenoceptor blocking drugs."3.66Verapamil in the long-term treatment of angina pectoris. ( Raftos, J, 1982)
"In 8 patients affected with acute myocardial infarction verapamil was highly effective in controlling ventricular extrasystoles."3.66Effects of verapamil in ventricular premature beats of acute myocardial infarction. ( Fazzini, PF; Marchi, F; Pucci, P, 1978)
"The effect of verapamil on ST changes was evaluated in 10 selected patients with acute myocardial infarction admitted to the Coronary Care Unit within 8 hours after the onset of symptoms."3.66[Effects of acute infusion of verampil on the ST segment elevation measured with the Frank orthogonal leads in patients with acute myocardial infarct]. ( Bracchetti, D; Cantelli, I; Lombardi, G, 1979)
"In 16 patients, a sustained supraventricular tachyarrhythmia occurring less than 72 hours after the first symptom of an acute myocardial infarction was treated with titrated doses of verapamil."3.66Verapamil in the management of supraventricular tachyarrhythmias occurring after a recent myocardial infarction. ( Hagemeijer, F, 1978)
"In 12 patients affected by acute myocardial infarction complicated only by ventricular extrasystoles, verapamil was highly effective in the control of the arrhythmias."3.65[The antiarrhythmic effects of verapamil in acute myocardial infarction. Considerations on the possible action mechanism (author's transl)]. ( Fazzini, PF; Marchi, F; Pucci, P, 1977)
"In the verapamil group ventricular arrhythmias increased from 25 to 33% (NS)."2.67Ventricular arrhythmias in patients recovering from myocardial infarction: do residual myocardial ischemia and anti-ischemic medical intervention influence the one-month prevalence? The Danish Study Group on Verapamil in Myocardial Infarction. ( Jespersen, CM; Vaage-Nilsen, M, 1993)
"In patients treated for heart failure during the acute phase of myocardial infarction, the lowest 18-month event rate was seen in the verapamil group (21."2.67The effect of verapamil on major events in patients with impaired cardiac function recovering from acute myocardial infarction. The Danish Study Group on Verapamil in Myocardial Infarction. ( Jespersen, CM, 1993)
"Verapamil is a calcium-channel blocking agent with antianginal and antiarrhythmic properties that have been widely studied."2.67The effects of verapamil on training in patients with ischemic heart disease. ( Horgan, JH; MacGowan, GA; O'Callaghan, D; Webb, H, 1992)
" The clinical syndrome was controlled by verapamil in 16 cases out of 20 (80% of cases) at the dosage of 360 mg/d in 14 patients and of 480 mg/d in two."2.67[Unstable angina and infarction without Q wave treated with verapamil: value of the early exercise test]. ( Ghadanfar, M; Guyon, P; Haiat, R; Halphen, C; Leroy, G; Richecoeur, J; Stoltz, JP, 1991)
"Verapamil was administered at the dose of 50 mg in continuous drip."2.65[Behaviour of serum CPK curves in acute myocardial infarction treated with digitalis, verapamil and combined verapamil-digitalis (author's transl)]. ( Allegri, P; Cappelletti, F; Comacchio, G; De Lio, U; Maiolino, P; Morlino, T; Ometto, R; Vincenzi, M; Zanchetta, M, 1981)
"Adenosine as treatment for no-reflow during PPCI could reduce angiographic no-reflow (TIMI flow grade < 3) but was found to increase adverse events."2.52Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction. ( Li, L; Nyi, TS; Su, Q, 2015)
" These differences can be attributed at least in part to the low catecholamine profile of verapamil and the marked rapid adrenergic activation with short-acting nifedipine, which could also explain the adverse effects found when this agent is given to patients with acute coronary syndromes."2.40Calcium channel blockers for hypertension: dissecting the evidence for adverse effects. ( Opie, LH, 1997)
"Verapamil has well proven efficacy in the treatment of patients with hypertension, and early studies indicated its efficacy in the treatment of coronary artery disease."2.39Verapamil: a review of its pharmacological properties and therapeutic use in coronary artery disease. ( Benfield, P; Brogden, RN, 1996)
"Nifedipine has been demonstrated to be no better than placebo both during and after an acute myocardial infarction."2.38Calcium antagonists and myocardial infarction. ( Hansen, JF, 1991)
"Pretreatment with verapamil reduced the size of these subendocardial infarcts from 34 +/- 8 to 8 +/- 3% of the ischemic circumflex vascular bed (anatomic area at risk)."2.37Effects of calcium-channel blockers on myocardial preservation during experimental acute myocardial infarction. ( Jennings, RB; Reimer, KA, 1985)
"Nifedipine generally has little depressant action in this setting and usually improves cardiac function, especially if the sympathetic reflexes are intact."2.37Use of calcium antagonists in ventricular dysfunction. ( Josephson, MA; Singh, BN, 1985)
"Treatment with nifedipine can safely be combined with administration of a beta receptor blocking agent."2.36Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazem. ( Henry, PD, 1980)
"Treatment with nicardipine, nitroprusside, and verapamil are equally effective in improving flow."1.36No-reflow phenomenon following percutaneous coronary intervention for acute myocardial infarction: incidence, outcome, and effect of pharmacologic therapy. ( Abdalrahman, IB; Dharmashankar, KC; Kloner, RA; Rezkalla, SH, 2010)
"Verapamil response was significantly correlated with cTnI."1.36Drug-disease interaction: reduced verapamil response in isoproterenol-induced myocardial injury in rats. ( El-Kadi, AO; Hanafy, S; Jamali, F, 2010)
"Verapamil-sensitive fascicular ventricular tachycardia (VT) of right bundle branch block (RBBB) and superior axis pattern is typically seen in young patients with structurally normal hearts and considered "idiopathic"."1.35Verapamil-sensitive left posterior fascicular ventricular tachycardia after myocardial infarction. ( Hart, D; Kantharia, BK; Liu, Z; Mehta, R; Nagra, B, 2008)
"Myocardial infarction is usually induced in small animals by means of invasive procedures: the aim of this study was to cause heart necrosis lesions by non-invasive means."1.32Myocardial infarction non-invasively induced in rabbits by administering isoproterenol and vasopressin: protective effects exerted by verapamil. ( Bertolini, B; Bonacina, E; Brenna, S; Pinelli, A; Tomasoni, L; Trivulzio, S; Vignati, S, 2004)
"Infarct, arrhythmia, heart rate and coronary artery flow were determined in hearts treated with vehicle, RST extract, Tet, Fan, or verapamil."1.31Cardiac effects of the extract and active components of radix stephaniae tetrandrae. II. Myocardial infarct, arrhythmias, coronary arterial flow and heart rate in the isolated perfused rat heart. ( Chen, CF; Pang, KT; Shan, J; Wang, GY; Wong, TM; Wu, S; Yu, XC, 2001)
" These results confirm the absorption of sildenafil, verapamil and trimetazidine before the death and hair analysis indicates the chronic use of sildenafil."1.31Last performance with VIAGRA: post-mortem identification of sildenafil and its metabolites in biological specimens including hair sample. ( Belooussoff, T; Cirimele, V; Dumestre-Toulet, V; Gromb, S; Kintz, P; Lavault, D; Ludes, B, 2002)
"Verapamil was administered in a 50 micrograms/kg dose followed by 2 micrograms/kg/min infusion."1.30Calcium antagonists and prevention of ventricular fibrillation induced by transient or persistent ischemia. ( Aupetit, JF; Bui-Xuan, B; Evreux, JC; Faucon, G; Freysz, M; Timour, Q, 1997)
"Mibefradil is a calcium antagonist with few negative inotropic effects at therapeutic concentrations."1.30Unique cardioprotective action of the new calcium antagonist mibefradil. ( Backenköhler, U; Dörge, H; Heusch, G; Jalowy, A; Post, H; Schulz, R; Vahlhaus, C, 1999)
"In nexopamil-treated pigs, this was paralleled by reduced release of creatine kinase (CK) into coronary venous blood."1.29Protection of reperfused ischemic pig myocardium by nexopamil, a new combined Ca2+ and serotonin antagonist. ( Braun, M; Hohlfeld, T; Schrör, K; Strobach, H, 1994)
"In verapamil-treated rats, there was an apparent reduction in infarct size as compared with untreated rats; 20% reduction in infarct size 5 h after coronary occlusion and 12% reduction after 24 h."1.28Problems related to infarct size measurements in the rat heart. ( Greve, G; Saetersdal, T, 1991)
" Long-term use of verapamil has contributed to better control of clinical symptomatology."1.28Prinzmetal angina. Multifocal ischemia, recurrent AV block, and bradycardia with patent coronary arteries responsive to verapamil. ( Haywood, LJ; Venkataramen, K, 1991)
"The verapamil was administered for 45 min, starting 15 min prior to ischaemia."1.28Does verapamil limit myocardial infarct size in a heart deficient in xanthine oxidase? ( Adachi, T; Goto, M; Iimura, O; Iwamoto, T; Miura, T; Noto, T; Ogawa, T; Ooiwa, H; Tsuchida, A, 1990)
"Pretreatment with verapamil reduced the size of these subendocardial infarcts from 34 +/- 8 to 8 +/- 3% of the ischemic circumflex vascular bed at risk (identified by postmortem perfusion of the previously occluded and unoccluded arteries with different dyes)."1.27Verapamil in two reperfusion models of myocardial infarction. Temporary protection of severely ischemic myocardium without limitation of ultimate infarct size. ( Jennings, RB; Reimer, KA, 1984)
"To study the hemodynamic and metabolic effects of isoptin, the drug was infused intravenously to 15 patients with acute transmural myocardial infarction at a dosage of 0."1.27[Use of isoptin in the acute period of myocardial infarction (its effect on hemodynamics and myocardial metabolism)]. ( Bogatyrev, IV; Poltavskaia, MG; Pomerantsev, EV; Serova, IV; Vakhliaev, VD, 1984)
"Verapamil was effective in 3 of 4 patients in whom it was tried."1.27Polymorphous ventricular tachycardia in acute myocardial infarction. ( Alpan, G; Binenboim, C; Grenadier, E; Keidar, S; Maor, N; Margulies, T; Palant, A, 1984)
"This arrhythmia, similar to the more common uniform AIVR, was intermittent, did not cause hemodynamic compromise, and was not related to more serious ventricular arrhythmias."1.27Multiform accelerated idioventricular rhythm in acute myocardial infarction: electrocardiographic characteristics and response to verapamil. ( Agmon, J; Arditi, A; Fuchs, J; Klainman, E; Kracoff, OH; Lewin, RF; Sclarovsky, S; Strasberg, B, 1983)
"Verapamil is an effective and relatively-safe antihypertensive drug."1.27Verapamil withdrawal as a possible cause of myocardial infarction in a hypertensive woman with a normal coronary angiogram. ( Beilin, LJ; Dimmitt, SB; Hockings, BE, 1988)
"Correspondingly, ventricular arrhythmias and fibrillation were almost completely prevented by metoprolol, d-sotalol or verapamil, but increased by lidocaine."1.27Comparative investigations on the antiarrhythmic and electrophysiologic effects of class I-IV antiarrhythmic agents following acute coronary artery occlusion. ( Gülker, H; Haverkamp, W; Hindricks, G; Thale, J, 1987)
"In subjects with known migraine, the occurrence of chest pain may represent coronary artery spasm, and should be investigated with concurrent electrocardiographs, as these two clinical entities may be related as part of a generalised vasospastic disorder."1.27A possible relationship between migraine and coronary artery spasm. ( Wayne, VS, 1986)
" Verapamil alone had no protective effect on reperfused myocardium, whereas dibunol, and particularly its combination with verapamil, essentially limited the size of necrosis, reduced plasma CPK activity and animal mortality rate and maintained ultrastructural integrity of cardiomyocytes, which was accompanied by a decrease of plasma lipid peroxidation products and a stabilization of cardiomyocyte sarcolemma."1.27[Prevention of myocardial damage during reperfusion of the coronary artery in dogs using dibunol combined with verapamil]. ( Golikov, AP; Konorev, EA; Pichugin, VV; Polumiskov, VIu; Sharov, VG, 1987)
"Verapamil pretreatment restored KCl contractile responses to normal in reperfused coronary rings and partially restored endothelium-dependent relaxation."1.27Reperfusion after acute coronary occlusion in dogs impairs endothelium-dependent relaxation to acetylcholine and augments contractile reactivity in vitro. ( Horwitz, LD; McMurtry, IF; VanBenthuysen, KM, 1987)
"Ibuprofen and verapamil treatment resulted in less myocardial damage after 48 h than placebo treatment but the differences were generally not statistically significant."1.27Evaluation of a rat model for assessing interventions to salvage ischaemic myocardium: effects of ibuprofen and verapamil. ( Evans, RG; Fischer, VW; Kulevich, J; Mueller, HS; Val-Mejias, JE, 1985)
" Nicardipine given by three different dosing schedules to baboons markedly limited myocardial infarction over a 6 h period of LAD occlusion."1.27Nicardipine in models of myocardial infarction. ( Alps, BJ; Calder, C; Wilson, A, 1985)
"The arrhythmias were prevented by higher doses of the calcium antagonist verapamil which, however, decreased the survival times."1.26Comparative investigation of the effects of metoprolol, propranolol, practolol, and verapamil in the acute phase of experimental myocardial infarction. ( Bernauer, W, 1982)
"Verapamil was given at the dose of 0."1.26[Treatment of acute myocardial infarction with verapamil. Hemodynamic effects and electrical changes studied by body surface maps (author's transl)]. ( Bonatti, V; Botti, G; Favaro, L; Musso, E; Rolli, A; Taccardi, B, 1981)
" Group III animals were given verapamil orally in the dosage of 4 mg/kg, three times a day, 10 days before coronary ligation."1.26Experimental myocardial infarction in rhesus monkeys. Verapamil pretreatment in the reduction of infarct size. ( Anand, IS; Chakravarti, RN; Sharma, PL; Wahi, PL, 1980)
"Reentrant ventricular arrhythmias (RVA) were analyzed in dogs 3--7 days after ligation of the anterior descending coronary artery using averaged "composite" recordings of electrical activity of reentrant pathways (RP) from the epicardial surface of the infarction zone (IZ)."1.26Reentrant ventricular arrhythmias in the late myocardial infarction period. 7. Effect of verapamil and D-600 and the role of the "slow channel". ( El-Sherif, N; Lazzara, R, 1979)
"Pretreatment with verapamil 25 mg/Kg s."1.26Effect of verapamil on the transmural energy metabolism in the isoproterenol-induced myocardial lesion. ( Higuchi, M; Takenaka, F, 1978)

Research

Studies (421)

TimeframeStudies, this research(%)All Research%
pre-1990222 (52.73)18.7374
1990's126 (29.93)18.2507
2000's54 (12.83)29.6817
2010's18 (4.28)24.3611
2020's1 (0.24)2.80

Authors

AuthorsStudies
Oinuma, H1
Takamura, T1
Hasegawa, T1
Nomoto, K1
Naitoh, T1
Daiku, Y1
Hamano, S1
Kakisawa, H1
Minami, N1
Novikov, VL1
Maximov, OB1
Elyakov, GB1
Levitsky, DO1
Lebedev, AV1
Sadretdinov, SM2
Shvilkin, AV2
Afonskaya, NI1
Cherpachenko, NM2
Sava, RI1
Chen, YE1
Smith, SM1
Gong, Y2
Cooper-DeHoff, RM3
Keeley, EC1
Pepine, CJ8
Handberg, EM2
Lawson, BD1
Khan, MZ1
Cooke, RH1
Exaire, JE1
Guzman, LA1
Gertz, ZM1
Zhao, M1
Tang, Y1
Ernst, PJ1
Kahn-Krell, A1
Fan, C1
Pretorius, D1
Zhu, H1
Lou, X1
Zhou, L1
Zhang, J1
Zhu, W1
Fu, Q1
Lu, W1
Huang, YJ1
Wu, Q1
Wang, LG1
Wang, HB1
Jiang, SZ1
Wang, YJ2
Aung Naing, K1
Li, L2
Su, Q2
Wu, T1
Faruk Akturk, I1
Arif Yalcin, A1
Biyik, I1
Sarikamis, C1
Turhan Caglar, N1
Erturk, M1
Celik, O1
Uzun, F1
Murat Caglar, I1
Oner, E1
Nyi, TS1
Reithmann, C1
Morishima, I1
Nogami, A1
Tsuboi, H1
Sone, T1
Bangalore, S2
Messerli, FH7
Cohen, JD1
Bacher, PH1
Sleight, P3
Mancia, G4
Kowey, P1
Zhou, Q1
Champion, A3
Kovacs, K1
Hanto, K1
Bognar, Z1
Tapodi, A1
Bognar, E1
Kiss, GN1
Szabo, A1
Rappai, G1
Kiss, T1
Sumegi, B1
Gallyas, F1
Mohan, IK2
Khan, M2
Wisel, S1
Selvendiran, K1
Sridhar, A2
Carnes, CA2
Bognar, B1
Kálai, T2
Hideg, K2
Kuppusamy, P2
Björkander, I4
Forslund, L6
Ericson, M2
Rehnqvist, N6
Hjemdahl, P6
Kahan, T3
Franklin, SS1
Tan, KT1
Niccoli, G1
Marino, M1
Spaziani, C1
Crea, F2
Tanzilli, G1
Greco, C1
Pasceri, V1
Pelliccia, F1
Arrivi, A1
Placanica, A1
Mangieri, E1
Rezkalla, SH1
Dharmashankar, KC1
Abdalrahman, IB1
Kloner, RA4
Hanafy, S1
El-Kadi, AO1
Jamali, F1
Gilchrist, IC1
Kostis, WJ1
Suh, WM1
Palacios, IF1
Wilson, W1
Eccleston, D1
Bavry, AA1
Khaliq, A1
Raake, PW1
Zhang, X1
Vinge, LE1
Brinks, H1
Gao, E1
Jaleel, N1
Li, Y1
Tang, M1
Most, P1
Dorn, GW1
Houser, SR1
Katus, HA1
Chen, X1
Koch, WJ1
Huang, D1
Qian, J1
Ge, L1
Jin, X1
Jin, H1
Ma, J1
Liu, Z2
Zhang, F1
Dong, L1
Wang, X1
Yao, K1
Ge, J1
Held, C4
Billing, E1
Eriksson, SV3
Näsman, P2
White, WB2
LaRocca, GM1
Werner, GS1
Lang, K1
Kuehnert, H1
Figulla, HR1
Sidorenko, GI1
Ostrovskiĭ, IuP1
Novikova, NA1
Resnic, FS1
Wainstein, M1
Lee, MK1
Behrendt, D1
Wainstein, RV1
Ohno-Machado, L1
Kirshenbaum, JM1
Rogers, CD1
Popma, JJ1
Piana, R1
Demir, I2
Yilmaz, H2
Ermis, C1
Sancaktar, O2
Guay, DR1
FISCHER, K1
Pasquetto, G1
Reimers, B1
Favero, L1
Saccà, S1
Cernetti, C1
Napodano, M1
Piccolo, P1
Pascotto, P1
Mafrici, A1
Alberti, A1
Corrada, E1
Ferrari, S1
Marenna, B1
Yu, XC2
Wu, S2
Chen, CF2
Pang, KT2
Wong, TM2
Gatsura, SV1
Kato, M1
Dote, K1
Sasaki, S1
Takemoto, H1
Habara, S1
Hasegawa, D1
Pinelli, A1
Trivulzio, S1
Tomasoni, L1
Bertolini, B1
Brenna, S1
Bonacina, E1
Vignati, S1
Mark, B1
Scheidt, T1
Zeymer, U1
Boyden, PA2
Dun, W1
Barbhaiya, C1
Ter Keurs, HE1
Alfayoumi, F1
Srinivasan, V1
Geller, M1
Gradman, A1
Hang, CL1
Wang, CP1
Yip, HK1
Yang, CH1
Guo, GB1
Wu, CJ1
Chen, SM1
Hendler, A1
Aronovich, A1
Kaluski, E1
Zyssman, I1
Gurevich, Y1
Blatt, A1
Reicher, M1
Leitman, M1
Czuriga, I1
Vered, Z1
Krakover, R1
Vijayalakshmi, K1
Whittaker, VJ1
Kunadian, B1
Graham, J1
Wright, RA1
Hall, JA1
Sutton, A1
de Belder, MA1
Kowey, PR1
Kupfer, S2
Kolloch, RE1
Benetos, A2
Coca, A1
Handberg, E1
Gaxiola, E1
Conti, CR3
Hewkin, AC2
Tavazzi, L1
Umemura, S1
Nakamura, S1
Sugiura, T1
Tsuka, Y1
Fujitaka, K1
Yoshida, S2
Baden, M1
Iwasaka, T1
Harding, SA1
Kolloch, R1
Yang, Y1
Zhu, WZ1
Joiner, ML1
Zhang, R1
Oddis, CV1
Hou, Y1
Yang, J1
Price, EE1
Gleaves, L1
Eren, M1
Ni, G1
Vaughan, DE1
Xiao, RP1
Anderson, ME1
Abu-Fanne, R1
Rott, D1
Klein, M1
Leitersdorf, E1
Pollak, A1
Almquist, T1
Kulik, A1
Rubens, FD1
Gunning, D1
Bourke, ME1
Mesana, TG1
Ruel, M1
Mandal, R1
Kutala, VK1
Varadharaj, S1
Nagra, B1
Mehta, R1
Hart, D1
Kantharia, BK1
Geddes, JS1
Adgey, AA1
Pantridge, JF1
Valentine, PA1
Sutton, LD1
Sloman, JG1
Bernauer, W1
Theisen, K3
Jahrmärker, H1
Sloan, RW1
Karlsberg, RP2
Aronow, WS1
Henry, PD2
Arita, M2
Kiyosue, T1
Faergeman, O1
Meinertz, H1
Hansen, JF36
Hall-Craggs, M1
Light, PD1
Peters, RW1
Hopf, R1
Drews, H1
Kaltenbach, M1
Bussmann, WD2
Seher, W2
Gruengras, M1
Avaliani, ShG2
Karpov, IuA1
Gratsianskiĭ, NA1
Ruda, MIa4
Thuesen, L1
Jørgensen, JR1
Kvistgaard, HJ1
Sørensen, JA1
Vaeth, M1
Jensen, EB1
Jensen, JJ1
Hagerup, L9
Grüngras, M1
Hasin, Y3
Kriwisky, M1
Gotsman, MS2
Mori, H1
Nagata, M1
Miyazaki, T1
Sakurai, K1
Ogawa, S1
Hattori, S1
Takahashi, M1
Nakamura, Y1
Gülker, H3
Thale, J3
Brisse, B1
Bender, F2
Buxton, AE1
Marchlinski, FE1
Doherty, JU1
Cassidy, DM1
Vassallo, JA1
Flores, BT1
Josephson, ME1
Di Giacomo, V1
Tedeschi, A1
Di Giacomo, M1
Toyooka, T1
Kamishiro, T1
Fumino, H1
Masaki, T1
Hosoda, S1
Reimer, KA4
Jennings, RB3
Alusík, S1
Kubis, M1
Hrcková, Y1
Oral, I1
Afonskaia, NI3
Makarovskiĭ, VV1
Saprygin, DB1
Agaev, MM1
Vakhliaev, VD1
Pomerantsev, EV1
Serova, IV1
Bogatyrev, IV1
Poltavskaia, MG1
Yellon, DM5
Downey, JM4
Hearse, DJ4
Strunge, P1
Engby, B1
Schmidt, E2
Trostmann, AF1
Bott-Silverman, C1
Heupler, FA1
Freiman, I1
Schwarz, T1
Weiss, AT1
Kristensen, SD1
Schmidt, EB1
Dyerberg, J1
El-Sherif, N2
Gough, WB1
Zeiler, RH1
Mehra, R1
Alps, BJ2
Calder, C2
Wilson, A2
Heuer, H1
Meyer, M1
Weiss, U1
Bendeer, F1
Heikkilä, J1
Nieminen, MS1
Kapur, PA1
Norel, E1
Dajee, H1
Cimochowski, G1
Davenport, N1
Goldstein, RE1
Bolli, R1
Epstein, SE1
Grenadier, E1
Alpan, G1
Maor, N1
Keidar, S1
Binenboim, C1
Margulies, T1
Palant, A1
Adamian, KG1
Tatinian, NG1
Gabrielian, RS1
Krishchian, EM1
Asatrian, SV1
Singh, BN8
Chew, CY3
Josephson, MA2
Packer, M1
Severi, S1
Davies, G2
Maseri, A2
Marzullo, P1
L'Abbate, A1
Genovese, A3
Chiariello, M2
Latte, S2
de Alfieri, W2
Cacciapuoti, AA3
Condorelli, M3
Frishman, WH2
Klein, NA1
Strom, JA1
Willens, H1
LeJemtel, TH1
Jentzer, J1
Siegel, L1
Klein, P1
Kirschen, N1
Silverman, R1
Pollack, S1
Doyle, R1
Kirsten, E1
Sonnenblick, EH1
Lessem, J1
Raftos, J1
Avaliani, AG1
Vikhert, AM1
Zysko, AP1
Dipalma, JR1
Hamm, CW2
Opie, LH4
Maxwell, MP2
Chambers, DE1
Sclarovsky, S1
Strasberg, B1
Fuchs, J1
Lewin, RF1
Arditi, A1
Klainman, E1
Kracoff, OH1
Agmon, J1
Tereshchenko, VP1
Nizhenkovskaia, IV1
Furuya, Y1
Yokoyama, S1
Morimoto, S1
Nagara, M1
Tanaka, S1
Fujita, M1
DeBoer, LW2
Strauss, HW1
Rude, RE1
Davis, RF1
Maroko, PR6
Braunwald, E4
Sigurd, B9
Mellemgaard, K10
Lyngbye, J2
Théroux, P2
Waters, DD2
Debaisieux, JC1
Szlachcic, J2
Mizgala, HF1
Bourassa, MG1
Ruedy, J1
Lukoshevichiute, AI1
Reĭngardene, DI1
Vincenzi, M2
Allegri, P1
Cappelletti, F2
Comacchio, G1
De Lio, U2
Morlino, T1
Ometto, R1
Zanchetta, M1
Maiolino, P2
Glogar, DH1
Darsee, JR1
Ertl, G1
Ingwall, JS1
Schwartz, A1
Miller, D1
Davis, J1
Glassman, R1
Wit, AL1
Ribeiro, LG4
Cheung, W1
Ku, DD1
Belhassen, B2
Shapira, I1
Kauli, N1
Keren, A1
Laniado, S2
Wong, SS1
Myerburg, RJ1
Cameron, JS1
Epstein, K1
Ezrin, AM1
Kozlovskis, P1
Bassett, AL1
Aquaro, G1
Ravera, A1
Belli, R1
Rey, L1
Possavino, G1
Pavia, M1
Idone, P1
Ferrari, G1
Zerboni, S1
Noseda, G1
Bonini, W1
Bassi, G1
Porro, G1
Faria, DB1
Cheung, WM1
Bracchetti, D4
Cantelli, I3
Lombardi, G2
Hecht, HS1
Collett, JT1
McAllister, RG1
Chakravarti, RN3
Sharma, PL3
Anand, IS3
Manga, PA1
Wahi, PL3
Nayler, WG2
Moraes, NL1
Fiorelli, AI1
Ribeiro, LF1
Gomes, OM1
Botti, G3
Bonatti, V3
Taccardi, B1
Rolli, A3
Favaro, L2
Musso, E1
Trevisan, G1
Spadaro, J1
Brandon, TA1
Kim, HS1
Titus, JL1
Miller, RR1
Carboni, A1
Ahmed, S1
Garan, H1
Fallon, JT1
Ruskin, JN1
Kupersmith, J1
Cohen, R1
Nunnally, RL1
Bottomley, PA1
Dersham, GH1
Han, J1
Hecht, H1
Collett, J1
Ormiston, J1
Jespersen, C1
Hohlfeld, T1
Braun, M1
Strobach, H1
Schrör, K1
Mazur, NA2
Pavlova, TS2
Vasil'eva, NN2
Kul'ginskaia, IV2
Arstall, MA2
Stewart, S1
Haste, MA1
Horowitz, JD4
Richard, V1
Tron, C1
Blanc, T1
Thuillez, C1
Iliceto, S2
Rizzon, P2
Launbjerg, J4
Fruergaard, P2
Madsen, JK3
Mortensen, LS8
Vaage-Nilsen, M8
Steinmetz, E3
Jespersen, CM14
Hisatome, I1
Ken, N1
Katsuo, K1
Nagao, K2
Vander Heide, RS1
Schwartz, LM1
Rasmussen, V4
Sørensen, MB2
Pedersen-Bjergaard, O3
Holländer, NH3
Nielsen, I2
Sigurd, BM1
Sterz, R1
Weiner, DA1
Dotzer, F1
Gromer, H1
Holländer, N1
Hven, PE1
Linde, NC1
Nielsen, J1
van Zwieten, PA1
Tijssen, JG1
Lie, KI1
de Leeuw, PW1
Andersen, L1
Hansen, J1
Fan, J1
Zhang, Y1
Zhang, M1
Rengo, F1
Carbonin, P1
Pahor, M1
DeCaprio, L1
Bernabei, R1
Ferrara, N1
Carosella, L1
Acanfora, D1
Parlati, S1
Vitale, D1
Yusuf, S3
Galatius-Jensen, S1
Brogden, RN1
Benfield, P1
Spaggiari, I1
Cavozza, C1
Fesani, F1
D'Amico, E1
Menozzi, E1
Sciaraffia, M1
Bonaduce, D1
Petretta, M1
Ianniciello, A1
Apicella, C1
Cavallaro, V1
Marciano, F1
Pedersen, F3
Timour, Q1
Bui-Xuan, B1
Aupetit, JF1
Freysz, M1
Evreux, JC1
Faucon, G1
Galenko-Iaroshevskiĭ, PA1
Melkumova, ER1
Bartashevich, VV1
Uvarov, AV1
Turovaia, AIu1
Khankoeva, AI1
Galygo, DS1
Sárosi, I1
Debreceni, G1
Mühl, D1
Kónyi, A1
Bogár, L1
Tekeres, M1
Tóth, K1
Habon, T1
Czopf, L1
Zámbó, K1
Waters, D1
Michalewicz, L1
Bjergaard, OP2
Taniyama, Y1
Ito, H1
Iwakura, K1
Masuyama, T1
Hori, M1
Takiuchi, S1
Nishikawa, N1
Higashino, Y1
Fujii, K1
Minamino, T1
Leitch, JW1
McElduff, P1
Dobson, A1
Heller, R1
Rubboli, A1
Sangiorgio, P1
Kouchi, I1
Murakami, T1
Nawada, R1
Akao, M1
Sasayama, S1
Pinar, E1
García-Alberola, A1
Llamas, C1
Vicente, T1
López-Candel, J1
Rojo, JL1
Fernández, R1
Valdés, M1
Sajadieh, A4
Black, HR1
Elliott, WJ1
Neaton, JD1
Grandits, G1
Grambsch, P1
Grimm, RH1
Hansson, L1
Lacoucière, Y1
Muller, J1
Weber, MA1
Williams, G1
Wittes, J1
Zanchetti, A1
Fakouhi, TD1
Faich, G1
Makuch, R1
Tashchuk, VK1
Polishchuk, OIu1
Hrechko, SI1
Makoviĭchuk, IO1
Polians'ka, OS1
Turubarova, NA1
Chaplyns'kyĭ, RB1
Sokur, IV1
Schulz, R1
Post, H1
Jalowy, A1
Backenköhler, U1
Dörge, H1
Vahlhaus, C1
Heusch, G1
Wendelboe, O1
Gillman, MW1
Ross-Degnan, D1
McLaughlin, TJ1
Gao, X1
Spiegelman, D1
Hertzmark, E1
Goldman, L1
Soumerai, SB1
Sage, PR1
Kiosoglous, AJ1
Wuttke, RD2
Natale, E1
Tubaro, M1
Di Marcotullio, G1
Celli, P1
Carelli, M1
Malinconico, U1
Polizzi, CA1
Milazzotto, F1
Vajola, SF1
Jollis, JG1
Simpson, RJ1
Chowdhury, MK1
Cascio, WE1
Crouse, JR1
Massing, MW1
Smith, SC1
Danenberg, HD1
Gilon, D1
Min, JY1
Sandmann, S2
Meissner, A1
Unger, T2
Simon, R1
Naik, P1
Malati, T1
Ratnakar, KS1
Naidu, MU1
Rajasekhar, A1
Rashid, H1
Marshall, RJ1
Diver, DJ1
Breall, JA1
Esmore, DS1
Burton, PR1
Smith, JA1
Rabinov, M1
Pick, A1
McMahon, J1
Rosenfeldt, FL1
Marangelli, V1
Memmola, C1
Brigiani, MS1
Boni, L1
Biasco, MG1
Scrutinio, D1
Pu, J1
Robinson, RB1
Gibson, RS2
Messerli, F1
Schechtman, KB2
Boden, WE2
Wasserstrom, JA1
Holt, E1
Sjaastad, I1
Lunde, PK1
Odegaard, A1
Sejersted, OM1
Claas, R1
Cleutjens, JP1
Daemen, MJ1
Wang, GY1
Shan, J1
Morris, CD1
Budde, JM1
Velez, DA1
Muraki, S1
Zhao, ZQ1
Puskas, JD1
Guyton, RA1
Vinten-Johansen, J1
Parsons, RW1
Hung, J1
Hanemaaijer, I1
Jbroadhurst, R1
Jamrozik, K1
Hobbs, MS1
Dumestre-Toulet, V1
Cirimele, V1
Gromb, S1
Belooussoff, T1
Lavault, D1
Ludes, B1
Kintz, P1
Belgi, A1
Rossi, P3
Tamiz, A3
Giordano, A3
Schiavo, B3
D'Aulerio, M1
Aina, F1
Minuco, G3
Sguazzini Viscontini, C1
Gaeta, V1
Fazzini, PF4
Marchi, F6
Pucci, P5
Buttafarro, A1
Pavia, L1
Siracusano, L1
Freni, F2
Bitto, U2
Casella, G2
Zipes, DP1
Besch, HR1
Watanabe, AM1
Ferrari, R1
Visioli, O1
Johansson, BW1
Lazzara, R1
Ledda, F1
Mugelli, A1
Ichikawa, M1
Saito, S1
Takahashi, N1
Tomobe, K1
Yamamoto, M1
Watanabe, I1
Komaki, K1
Tanigawa, N1
Ozawa, Y1
Hatano, M1
Ginger-Mortensen, K1
Albuquerque, DC1
da Rocha, PJ1
Albanesi Filho, FM1
Benchimol, CB1
Albuquerque, EN1
Schlesinger, P1
Benchimol, AB1
Bray, A1
Montinaro, A1
Lombardi, R1
Calabrese, G1
De Giorgi, V1
Spirito, F1
Bacca, F1
Polverino, W2
Petillo, F1
Basso, A1
Hagemeijer, F1
Shargorodskiĭ, BM1
Fazzini, P1
Higuchi, M1
Takenaka, F1
Spear, JF1
Horowitz, LN1
Hodess, AB1
MacVaugh, H1
Moore, EN1
Smith, HJ2
Norris, RM2
Bleifeld, W1
Ahmed, SA1
Sobel, BE1
Roberts, R2
Janke, J1
Fleckenstein, A1
Döring, HJ1
Leder, O1
Contini, C1
Nisbet, HD1
Wolf, R1
Nötges, A1
Witt, E1
Habel, F1
Everling, F1
Hochrein, H1
Steinbach, K1
Roma, F1
Taurino, L1
Miccoli, A1
Schartl, M1
Krejcy, K1
Krumpl, G1
Todt, H1
Raberger, G1
Shokareva, GV1
Konakbaeva, TN1
Iskakov, KM1
Zhu, JQ1
Zeng, FD1
Hu, CJ1
Rong, P1
Dai, DZ1
Zhang, JE1
Aghi, M1
Husain, Z1
Pillai, KK1
Qadry, JS1
Balani, DK1
Imran, M1
Beltrame, JF1
Mohan, P1
Esterman, AJ1
Zhdanova, SM1
Billman, GE1
Erhardt, L1
Kristensen, KS1
Bailey, KR2
Sullivan, AT1
Baker, DJ1
Drew, GM1
Persson, S1
Greve, G1
Saetersdal, T1
MacGowan, GA1
O'Callaghan, D1
Webb, H1
Horgan, JH1
Chung, JK1
Lim, SM1
Lee, MC1
Koh, CS1
Lee, M1
Seo, JW1
Gheorghiade, M1
Boesgaard, S1
Hyldstrup, L1
Feldstedt, M1
Leroy, G1
Ghadanfar, M1
Guyon, P1
Richecoeur, J1
Halphen, C1
Stoltz, JP1
Haiat, R1
Levitskiĭ, DO1
Eichstädt, H1
Clozel, JP2
Véniant, M1
Osterrieder, W1
Held, P1
Furberg, C1
Haywood, LJ1
Venkataramen, K1
Adachi, T1
Miura, T1
Noto, T1
Ooiwa, H1
Ogawa, T1
Tsuchida, A1
Iwamoto, T1
Goto, M1
Iimura, O1
da-Luz, PL2
Silveira, MC1
Chagas, AC1
Pileggi, F2
Butzeck, J1
Kothe, K1
Porstmann, B1
Aurisch, R1
Hübner, R1
Molodan, VI1
Kopitsa, NP1
Dykun, IaV1
Zarivchatskaia, IT1
Tishkin, VS1
Dunaev, VV1
Kryzhanovskiĭ, SA1
Riabinin, VA3
Favoritov, VN1
Danilovich, MI1
Kacharava, VG1
Komissarov, VA1
Golikov, AP6
Huang, J1
Conorev, EA1
Rudnev, DV3
Conorev, LA1
Polumiskov, VY1
Weinstein, GS1
Rao, PS1
Tyras, DH1
Umezawa, S1
Chun, YH1
Obayashi, T1
Adachi, H1
Kanayama, M1
Korenaga, M1
Inada, M1
Au, TL1
Curtis, MJ1
Walker, MJ1
Lynch, JJ1
Lucchesi, BR1
Sung, RJ1
Huycke, EC1
Lai, WT1
Tseng, CD1
Chu, H1
Keung, EC1
Finardi, A1
Aurier, E1
Pichigin, VV1
Konorev, EA3
Konorev, LA1
Polumiskov, VIu3
Kingma, JG2
Denniss, AR2
Mehmel, HC1
Vogler, AC1
Silber, S1
Vogel, M1
Skolnick, AE1
Kiricuta, IC1
Schmitt, WG1
Beyer, HK1
Aniukhovskiĭ, EP2
Ivanovich, T1
Beloshapko, GG2
Rozenshtraukh, LV2
Fellenius, E1
Hansen, CA1
Mjøs, O1
Neely, JR1
Anderson, JL1
Buonanno, C1
Lotto, A1
Massari, FM1
Bertoni, T1
Ambrosini, F1
Finzi, A1
Foresti, A1
Valentini, R1
Matta, F1
Vassanelli, C1
Menegatti, G1
Nidasio, GP1
Franceschini, L1
Cocco, C1
Rizzotti, P1
Lee, KJ1
McKay, WJ1
Goble, AJ1
Huang, SY1
Barasch, E1
Turgeman, Y1
Rosenfeld, T1
Dimmitt, SB1
Beilin, LJ1
Hockings, BE1
Kanmatsuse, K1
Kajiwara, N1
Onikura, S1
Satoh, Y1
Yumi, K1
Da-Silveira, MC1
Murad-Neto, A1
Massumi, RA1
Udhoji, VN1
Muller, CA1
Peisach, M1
Pineda, CA1
Thandroyen, FT1
Zhuravlev, AK1
Murashko, VV1
Kamchatnov, PR1
Haverkamp, W1
Hindricks, G1
Cheng, GM1
Shao, G1
Pan, ZY1
Wayne, VS1
Cheung, JY1
Bonventre, JV1
Malis, CD1
Leaf, A1
Moss, AJ2
Kendall, MJ2
Horton, RC2
Widomska-Czekajska, T1
Kutarski, A1
Dubejko, J1
Rumiński, W1
Yuan, JN1
Wang, LH1
Xu, YY1
Mazzù, A1
Magnus, O1
Pichugin, VV1
Sharov, VG1
Avilova, OA1
Berestov, AA1
Ohta, T1
Toyama, J1
Hirai, M1
Osaka, T1
Kodama, I1
Yamada, K1
Tenczer, J1
Littmann, L1
Kinnaird, AA1
Man, RY1
Vasil'tsev, IaS1
Karpov, RS1
Markov, VA1
Varvarenko, VI1
Kun, VI1
Sokolov, AM1
Ivanova, GA1
Suloeva, MN1
Siddiqui, MA1
Mirza, MR1
Aziz, M1
Verma, AK1
VanBenthuysen, KM1
McMurtry, IF1
Horwitz, LD1
Cobb, FR1
Murdock, RH1
Greenfield, JC1
Becker, LC1
Bulkley, BH1
Hutchins, GM1
Schwartz, RP1
Winniford, MD1
Willerson, JT1
Hillis, LD1
Kasanuki, H1
Onishi, S1
Hirosawa, K1
Deanfield, J1
Crean, P1
Sharom, M1
Poole-Wilson, PA1
Evans, RG1
Val-Mejias, JE1
Kulevich, J1
Fischer, VW1
Mueller, HS1
Sakai, M1
Ueda, K1
Nakahara, K1
Tsuchimochi, H1
Mutsushita, S1
Kuramoto, K1
Murakami, M1
Kaur, AH1
Singh, M1
Singh, J1
Jain, K1
Savov, VM1
Didenko, VV1
Dosmagambetova, RS1
Meerson, FZ1
Kagan, VE1
Temesy-Armos, PN1
Legenza, M1
Southworth, SR1
Hoffman, BF1
Lo, HM1
Gupta, RC1
Sharma, SK1
Arora, YK1
Tripathi, K1
Doscicin, VL1
Barousch, R1
Chazov, EI1
Cranefield, PF1
Kesler, DF1
Filias, N1
Södermark, T1
Winge, T1
Waris, E1
Yokoyama, H1
Osugi, S1
Votcal, BE1
Lozinskij, LG1
Goldberg, VA1
Venediktova, MG1
Gribova, OA1
Cherchi, A1
Raffo, M1
Bina, M1
Fonzo, R1
Maxia, G1
Esu, MP1
de Abrantes, IB1
Villela, RA1
Faillace, S1
Villela, AA1
Zeman, B1

Clinical Trials (5)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
INternational VErapamil SR Trandolapril STudy[NCT00133692]Phase 422,000 participants Interventional1997-09-30Completed
Reversal of No-reflow/Slow-flow During Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction--a Prospective Randomized Study Comparing Intracoronary Infusion of Diltiazem, Verapamil and Nitroglycerin[NCT00712894]Phase 4102 participants (Actual)Interventional2006-12-31Completed
Effect of Early Administration of Intracoronary Nicorandil Via Thrombus Aspiration Catheter Device During Primary Percutaneous Coronary Intervention for the Patients of Acute ST Segment Elevation Myocardial Infarction[NCT02435797]Phase 4100 participants (Anticipated)Interventional2015-04-30Recruiting
DiME Study: Comparison of Diltiazem and Metoprolol in the Management of Acute Atrial Fibrillation or Atrial Flutter With Rapid Ventricular Response: A Prospective Randomized and Double-Blinded Non-Inferiority Trial of Safety and Efficacy[NCT01914926]Phase 454 participants (Actual)Interventional2009-06-30Completed
Verapamil as Adjunctive Seizure Therapy for Children and Young Adults With Dravet Syndrome[NCT01607073]Phase 22 participants (Actual)Interventional2012-04-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Percent of Patients Reaching Target HR<100bpm Within 30 Minutes

Percent of patient who reached a HR<100bpm within 30 minutes from baseline. (NCT01914926)
Timeframe: 30 minutes

Interventionpercentage of participants (Number)
Metoprolol Study Group46.4
Diltiazem Study Group95.8

Change in Number of Absence Seizures From Week 8 (Baseline) to Week 12

The secondary outcome measure is the change in number of absence seizures from Week 8 (Baseline) to Week 12 (NCT01607073)
Timeframe: Week 8 to Week 12

InterventionAbscence seizures (Number)
Week 8 Baseline165
Week 12 Verapamil 4mg/kg/Day101

Change in Number of General Tonic-clonic Seizures From Week 8 (Baseline) Visit to Week 12 Visit

The primary study endpoint is the change in number of seizures from baseline. Since we only had one participant finish the study, the endpoint was changed to Week 12 visit. Participants were on verapamil for 4 weeks at Week 12. (NCT01607073)
Timeframe: Week 8 (baseline) to Week 12

InterventionGeneral tonic-clonic seizures (Number)
Week 8 Baseline39
Week 12 Verapamil 4mg/kg/Day14

Change in Number of Myoclonic Seizures From Week 8 (Baseline) to Week 12

The secondary outcome is the change in number of myoclonic seizures between baseline Week 8 visit and Week 12 visit. (NCT01607073)
Timeframe: Week 8 (baseline) to Week 12

InterventionMyoclonic seizures (Number)
Week 8 Baseline116
Week 12 Verapamil 4mg/kg/Day175

Reviews

59 reviews available for verapamil and Cardiovascular Stroke

ArticleYear
Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction.
    The Cochrane database of systematic reviews, 2013, Jun-04, Issue:6

    Topics: Adenosine; Cause of Death; Humans; Myocardial Infarction; No-Reflow Phenomenon; Percutaneous Coronar

2013
Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction.
    The Cochrane database of systematic reviews, 2015, May-18, Issue:5

    Topics: Adenosine; Cause of Death; Humans; Myocardial Infarction; No-Reflow Phenomenon; Percutaneous Coronar

2015
Prevention and treatment of no-reflow.
    Acute cardiac care, 2010, Volume: 12, Issue:3

    Topics: Abciximab; Adenosine; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Electrocardiography; H

2010
Chronopharmacology of cardiovascular therapy.
    Blood pressure monitoring, 2002, Volume: 7, Issue:4

    Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Arrhythmias, Cardiac; Blood Pressure; Blood Pressu

2002
[The no-reflow phenomenon and its clinical significance].
    Kardiologiia, 2002, Volume: 42, Issue:5

    Topics: Adenosine; Angioplasty, Balloon, Coronary; Atherectomy; Coronary Angiography; Coronary Artery Bypass

2002
Trandolapril: a newer angiotensin-converting enzyme inhibitor.
    Clinical therapeutics, 2003, Volume: 25, Issue:3

    Topics: Acute Disease; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Clinical Trials as

2003
The no-reflow phenomenon: epidemiology, pathophysiology, and therapeutic approach.
    Reviews in cardiovascular medicine, 2005,Spring, Volume: 6, Issue:2

    Topics: Adenosine; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Echocardiography; Hum

2005
Prevention of cardiogenic shock.
    American heart journal, 1980, Volume: 99, Issue:2

    Topics: Adrenergic beta-Antagonists; Coronary Disease; Creatine Kinase; Echocardiography; Electrocardiograph

1980
[Medical treatment of extrasystole and tachycardia (author's transl)].
    MMW, Munchener medizinische Wochenschrift, 1980, Jan-18, Volume: 122, Issue:3

    Topics: Action Potentials; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Bretylium Compounds; Calcium; Cardi

1980
Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazem.
    The American journal of cardiology, 1980, Dec-01, Volume: 46, Issue:6

    Topics: Angina Pectoris; Angina Pectoris, Variant; Animals; Arrhythmias, Cardiac; Benzazepines; Calcium; Car

1980
Part I: pharmacologic and hemodynamic actions and interactions. Pharmacologic and hemodynamic mechanisms underlying the antianginal actions of verapamil.
    The American journal of cardiology, 1982, Volume: 50, Issue:4

    Topics: Angina Pectoris; Animals; Cardiac Pacing, Artificial; Coronary Circulation; Coronary Disease; Dogs;

1982
Verapamil.
    Clinical and investigative medicine. Medecine clinique et experimentale, 1981, Volume: 4, Issue:2

    Topics: Action Potentials; Angina Pectoris; Animals; Calcium; Cardiovascular System; Heart Diseases; Hemodyn

1981
[Value of drug tests in Wolff-Parkinson-White syndrome].
    Kardiologiia, 1981, Volume: 21, Issue:10

    Topics: Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Atrioventricular Node; Diagnosis, Differential; Electr

1981
Pharmacological basis for the therapeutic applications of slow-channel blocking drugs.
    Angiology, 1982, Volume: 33, Issue:8

    Topics: Animals; Atrioventricular Node; Calcium Channel Blockers; Coronary Circulation; Electrophysiology; H

1982
[Post-infarction, myocardial ischemia: clinical importance and risk factor].
    Archives des maladies du coeur et des vaisseaux, 1995, Volume: 88 Spec No 4

    Topics: Arrhythmias, Cardiac; Humans; Myocardial Infarction; Myocardial Ischemia; Risk Factors; Verapamil

1995
Review of postinfarct treatment with verapamil: combined experience of early and late intervention studies with verapamil in patients with acute myocardial infarction. Danish Study Group on Verapamil in Myocardial Infarction.
    Cardiovascular drugs and therapy, 1994, Volume: 8 Suppl 3

    Topics: Denmark; Double-Blind Method; Drug Administration Schedule; Drug Evaluation; Humans; Myocardial Infa

1994
[Anti-ischemic therapy with verapamil. Improving prognosis by secondary prevention after acute myocardial infarct].
    Fortschritte der Medizin, 1993, May-20, Volume: 111, Issue:14

    Topics: Coronary Circulation; Drug Therapy, Combination; Humans; Myocardial Infarction; Myocardial Ischemia;

1993
Anti-ischaemic intervention with verapamil in patients recovering from acute myocardial infarction.
    European heart journal, 1995, Volume: 16 Suppl H

    Topics: Angina Pectoris; Calcium Channel Blockers; Humans; Myocardial Infarction; Myocardial Ischemia; Preva

1995
Verapamil: a review of its pharmacological properties and therapeutic use in coronary artery disease.
    Drugs, 1996, Volume: 51, Issue:5

    Topics: Angina Pectoris; Animals; Calcium Channel Blockers; Coronary Disease; Humans; Myocardial Infarction;

1996
Re-examining the clinical safety and roles of calcium antagonists in cardiovascular medicine.
    The American journal of cardiology, 1996, Nov-07, Volume: 78, Issue:9A

    Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Channel Blockers; Cardiovascular Diseases; Cor

1996
Calcium channel blockers for hypertension: dissecting the evidence for adverse effects.
    American journal of hypertension, 1997, Volume: 10, Issue:5 Pt 1

    Topics: Calcium Channel Blockers; Catecholamines; Cerebrovascular Disorders; Drug Evaluation; Gastrointestin

1997
Treatment with verapamil and trandolapril in patients with congestive heart failure and myocardial infarction. The Danish Verapamil Infarction Trial (DAVIT Study Group).
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1997, Volume: 15, Issue:2

    Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Clinica

1997
[Comparative study of verapamil and bisoprolol in the secondary prevention of myocardial infarction].
    Orvosi hetilap, 1997, Aug-03, Volume: 138, Issue:31

    Topics: Adrenergic beta-Antagonists; Bisoprolol; Calcium Channel Blockers; Female; Humans; Male; Middle Aged

1997
Calcium channel blockers: an evidence-based review.
    The Canadian journal of cardiology, 1997, Volume: 13, Issue:8

    Topics: Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Diltiazem; Humans; Myocardial In

1997
Safety of heart rate-lowering calcium antagonists: lessons from controlled trials.
    American heart journal, 1997, Volume: 134, Issue:2 Pt 2

    Topics: Calcium Channel Blockers; Controlled Clinical Trials as Topic; Diltiazem; Humans; Meta-Analysis as T

1997
Congestive heart failure and ischaemic heart disease treated with trandolapril and verapamil. DAVIT Study Group. Danish Verapamil Infarction Trial.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1998, Volume: 16, Issue:1

    Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Clinica

1998
[Verapamil in myocardial infarct].
    Cardiologia (Rome, Italy), 1997, Volume: 42, Issue:12

    Topics: Anti-Arrhythmia Agents; Humans; Myocardial Infarction; Verapamil

1997
Verapamil use in patients with cardiovascular disease: an overview of randomized trials.
    Clinical cardiology, 1998, Volume: 21, Issue:9

    Topics: Angina Pectoris; Calcium Channel Blockers; Cardiovascular Diseases; Female; Humans; Hypertension; Ma

1998
Verapamil in acute myocardial infarction. The rationales of the VAMI and DAVIT III trials.
    Cardiovascular drugs and therapy, 1999, Volume: 13, Issue:4

    Topics: Acute Disease; Angina Pectoris; Angina, Unstable; Calcium Channel Blockers; Clinical Trials as Topic

1999
Verapamil in acute myocardial infarction. The rationales of the VAMI and DAVIT III trials.
    Cardiovascular drugs and therapy, 2000, Volume: 14, Issue:1

    Topics: Acute Disease; Angina Pectoris; Angina, Unstable; Calcium Channel Blockers; Clinical Trials as Topic

2000
Heart rate-lowering calcium antagonists in hypertensive post-myocardial infarction patients.
    Journal of hypertension, 2001, Volume: 19, Issue:5

    Topics: Aged; Calcium Channel Blockers; Diltiazem; Female; Heart Rate; Humans; Hypertension; Lung Diseases;

2001
Role of the slow current in cardiac electrophysiology.
    Circulation, 1975, Volume: 51, Issue:5

    Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Atrioventricular Node; Calcium; Cyclic AMP; Digita

1975
Clinical aspects of Ca-blocking agents.
    Acta pharmacologica et toxicologica, 1978, Volume: 43 Suppl 1

    Topics: Angina Pectoris; Animals; Arrhythmias, Cardiac; Calcium; Coronary Disease; Cricetinae; Humans; Hyper

1978
[Possibilities of preserving ischemic myocardium].
    Deutsche medizinische Wochenschrift (1946), 1976, Jun-18, Volume: 101, Issue:25

    Topics: Acute Disease; Animals; Coronary Circulation; Coronary Disease; Dipyridamole; Fibrinolysis; Humans;

1976
Calcium antagonists in the treatment early after myocardial infarction. The DEFIANT Research Group.
    Journal of cardiovascular pharmacology, 1992, Volume: 20 Suppl 5

    Topics: Adult; Aged; Calcium Channel Blockers; Denmark; Diltiazem; Echocardiography, Doppler; Humans; Middle

1992
[Verapamil therapy improves the prognosis after acute myocardial infarction. A review over the Danish studies of verapamil therapy during and after acute myocardial infarction].
    Ugeskrift for laeger, 1992, Feb-10, Volume: 154, Issue:7

    Topics: Denmark; Humans; Myocardial Infarction; Prognosis; Recurrence; Verapamil

1992
Treatment with verapamil after an acute myocardial infarction. Review of the Danish studies on verapamil in myocardial infarction (DAVIT I and II).
    Drugs, 1991, Volume: 42 Suppl 2

    Topics: Angina Pectoris; Blood Pressure; Denmark; Double-Blind Method; Female; Heart Rate; Humans; Male; Met

1991
Calcium antagonists in secondary prevention after myocardial infarction.
    Drugs, 1991, Volume: 42 Suppl 2

    Topics: Calcium Channel Blockers; Diltiazem; Female; Humans; Male; Meta-Analysis as Topic; Myocardial Infarc

1991
Treatment with verapamil during and after an acute myocardial infarction: a review based on the Danish Verapamil Infarction Trials I and II. The Danish Study Group on Verapamil in Myocardial Infarction.
    Journal of cardiovascular pharmacology, 1991, Volume: 18 Suppl 6

    Topics: Arrhythmias, Cardiac; Blood Pressure; Death, Sudden, Cardiac; Denmark; Double-Blind Method; Female;

1991
Calcium channel blockers in the management of myocardial infarction patients.
    Henry Ford Hospital medical journal, 1991, Volume: 39, Issue:3-4

    Topics: Calcium Channel Blockers; Diltiazem; Humans; Myocardial Infarction; Nifedipine; Verapamil

1991
Calcium antagonists and myocardial infarction.
    Cardiovascular drugs and therapy, 1991, Volume: 5, Issue:4

    Topics: Calcium Channel Blockers; Diltiazem; Humans; Myocardial Infarction; Nifedipine; Verapamil

1991
[Cardiovascular therapy with calcium antagonists].
    Zeitschrift fur arztliche Fortbildung, 1991, Jul-10, Volume: 85, Issue:13

    Topics: Calcium Channel Blockers; Coronary Disease; Electrocardiography; Hemodynamics; Humans; Myocardial In

1991
Secondary prevention with verapamil after myocardial infarction. The Danish Study Group on Verapamil in Myocardial Infarction.
    The American journal of cardiology, 1990, Dec-18, Volume: 66, Issue:21

    Topics: Cholesterol; Double-Blind Method; Female; Humans; Male; Meta-Analysis as Topic; Myocardial Infarctio

1990
Clinical and electrophysiologic mechanisms of exercise-induced ventricular tachyarrhythmias.
    Pacing and clinical electrophysiology : PACE, 1988, Volume: 11, Issue:9

    Topics: Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Electrophysiology; Humans; Myocardial Infarction;

1988
Calcium channel blockers in myocardial infarction.
    Archives of internal medicine, 1989, Volume: 149, Issue:7

    Topics: Calcium Channel Blockers; Diltiazem; Humans; Myocardial Infarction; Nifedipine; Verapamil

1989
[Possibilities of phosphorus 31 spectroscopy in assessing the therapeutic effects on cellular energy metabolism of the myocardium].
    Herz, 1989, Volume: 14, Issue:4

    Topics: Acebutolol; Cardioplegic Solutions; Chlorpromazine; Energy Metabolism; Humans; Magnetic Resonance Sp

1989
Review of calcium antagonist trials in acute myocardial infarction.
    Clinical cardiology, 1989, Volume: 12, Issue:7 Suppl 3

    Topics: Calcium Channel Blockers; Diltiazem; Humans; Myocardial Infarction; Nifedipine; Randomized Controlle

1989
Rationale of combination antiarrhythmic drug therapy.
    Cardiovascular clinics, 1985, Volume: 16, Issue:1

    Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Bretylium Compounds; Digitalis Glyc

1985
The path to myocardial salvage by thrombolytic therapy.
    Circulation, 1987, Volume: 76, Issue:2 Pt 2

    Topics: Animals; Coronary Circulation; Humans; Myocardial Infarction; Receptors, Adrenergic, beta; Streptoki

1987
[Calcium antagonists in acute myocardial infarction].
    Giornale italiano di cardiologia, 1988, Volume: 18, Issue:11

    Topics: Calcium Channel Blockers; Diltiazem; Gallopamil; Hemodynamics; Humans; Myocardial Infarction; Nifedi

1988
Calcium channel antagonists. Part II: Use and comparative properties of the three prototypical calcium antagonists in ischemic heart disease, including recommendations based on an analysis of 41 trials.
    Cardiovascular drugs and therapy, 1988, Volume: 1, Issue:5

    Topics: Angina Pectoris; Angina, Unstable; Calcium Channel Blockers; Coronary Disease; Diltiazem; Drug Thera

1988
Calcium and ischemic injury.
    The New England journal of medicine, 1986, Jun-26, Volume: 314, Issue:26

    Topics: Animals; Calcium; Calcium Channel Blockers; Chlorpromazine; Cytosol; Extracellular Space; Homeostasi

1986
A clinical review of calcium antagonists in acute myocardial infarction.
    Arquivos brasileiros de cardiologia, 1986, Volume: 46, Issue:1

    Topics: Animals; Calcium Channel Blockers; Coronary Circulation; Heart Rate; Humans; Myocardial Infarction;

1986
Secondary prevention with calcium channel-blocking drugs in patients after myocardial infarction: a critical review.
    Circulation, 1987, Volume: 75, Issue:6 Pt 2

    Topics: Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; Humans; Myocardial Infarction; Nifedi

1987
Effects of calcium-channel blockers on myocardial preservation during experimental acute myocardial infarction.
    The American journal of cardiology, 1985, Jan-25, Volume: 55, Issue:3

    Topics: Animals; Calcium Channel Blockers; Collateral Circulation; Coronary Circulation; Coronary Disease; D

1985
Calcium antagonists for acute ischemic heart disease.
    The American journal of cardiology, 1985, Jan-25, Volume: 55, Issue:3

    Topics: Acute Disease; Angina Pectoris, Variant; Angina, Unstable; Calcium Channel Blockers; Coronary Diseas

1985
Use of calcium antagonists in ventricular dysfunction.
    The American journal of cardiology, 1985, Jan-25, Volume: 55, Issue:3

    Topics: Calcium Channel Blockers; Diltiazem; Heart Diseases; Heart Ventricles; Hemodynamics; Humans; Hyperte

1985
Are calcium antagonists cardioprotective?
    Journal of the Royal College of Physicians of London, 1985, Volume: 19, Issue:2

    Topics: Angina Pectoris; Animals; Blood Viscosity; Calcium Channel Blockers; Clinical Trials as Topic; Coron

1985
[Treatment of arrhythmia in myocardial infarct].
    Kardiologiia, 1968, Volume: 8, Issue:10

    Topics: Amides; Arrhythmias, Cardiac; Atrial Fibrillation; Atropine; Cardiac Complexes, Premature; Cardiac G

1968

Trials

100 trials available for verapamil and Cardiovascular Stroke

ArticleYear
Effects of verapamil and adenosine in an adjunct to tirofiban on resolution and prognosis of noreflow phenomenon in patients with acute myocardial infarction.
    Minerva cardioangiologica, 2014, Volume: 62, Issue:5

    Topics: Adenosine; Aged; Female; Fibrinolytic Agents; Follow-Up Studies; Hospital Mortality; Humans; Male; M

2014
Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
    American heart journal, 2008, Volume: 156, Issue:2

    Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Atenol

2008
Long-term stability of heart rate variability in chronic stable angina pectoris, and the impact of an acute myocardial infarction.
    Clinical physiology and functional imaging, 2009, Volume: 29, Issue:3

    Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Calcium Channel Blockers; Chronic Disease; Coron

2009
Pulse pressure and risk of cardiovascular outcomes in patients with hypertension and coronary artery disease: an INternational VErapamil SR-trandolapril STudy (INVEST) analysis.
    European heart journal, 2009, Volume: 30, Issue:11

    Topics: Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Coronary Artery Disease; Coronary Disease;

2009
Dipyridamole versus verapamil for treatment of no-reflow during primary angioplasty.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2010, Nov-15, Volume: 76, Issue:6

    Topics: Aged; Angioplasty, Balloon, Coronary; Chi-Square Distribution; Coronary Angiography; Coronary Circul

2010
REstoration of COronary flow in patients with no-reflow after primary coronary interVEntion of acute myocaRdial infarction (RECOVER).
    American heart journal, 2012, Volume: 164, Issue:3

    Topics: Aged; Coronary Circulation; Diltiazem; Electrocardiography; Female; Follow-Up Studies; Humans; Male;

2012
Risk prediction in stable angina pectoris.
    European journal of clinical investigation, 2013, Volume: 43, Issue:2

    Topics: Aged; Angina, Stable; Anti-Arrhythmia Agents; Blood Glucose; Creatinine; Double-Blind Method; Female

2013
Intracoronary verapamil for reversal of no-reflow during coronary angioplasty for acute myocardial infarction.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2002, Volume: 57, Issue:4

    Topics: Aged; Angioplasty, Balloon, Coronary; Calcium Channel Blockers; Cardiac Catheterization; Cohort Stud

2002
[Effect of calcium antagonists on long-term prognosis of patients with myocardial infarction].
    Kardiologiia, 2002, Volume: 42, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Calcium Channel Blockers; Drug Therapy, Combinatio

2002
Favourable long term prognosis in stable angina pectoris: an extended follow up of the angina prognosis study in Stockholm (APSIS).
    Heart (British Cardiac Society), 2006, Volume: 92, Issue:2

    Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Death, Sudden, Cardiac; Diab

2006
Early administration of intracoronary verapamil improves myocardial perfusion during percutaneous coronary interventions for acute myocardial infarction.
    Chest, 2005, Volume: 128, Issue:4

    Topics: Aged; Angioplasty, Balloon, Coronary; Blood Flow Velocity; Calcium Channel Blockers; Catheterization

2005
Optimization of myocardial perfusion after primary coronary angioplasty following an acute myocardial infarction. Beyond TIMI 3 flow.
    The Journal of invasive cardiology, 2006, Volume: 18, Issue:1

    Topics: Adenosine; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Circulation; Echocardiogra

2006
Prospective, randomised, controlled trial to study the effect of intracoronary injection of verapamil and adenosine on coronary blood flow during percutaneous coronary intervention in patients with acute coronary syndromes.
    Heart (British Cardiac Society), 2006, Volume: 92, Issue:9

    Topics: Adenosine; Angioplasty, Balloon, Coronary; Cohort Studies; Coronary Angiography; Coronary Circulatio

2006
The effect of verapamil on the restoration of myocardial perfusion and functional recovery in patients with angiographic no-reflow after primary percutaneous coronary intervention.
    Nuclear medicine communications, 2006, Volume: 27, Issue:3

    Topics: Aged; Angioplasty, Balloon, Coronary; Humans; Male; Myocardial Infarction; Myocardial Reperfusion In

2006
Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?
    Annals of internal medicine, 2006, Jun-20, Volume: 144, Issue:12

    Topics: Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Cause of Death; Coronary Artery Disease; Di

2006
Prognostic implications of renal dysfunction in patients with stable angina pectoris.
    Journal of internal medicine, 2006, Volume: 260, Issue:6

    Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Calcium Channel Blockers; Cardiovascular Disease

2006
Calcium channel blockers: indications and limitations 2. Use in angina and other cardiac disorders.
    Postgraduate medicine, 1982, Volume: 72, Issue:5

    Topics: Administration, Oral; Angina Pectoris; Angina Pectoris, Variant; Calcium Channel Blockers; Cardiomeg

1982
Serum lipoproteins after treatment with verapamil for 6 months.
    Acta medica Scandinavica. Supplementum, 1984, Volume: 681

    Topics: Adult; Aged; Cholesterol; Clinical Trials as Topic; Female; Humans; Lipoproteins; Male; Middle Aged;

1984
Verapamil in acute myocardial infarction. The Danish Study Group on Verapamil in Myocardial Infarction.
    European heart journal, 1984, Volume: 5, Issue:7

    Topics: Aged; Clinical Trials as Topic; Denmark; Double-Blind Method; Female; Follow-Up Studies; Humans; Mal

1984
Abrupt withdrawal of verapamil in ischaemic heart disease. The Danish Study Group on Verapamil in Myocardial Infarction.
    European heart journal, 1984, Volume: 5, Issue:7

    Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Clinical Trials as Topic; Double-Blind Method; F

1984
[Anti-angina effect of gallopamil in comparison with another calcium antagonist and a placebo].
    Zeitschrift fur Kardiologie, 1984, Volume: 73, Issue:9

    Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Double-Bli

1984
Reduction of creatine kinase and creatine kinase-MB indexes of infarct size by intravenous verapamil.
    The American journal of cardiology, 1984, Dec-01, Volume: 54, Issue:10

    Topics: Blood Pressure; Clinical Enzyme Tests; Clinical Trials as Topic; Creatine Kinase; Hemodynamics; Huma

1984
Verapamil in acute myocardial infarction. Danish Multicenter Study Group on Verapamil in Myocardial Infarction.
    The American journal of cardiology, 1984, Dec-21, Volume: 54, Issue:11

    Topics: Administration, Oral; Aged; Clinical Trials as Topic; Denmark; Female; Humans; Injections, Intraveno

1984
[Effect of isoptin (verapamil) on the indicators of central hemodynamics in patients with acute myocardial infarction].
    Kardiologiia, 1984, Volume: 24, Issue:10

    Topics: Adult; Aged; Blood Pressure; Cardiac Output; Clinical Trials as Topic; Depression, Chemical; Female;

1984
Effect of verapamil on enzyme release after early intravenous administration in acute myocardial infarction: double blind randomised trial.
    British medical journal (Clinical research ed.), 1983, Apr-02, Volume: 286, Issue:6371

    Topics: Aged; Clinical Trials as Topic; Creatine Kinase; Double-Blind Method; Female; Humans; Male; Myocardi

1983
[Reduction in CK- and CKMB-measured infarct size by verapamil].
    Deutsche medizinische Wochenschrift (1946), 1983, Jul-08, Volume: 108, Issue:27

    Topics: Blood Pressure; Creatine Kinase; Dose-Response Relationship, Drug; Furosemide; Heart Block; Heart Ra

1983
Variation of serum lipoproteins in postmyocardial infarction patients treated with verapamil or placebo.
    Acta medica Scandinavica. Supplementum, 1984, Volume: 681

    Topics: Adult; Aged; Cholesterol; Female; Humans; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Male;

1984
Verapamil does not alter platelet function in patients with recent myocardial infarction.
    Thrombosis research, 1983, Nov-15, Volume: 32, Issue:4

    Topics: Aged; Blood Platelets; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregatio

1983
Effects of verapamil in patients with acute myocardial infarction: hemodynamics and function of normal and ischemic left ventricular myocardium.
    American heart journal, 1984, Volume: 107, Issue:2

    Topics: Adult; Aged; Coronary Disease; Drug Evaluation; Echocardiography; Electrocardiography; Female; Heart

1984
Verapamil in acute myocardial infarction. The Danish Multicentre Study Group.
    Clinical and experimental pharmacology & physiology. Supplement, 1982, Volume: 6

    Topics: Calcium Channel Blockers; Clinical Trials as Topic; Coronary Care Units; Coronary Vasospasm; Denmark

1982
Superiority of verapamil to propranolol in stable angina pectoris: a double-blind, randomized crossover trail.
    Circulation, 1982, Volume: 65, Issue:1 Pt 2

    Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Electrocardiography; Fe

1982
Radionuclide evaluation of CHF.
    Acta medica Scandinavica. Supplementum, 1981, Volume: 652

    Topics: Adolescent; Adult; Coronary Disease; Digoxin; Female; Heart Aneurysm; Heart Failure; Hemodynamics; H

1981
[Results of trials of limiting the size of the focal lesion in myocardial infarct infarct by drugs].
    Terapevticheskii arkhiv, 1982, Volume: 54, Issue:11

    Topics: Clinical Trials as Topic; Electrocardiography; Humans; Hyaluronoglucosaminidase; Myocardial Infarcti

1982
Verapamil in acute myocardial infarction.
    Danish medical bulletin, 1980, Volume: 27, Issue:2

    Topics: Aged; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Myocardial Infarction; Random All

1980
Verapamil in acute myocardial infarction.
    Clinical and investigative medicine. Medecine clinique et experimentale, 1980, Volume: 3, Issue:1-2

    Topics: Adult; Aged; Clinical Trials as Topic; Female; Heart Block; Heart Failure; Humans; Male; Middle Aged

1980
Hemodynamic effects of calcium ion antagonists after acute myocardial infarction.
    Clinical and investigative medicine. Medecine clinique et experimentale, 1980, Volume: 3, Issue:1-2

    Topics: Adult; Aged; Benzazepines; Blood Pressure; Clinical Trials as Topic; Diltiazem; Heart Rate; Humans;

1980
[Behaviour of serum CPK curves in acute myocardial infarction treated with digitalis, verapamil and combined verapamil-digitalis (author's transl)].
    Giornale italiano di cardiologia, 1981, Volume: 11, Issue:7

    Topics: Adult; Aged; Clinical Enzyme Tests; Creatine Kinase; Digoxin; Female; Glucose; Humans; Insulin; Male

1981
Postinfarct treatment with verapamil. Effect of verapamil in patients with hypertension.
    Drugs, 1993, Volume: 46 Suppl 2

    Topics: Cerebrovascular Disorders; Death, Sudden, Cardiac; Denmark; Double-Blind Method; Follow-Up Studies;

1993
[The comparative efficacy of verapamil, nifedipine and propranolol in patients with IHD and an enhanced risk of a fatal outcome].
    Terapevticheskii arkhiv, 1994, Volume: 66, Issue:8

    Topics: Adult; Cardiac Complexes, Premature; Electrocardiography, Ambulatory; Exercise Tolerance; Humans; Ma

1994
[10-year mortality of patients admitted to coronary units with or without confirmed diagnosis of myocardial infarction. A relation to anamnesis and diagnosis at discharge].
    Ugeskrift for laeger, 1995, Jul-03, Volume: 157, Issue:27

    Topics: Adult; Aged; Coronary Care Units; Denmark; Female; Humans; Male; Middle Aged; Myocardial Infarction;

1995
Short- and long-term prognostic implications of in-hospital postinfarction arrhythmias. DAVIT II Study Group.
    Cardiology, 1995, Volume: 86, Issue:1

    Topics: Aged; Arrhythmias, Cardiac; Humans; Multivariate Analysis; Myocardial Infarction; Prognosis; Verapam

1995
Role of ischemia in postinfarction heart failure: hypothetical considerations based on use of verapamil in the DAVIT II Study. Danish Study Group on Verapamil in Myocardial Infarction.
    Cardiovascular drugs and therapy, 1994, Volume: 8, Issue:6

    Topics: Angina Pectoris; Computer Communication Networks; Double-Blind Method; Heart Failure; Humans; Myocar

1994
Effect of verapamil on the prognosis of patients with early postinfarction electrical or mechanical complications. The Danish Verapamil Infarction Trial II (DAVIT II).
    International journal of cardiology, 1995, Mar-03, Volume: 48, Issue:3

    Topics: Aged; Arrhythmias, Cardiac; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Humans; M

1995
Review of postinfarct treatment with verapamil: combined experience of early and late intervention studies with verapamil in patients with acute myocardial infarction. Danish Study Group on Verapamil in Myocardial Infarction.
    Cardiovascular drugs and therapy, 1994, Volume: 8 Suppl 3

    Topics: Denmark; Double-Blind Method; Drug Administration Schedule; Drug Evaluation; Humans; Myocardial Infa

1994
The prognostic significance of post-infarction angina pectoris and the effect of verapamil on the incidence of angina pectoris and prognosis. The Danish Study Group on Verapamil in Myocardial Infarction.
    European heart journal, 1994, Volume: 15, Issue:2

    Topics: Adult; Aged; Angina Pectoris; Denmark; Double-Blind Method; Female; Follow-Up Studies; Humans; Male;

1994
Effect of verapamil on arrhythmias and heart rate during 16 months following an acute myocardial infarction. The Danish Study Group on Verapamil in Myocardial Infarction.
    Cardiovascular drugs and therapy, 1994, Volume: 8, Issue:1

    Topics: Aged; Arrhythmias, Cardiac; Double-Blind Method; Electrocardiography; Female; Heart Rate; Humans; Ma

1994
Mortality of patients excluded from the Danish Verapamil Infarction Trail II. The DAVIT-II Study Group.
    European heart journal, 1993, Volume: 14, Issue:3

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Calcium Channel Blockers; Clinical Protocols; Clinical Tri

1993
Effect of verapamil on reinfarction and cardiovascular events in patients with arterial hypertension included in the Danish Verapamil Infarction Trial II. The Danish Study Group on Verapamil in Myocardial Infarction.
    Journal of human hypertension, 1994, Volume: 8, Issue:2

    Topics: Aged; Blood Pressure; Cardiovascular System; Denmark; Double-Blind Method; Female; Humans; Hypertens

1994
Does exercise-induced ST-segment depression predict benefit of medical intervention in patients recovering from acute myocardial infarction? The Danish Study Group on Verapamil in Myocardial Infarction.
    Journal of internal medicine, 1993, Volume: 233, Issue:1

    Topics: Aged; Electrocardiography; Exercise Test; Female; Follow-Up Studies; Heart Failure; Humans; Male; Mi

1993
Ventricular arrhythmias in patients recovering from myocardial infarction: do residual myocardial ischemia and anti-ischemic medical intervention influence the one-month prevalence? The Danish Study Group on Verapamil in Myocardial Infarction.
    Clinical cardiology, 1993, Volume: 16, Issue:2

    Topics: Aged; Arrhythmias, Cardiac; Double-Blind Method; Electrocardiography, Ambulatory; Exercise Test; Fem

1993
The effect of verapamil on major events in patients with impaired cardiac function recovering from acute myocardial infarction. The Danish Study Group on Verapamil in Myocardial Infarction.
    European heart journal, 1993, Volume: 14, Issue:4

    Topics: Denmark; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction;

1993
Verapamil and circadian variation of sudden cardiac death.
    American heart journal, 1996, Volume: 131, Issue:2

    Topics: Calcium Channel Blockers; Circadian Rhythm; Death, Sudden, Cardiac; Double-Blind Method; Humans; Myo

1996
A controlled trial of verapamil in patients after acute myocardial infarction: results of the calcium antagonist reinfarction Italian study (CRIS)
    The American journal of cardiology, 1996, Feb-15, Volume: 77, Issue:5

    Topics: Adult; Aged; Calcium Channel Blockers; Double-Blind Method; Female; Humans; Male; Middle Aged; Myoca

1996
Comparison of verapamil versus felodipine on heart rate variability after acute myocardial infarction.
    The American journal of cardiology, 1997, Mar-01, Volume: 79, Issue:5

    Topics: Blood Pressure; Calcium Channel Blockers; Delayed-Action Preparations; Electrocardiography, Ambulato

1997
Cardiac event rates after acute myocardial infarction in patients treated with verapamil and trandolapril versus trandolapril alone. Danish Verapamil Infarction Trial (DAVIT) Study Group.
    The American journal of cardiology, 1997, Mar-15, Volume: 79, Issue:6

    Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Denmark; Diuretics; Double

1997
The prognostic significance of angina pectoris experienced during the first month following acute myocardial infarction.
    Clinical cardiology, 1997, Volume: 20, Issue:7

    Topics: Adult; Aged; Angina Pectoris; Calcium Channel Blockers; Chi-Square Distribution; Confidence Interval

1997
[Comparative study of verapamil and bisoprolol in the secondary prevention of myocardial infarction].
    Orvosi hetilap, 1997, Aug-03, Volume: 138, Issue:31

    Topics: Adrenergic beta-Antagonists; Bisoprolol; Calcium Channel Blockers; Female; Humans; Male; Middle Aged

1997
Calcium channel blockers: an evidence-based review.
    The Canadian journal of cardiology, 1997, Volume: 13, Issue:8

    Topics: Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Diltiazem; Humans; Myocardial In

1997
Treatment with verapamil and trandolapril in patients with congestive heart failure and angina pectoris or myocardial infarction. The DAVIT Study Group. Danish Verapamil Infarction Trial.
    American heart journal, 1997, Volume: 134, Issue:2 Pt 2

    Topics: Adult; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Diuretic

1997
Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction.
    Journal of the American College of Cardiology, 1997, Nov-01, Volume: 30, Issue:5

    Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Vessels; Echocardiograph

1997
Congestive heart failure and ischaemic heart disease treated with trandolapril and verapamil. DAVIT Study Group. Danish Verapamil Infarction Trial.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1998, Volume: 16, Issue:1

    Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Clinica

1998
Comparison of the prognosis after early versus late recurrent nonfatal myocardial infarction. DAVIT Study Group. Danish Verapamil Infarction Trial.
    American heart journal, 1998, Volume: 136, Issue:1

    Topics: Aged; Denmark; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Myocardial Infarctio

1998
Rationale and design for the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) Trial.
    Controlled clinical trials, 1998, Volume: 19, Issue:4

    Topics: Aged; Antihypertensive Agents; Atenolol; Cardiovascular Diseases; Cerebrovascular Disorders; Double-

1998
Effect of verapamil on heart rate variability after an acute myocardial infarction. Danish Verapamil Infarction Trial II.
    Cardiovascular drugs and therapy, 1998, Volume: 12, Issue:3

    Topics: Aged; Anti-Arrhythmia Agents; Circadian Rhythm; Double-Blind Method; Female; Heart Rate; Humans; Mal

1998
Temporal pattern of the effect of verapamil on myocardial reinfarction. DAVIT Study Group. Danish Verapamil Infarction Trial.
    Cardiovascular drugs and therapy, 1998, Volume: 12, Issue:4

    Topics: Aged; Double-Blind Method; Humans; Myocardial Infarction; Secondary Prevention; Time Factors; Verapa

1998
Nonsteroidal anti-inflammatory drugs after acute myocardial infarction. DAVIT Study Group. Danish Verapamil Infarction Trial.
    The American journal of cardiology, 1999, Apr-15, Volume: 83, Issue:8

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Calcium Channel Blockers; Drug Therapy, Combination;

1999
The effect of verapamil on left ventricular remodelling and diastolic function after acute myocardial infarction (the Verapamil Infarction Study on Remodelling and Relaxation--VISOR).
    Cardiovascular drugs and therapy, 1999, Volume: 13, Issue:4

    Topics: Calcium Channel Blockers; Diastole; Double-Blind Method; Echocardiography; Echocardiography, Doppler

1999
Early administration of verapamil after thrombolysis in acute anterior myocardial infarction. Effect on left ventricular remodeling and clinical outcome. VAMI Study Group. Verapamil Acute Myocardial Infarction.
    Italian heart journal : official journal of the Italian Federation of Cardiology, 2000, Volume: 1, Issue:5

    Topics: Calcium Channel Blockers; Double-Blind Method; Echocardiography; Female; Humans; Male; Middle Aged;

2000
Long-term effects of diltiazem and verapamil on mortality and cardiac events in non-Q-wave acute myocardial infarction without pulmonary congestion: post hoc subset analysis of the multicenter diltiazem postinfarction trial and the second danish verapamil
    The American journal of cardiology, 2000, Aug-01, Volume: 86, Issue:3

    Topics: Adult; Aged; Calcium Channel Blockers; Denmark; Diltiazem; Electrocardiography; Female; Follow-Up St

2000
Prognostic implications of intima-media thickness and plaques in the carotid and femoral arteries in patients with stable angina pectoris.
    European heart journal, 2001, Volume: 22, Issue:1

    Topics: Aged; Angina Pectoris; Arteriosclerosis; Carotid Arteries; Carotid Artery Diseases; Coronary Artery

2001
Prognostic implications of autonomic function assessed by analyses of catecholamines and heart rate variability in stable angina pectoris.
    Heart (British Cardiac Society), 2002, Volume: 87, Issue:5

    Topics: Adult; Aged; Angina Pectoris; Anti-Arrhythmia Agents; Autonomic Nervous System Diseases; Biomarkers;

2002
Effects of training and of verapamil on exercise capacity in patients recovering from myocardial infarction. A double-blind study.
    Cardiology, 1979, Volume: 64, Issue:6

    Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Exercise Test; Female; Hemodynamics; Hum

1979
Calcium antagonists in the treatment early after myocardial infarction. The DEFIANT Research Group.
    Journal of cardiovascular pharmacology, 1992, Volume: 20 Suppl 5

    Topics: Adult; Aged; Calcium Channel Blockers; Denmark; Diltiazem; Echocardiography, Doppler; Humans; Middle

1992
Secondary prevention with calcium antagonists after acute myocardial infarction.
    Drugs, 1992, Volume: 44 Suppl 1

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Diltiazem; Female; Humans; Male; Middle Aged; Myocardial I

1992
The significance of myocardial ischaemia and verapamil treatment on the prevalence of supraventricular tachyarrhythmias in patients recovering from acute myocardial infarction. Danish Study Group on Verapamil in Myocardial Infarction.
    European heart journal, 1992, Volume: 13, Issue:10

    Topics: Double-Blind Method; Electrocardiography, Ambulatory; Exercise Test; Female; Humans; Male; Middle Ag

1992
[Calcium antagonists. The prevention of a recurrent myocardial infarct and sudden death].
    Terapevticheskii arkhiv, 1992, Volume: 64, Issue:9

    Topics: Calcium Channel Blockers; Death, Sudden, Cardiac; Drug Therapy, Combination; Electrocardiography, Am

1992
[Verapamil therapy improves the prognosis after acute myocardial infarction. A review over the Danish studies of verapamil therapy during and after acute myocardial infarction].
    Ugeskrift for laeger, 1992, Feb-10, Volume: 154, Issue:7

    Topics: Denmark; Humans; Myocardial Infarction; Prognosis; Recurrence; Verapamil

1992
[Verapamil and "fatherhood"].
    Ugeskrift for laeger, 1992, Mar-23, Volume: 154, Issue:13

    Topics: Humans; Myocardial Infarction; Verapamil

1992
Prevalence of transient myocardial ischaemia during the first year after a myocardial infarction. Effect of treatment with verapamil. The Danish Study Group on Verapamil in Myocardial Infarction.
    European heart journal, 1992, Volume: 13, Issue:5

    Topics: Aged; Circadian Rhythm; Coronary Disease; Denmark; Double-Blind Method; Drug Administration Schedule

1992
Treatment with verapamil after an acute myocardial infarction. Review of the Danish studies on verapamil in myocardial infarction (DAVIT I and II).
    Drugs, 1991, Volume: 42 Suppl 2

    Topics: Angina Pectoris; Blood Pressure; Denmark; Double-Blind Method; Female; Heart Rate; Humans; Male; Met

1991
Treatment with verapamil during and after an acute myocardial infarction: a review based on the Danish Verapamil Infarction Trials I and II. The Danish Study Group on Verapamil in Myocardial Infarction.
    Journal of cardiovascular pharmacology, 1991, Volume: 18 Suppl 6

    Topics: Arrhythmias, Cardiac; Blood Pressure; Death, Sudden, Cardiac; Denmark; Double-Blind Method; Female;

1991
Effect of verapamil on ischemia and ventricular arrhythmias after an acute myocardial infarction: prognostic implications. The Danish Verapamil Infarction Trial II Study Group.
    Journal of cardiovascular pharmacology, 1991, Volume: 18 Suppl 6

    Topics: Analysis of Variance; Arrhythmias, Cardiac; Coronary Disease; Female; Heart Rate; Humans; Male; Myoc

1991
The effect of verapamil on major events in patients with exercise-induced ischemia recovering from acute myocardial infarction: a review. The Danish Study Group on Verapamil in Myocardial Infarction.
    Journal of cardiovascular pharmacology, 1991, Volume: 18 Suppl 6

    Topics: Blood Pressure; Coronary Disease; Double-Blind Method; Electrocardiography; Exercise Test; Female; H

1991
The effects of verapamil on training in patients with ischemic heart disease.
    Chest, 1992, Volume: 101, Issue:2

    Topics: Anaerobic Threshold; Double-Blind Method; Energy Metabolism; Exercise Therapy; Heart Rate; Humans; M

1992
Changes in calcium homoeostasis and bone formation in patients recovering from acute myocardial infarction: effect of verapamil treatment. Danish Study Group on Verapamil in Myocardial Infarction.
    European journal of clinical pharmacology, 1991, Volume: 41, Issue:6

    Topics: Alkaline Phosphatase; Bone Remodeling; Calcium; Denmark; Diphosphonates; Double-Blind Method; Female

1991
[Unstable angina and infarction without Q wave treated with verapamil: value of the early exercise test].
    Annales de cardiologie et d'angeiologie, 1991, Volume: 40, Issue:6

    Topics: Adult; Aged; Angina, Unstable; Electrocardiography; Exercise Test; Female; Humans; Male; Middle Aged

1991
Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies.
    The American journal of cardiology, 1991, Jun-01, Volume: 67, Issue:15

    Topics: Angina, Unstable; Calcium Channel Blockers; Denmark; Humans; Myocardial Infarction; Nicardipine; Nif

1991
Secondary prevention of death and reinfarction with verapamil after an acute myocardial infarction. The Danish Study Group on Verapamil in Myocardial Infarction.
    Journal of human hypertension, 1990, Volume: 4 Suppl 5

    Topics: Anti-Arrhythmia Agents; Antihypertensive Agents; Coronary Disease; Death, Sudden; Denmark; Double-Bl

1990
Secondary prevention with verapamil after myocardial infarction. The Danish Study Group on Verapamil in Myocardial Infarction.
    The American journal of cardiology, 1990, Dec-18, Volume: 66, Issue:21

    Topics: Cholesterol; Double-Blind Method; Female; Humans; Male; Meta-Analysis as Topic; Myocardial Infarctio

1990
[The effect of various types of stress-limiting therapy on the outcome of myocardial infarction].
    Kardiologiia, 1990, Volume: 30, Issue:3

    Topics: Aged; Antioxidants; Clinical Trials as Topic; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Fe

1990
Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II--DAVIT II)
    The American journal of cardiology, 1990, Oct-01, Volume: 66, Issue:10

    Topics: Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Myocardial Infarction; Verapamil

1990
Assessment of blindness in the Danish Verapamil Infarction Trial II (DAVIT II). Danish Study Group on Verapamil in Myocardial Infarction.
    European journal of clinical pharmacology, 1990, Volume: 39, Issue:1

    Topics: Adolescent; Adult; Aged; Angina Pectoris; Denmark; Female; Humans; Male; Middle Aged; Multicenter St

1990
Reduction of myocardial injury with verapamil before aortic cross-clamping.
    The Annals of thoracic surgery, 1990, Volume: 49, Issue:3

    Topics: Aged; Aged, 80 and over; Aorta; Cardioplegic Solutions; Cardiopulmonary Bypass; Coronary Artery Bypa

1990
Review of calcium antagonist trials in acute myocardial infarction.
    Clinical cardiology, 1989, Volume: 12, Issue:7 Suppl 3

    Topics: Calcium Channel Blockers; Diltiazem; Humans; Myocardial Infarction; Nifedipine; Randomized Controlle

1989
Current status of calcium channel blocking drugs after myocardial infarction.
    European heart journal, 1986, Volume: 7 Suppl A

    Topics: Calcium Channel Blockers; Canada; Clinical Trials as Topic; Denmark; Diltiazem; Humans; Myocardial I

1986
The Danish studies on verapamil in acute myocardial infarction. The Danish Study Group on Verapamil in Myocardial Infarction.
    British journal of clinical pharmacology, 1986, Volume: 21 Suppl 2

    Topics: Aged; Clinical Trials as Topic; Denmark; Female; Humans; Male; Middle Aged; Myocardial Infarction; R

1986
Secondary prevention with calcium channel-blocking drugs in patients after myocardial infarction: a critical review.
    Circulation, 1987, Volume: 75, Issue:6 Pt 2

    Topics: Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; Humans; Myocardial Infarction; Nifedi

1987
Are calcium antagonists cardioprotective?
    Journal of the Royal College of Physicians of London, 1985, Volume: 19, Issue:2

    Topics: Angina Pectoris; Animals; Blood Viscosity; Calcium Channel Blockers; Clinical Trials as Topic; Coron

1985
Effects of verapamil in preventing early postinfarction angina and reinfarction.
    The American journal of cardiology, 1985, Apr-01, Volume: 55, Issue:8

    Topics: Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Creatine Kinase; Electrocardiograph

1985
[The antiarrhythmic and coronary-dilating properties of verapamil in patients ith ischemic heart disease].
    Arzneimittel-Forschung, 1970, Volume: 20

    Topics: Adult; Anti-Arrhythmia Agents; Antihypertensive Agents; Arrhythmias, Cardiac; Arteriosclerosis; Bloo

1970

Other Studies

274 other studies available for verapamil and Cardiovascular Stroke

ArticleYear
Synthesis and biological evaluation of substituted benzenesulfonamides as novel potent membrane-bound phospholipase A2 inhibitors.
    Journal of medicinal chemistry, 1991, Volume: 34, Issue:7

    Topics: Animals; Benzene Derivatives; Cell Membrane; Chemical Phenomena; Chemistry; Enzyme Inhibitors; Heart

1991
Synthesis of some hydroxynaphthazarins and their cardioprotective effects under ischemia-reperfusion in vivo.
    Bioorganic & medicinal chemistry letters, 1998, Mar-17, Volume: 8, Issue:6

    Topics: Animals; Hydroxylation; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Models, Chemical;

1998
Risk and Blood Pressure Control Rates Across the Spectrum of Coronary Artery Disease in Hypertensive Women: An Analysis from The INternational VErapamil SR-Trandolapril STudy (INVEST).
    Journal of women's health (2002), 2020, Volume: 29, Issue:2

    Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Cha

2020
Safety of Calcium-Channel Blockers During Radial Cardiac Catheterization in Patients With Acute Myocardial Infarction or Systolic Heart Failure.
    The Journal of invasive cardiology, 2019, Volume: 31, Issue:4

    Topics: Aged; Calcium Channel Blockers; Cardiac Catheterization; Catheterization, Peripheral; Drug Monitorin

2019
Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity.
    Journal of visualized experiments : JoVE, 2019, 07-10, Issue:149

    Topics: Amides; Animals; Cell Adhesion; Cell Adhesion Molecules; Cell Differentiation; Cells, Cultured; Dise

2019
Verapamil reverses myocardial no-reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction.
    Cell biochemistry and biophysics, 2013, Volume: 67, Issue:3

    Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Atropine; Bradycardia; Coronary Angiography; Female;

2013
Delayed Purkinje potentials during sinus rhythm in post MI patients-an underrecognized target for VT ablation?
    Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2008, Volume: 22, Issue:3

    Topics: Electrocardiography; Humans; Male; Middle Aged; Myocardial Infarction; Purkinje Fibers; Tachycardia,

2008
Verapamil-sensitive left anterior fascicular ventricular tachycardia associated with a healed myocardial infarction: changes in the delayed Purkinje potential during sinus rhythm.
    Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2008, Volume: 22, Issue:3

    Topics: Electrocardiography; Humans; Male; Middle Aged; Myocardial Infarction; Purkinje Fibers; Tachycardia,

2008
Prevalent role of Akt and ERK activation in cardioprotective effect of Ca(2+) channel- and beta-adrenergic receptor blockers.
    Molecular and cellular biochemistry, 2009, Volume: 321, Issue:1-2

    Topics: Adrenergic beta-Antagonists; Animals; Benzimidazoles; Calcium Channel Blockers; Cardiotonic Agents;

2009
Cardioprotection by HO-4038, a novel verapamil derivative, targeted against ischemia and reperfusion-mediated acute myocardial infarction.
    American journal of physiology. Heart and circulatory physiology, 2009, Volume: 296, Issue:1

    Topics: Animals; Anti-Arrhythmia Agents; Antioxidants; Blotting, Western; Calcium Channel Blockers; Calcium

2009
Pathology, imaging and treatment of cardiac microvascular obstruction.
    Thrombosis research, 2010, Volume: 125, Issue:2

    Topics: Adenosine; Coronary Vessels; Humans; Magnetic Resonance Angiography; Myocardial Infarction; Nicorand

2010
No-reflow phenomenon following percutaneous coronary intervention for acute myocardial infarction: incidence, outcome, and effect of pharmacologic therapy.
    Journal of interventional cardiology, 2010, Volume: 23, Issue:5

    Topics: Angioplasty, Balloon, Coronary; Calcium Channel Blockers; Cardiac Catheterization; Female; Fractiona

2010
Drug-disease interaction: reduced verapamil response in isoproterenol-induced myocardial injury in rats.
    Pharmacology, 2010, Volume: 86, Issue:4

    Topics: Animals; Blotting, Western; Calcium Channel Blockers; Calcium Channels, L-Type; Disease Models, Anim

2010
No-reflow: Still searching for that magic bullet.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2010, Nov-15, Volume: 76, Issue:6

    Topics: Angioplasty, Balloon, Coronary; Coronary Circulation; Dipyridamole; Humans; Myocardial Infarction; N

2010
Acute myocardial infarction caused by multivessel coronary spasm due to calcium channel blocker withdrawal.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2011, Aug-01, Volume: 78, Issue:2

    Topics: Calcium Channel Blockers; Coronary Angiography; Coronary Vasospasm; Drug Administration Schedule; El

2011
How to manage no reflow phenomenon with local drug delivery via a rapid exchange catheter.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2011, Feb-01, Volume: 77, Issue:2

    Topics: Aged; Angioplasty, Balloon, Coronary; Catheters; Coronary Angiography; Drug Administration Routes; D

2011
Harmful effects of NSAIDs among patients with hypertension and coronary artery disease.
    The American journal of medicine, 2011, Volume: 124, Issue:7

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Blood Pressure; Celec

2011
Cardiac G-protein-coupled receptor kinase 2 ablation induces a novel Ca2+ handling phenotype resistant to adverse alterations and remodeling after myocardial infarction.
    Circulation, 2012, May-01, Volume: 125, Issue:17

    Topics: Adrenergic beta-Agonists; Animals; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Cycl

2012
No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention.
    American heart journal, 2003, Volume: 145, Issue:1

    Topics: Aged; Angioplasty, Balloon, Coronary; Case-Control Studies; Cause of Death; Coronary Angiography; Co

2003
Treatment of no-reflow phenomenon with verapamil after primary stent deployment during myocardial infarction.
    Japanese heart journal, 2002, Volume: 43, Issue:6

    Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Circulation; Female; Humans; Middle A

2002
[DRUG THERAPY OF CORONARY INSUFFICIENCY].
    Medizinische Klinik, 1965, May-21, Volume: 60

    Topics: Anti-Arrhythmia Agents; Coronary Artery Disease; Coronary Disease; Humans; Myocardial Infarction; Ve

1965
Distal filter protection during percutaneous coronary intervention in native coronary arteries and saphenous vein grafts in patients with acute coronary syndromes.
    Italian heart journal : official journal of the Italian Federation of Cardiology, 2003, Volume: 4, Issue:9

    Topics: Acute Disease; Aged; Angioplasty, Balloon, Coronary; Balloon Occlusion; Biomarkers; Blood Vessel Pro

2003
Management of patients with persistent chest pain and ST-segment elevation during 5-fluorouracil treatment: report about two cases.
    Italian heart journal : official journal of the Italian Federation of Cardiology, 2003, Volume: 4, Issue:12

    Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Antimetabolites, Antineoplas

2003
Antihypertensive and anti-arrhythmic effects of an extract of Radix Stephaniae Tetrandrae in the rat.
    The Journal of pharmacy and pharmacology, 2004, Volume: 56, Issue:1

    Topics: Alkaloids; Animals; Arrhythmias, Cardiac; Arterial Occlusive Diseases; Benzylisoquinolines; Calcium

2004
Oxygen-dependent mechanisms underlying the antiischemic effect of verapamil and amlodipine.
    Bulletin of experimental biology and medicine, 2004, Volume: 137, Issue:1

    Topics: Amlodipine; Animals; Hemoglobins; Lipid Peroxidation; Malondialdehyde; Myocardial Infarction; Myocar

2004
Intracoronary verapamil rapidly terminates reperfusion tachyarrhythmias in acute myocardial infarction.
    Chest, 2004, Volume: 126, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Anti-Arrhythmia Agents; Calcium Chan

2004
Myocardial infarction non-invasively induced in rabbits by administering isoproterenol and vasopressin: protective effects exerted by verapamil.
    Fundamental & clinical pharmacology, 2004, Volume: 18, Issue:6

    Topics: Animals; Blood Pressure; Calcium Channel Blockers; Disease Models, Animal; Electrocardiography; Hear

2004
Large myocardial infarction and a severe spasm of the left coronary artery.
    Zeitschrift fur Kardiologie, 2004, Volume: 93, Issue:12

    Topics: Adult; Contrast Media; Coronary Angiography; Coronary Vasospasm; Diagnosis, Differential; Female; Fo

2004
2APB- and JTV519(K201)-sensitive micro Ca2+ waves in arrhythmogenic Purkinje cells that survive in infarcted canine heart.
    Heart rhythm, 2004, Volume: 1, Issue:2

    Topics: Adrenergic beta-Agonists; Aniline Compounds; Animals; Boron Compounds; Calcium; Calcium Channel Bloc

2004
Predictors of adverse outcome among patients with hypertension and coronary artery disease.
    Journal of the American College of Cardiology, 2006, Feb-07, Volume: 47, Issue:3

    Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Calcium

2006
The role of vasodilators in the prevention and treatment of no-reflow following percutaneous coronary intervention.
    Heart (British Cardiac Society), 2006, Volume: 92, Issue:9

    Topics: Adenosine; Angioplasty, Balloon, Coronary; Humans; Microcirculation; Myocardial Infarction; Myocardi

2006
Calmodulin kinase II inhibition protects against myocardial cell apoptosis in vivo.
    American journal of physiology. Heart and circulatory physiology, 2006, Volume: 291, Issue:6

    Topics: Adrenergic beta-Agonists; Animals; Apoptosis; Calcium; Calcium Channel Blockers; Calcium-Binding Pro

2006
Recurrent apical ballooning despite treatment with verapamil.
    Cardiology, 2007, Volume: 108, Issue:3

    Topics: Aged; Calcium Channel Blockers; Cardiomyopathies; Coronary Angiography; Diagnosis, Differential; Ele

2007
Radial artery graft treatment with phenoxybenzamine is clinically safe and may reduce perioperative myocardial injury.
    The Annals of thoracic surgery, 2007, Volume: 83, Issue:2

    Topics: Aged; Cardiac Output, Low; Coronary Artery Bypass; Creatine Kinase; Drug Combinations; Electrocardio

2007
N-hydroxy-pyrroline modification of verapamil exhibits antioxidant protection of the heart against ischemia/reperfusion-induced cardiac dysfunction without compromising its calcium antagonistic activity.
    The Journal of pharmacology and experimental therapeutics, 2007, Volume: 323, Issue:1

    Topics: Action Potentials; Animals; Calcium Channel Blockers; Calcium Channels; Free Radical Scavengers; In

2007
Verapamil-sensitive left posterior fascicular ventricular tachycardia after myocardial infarction.
    Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2008, Volume: 21, Issue:1

    Topics: Anti-Arrhythmia Agents; Bundle-Branch Block; Humans; Male; Middle Aged; Myocardial Infarction; Tachy

2008
Recent concepts in the management of ischaemic cardiac syndromes.
    Australian family physician, 1982, Volume: 11, Issue:1

    Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina Pectoris, Variant; Calcium Channel Blockers; Co

1982
Comparative investigation of the effects of metoprolol, propranolol, practolol, and verapamil in the acute phase of experimental myocardial infarction.
    Klinische Wochenschrift, 1982, Jan-15, Volume: 60, Issue:2

    Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Blood Pressure; Calcium Channel Blockers

1982
Atrial fibrillation.
    American family physician, 1982, Volume: 25, Issue:6

    Topics: Age Factors; Aged; Atrial Fibrillation; Cardiomegaly; Digoxin; Electric Countershock; Electrocardiog

1982
Modification of "depressed fast channel dependent slow conduction" by lidocaine and verapamil in the presence or absence of catecholamines--evidence for alteration of preferential ionic channels for slow conduction.
    Japanese circulation journal, 1983, Volume: 47, Issue:1

    Topics: Action Potentials; Animals; Catecholamines; Guinea Pigs; Heart Conduction System; In Vitro Technique

1983
Development of immune complex nephritis during treatment with the calcium channel-blocking agent nifedipine.
    Human pathology, 1984, Volume: 15, Issue:7

    Topics: Antigen-Antibody Complex; Fluorescent Antibody Technique; Glomerulonephritis; Humans; Kidney; Kidney

1984
Verapamil in ventricular tachycardia.
    Cardiology, 1984, Volume: 71, Issue:4

    Topics: Adolescent; Adult; Aged; Cardiac Pacing, Artificial; Coronary Disease; Dose-Response Relationship, D

1984
Protection of hypoxic myocardium by intracoronary administration of verapamil in open-chest dogs.
    Circulation, 1984, Volume: 70, Issue:4

    Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Dogs; Energy Metabo

1984
[Comparative studies on the anti-arrhythmic and anti-fibrillatory effectiveness of verapamil and nifedipine following acute coronary artery occlusion and reperfusion].
    Zeitschrift fur Kardiologie, 1984, Volume: 73, Issue:8

    Topics: Animals; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Coronary Circulation; Dogs; Electrocardio

1984
Repetitive, monomorphic ventricular tachycardia: clinical and electrophysiologic characteristics in patients with and patients without organic heart disease.
    The American journal of cardiology, 1984, Nov-01, Volume: 54, Issue:8

    Topics: Adolescent; Adult; Aged; Cardiac Pacing, Artificial; Electrocardiography; Exercise Test; Female; Hum

1984
Conversion of longstanding atrial flutter to sinus rhythm and transient complete A-V block following oral administration of verapamil. Report of a case.
    Giornale italiano di cardiologia, 1984, Volume: 14, Issue:8

    Topics: Aged; Atrial Flutter; Electrocardiography; Heart Block; Humans; Male; Myocardial Infarction; Verapam

1984
Rabbit hearts for the critical evaluation of drugs to reduce the size of experimentally produced acute myocardial infarction.
    Japanese heart journal, 1984, Volume: 25, Issue:4

    Topics: Animals; Calcium Channel Blockers; Dilazep; Male; Myocardial Infarction; Myocardium; Propranolol; Ra

1984
Verapamil in two reperfusion models of myocardial infarction. Temporary protection of severely ischemic myocardium without limitation of ultimate infarct size.
    Laboratory investigation; a journal of technical methods and pathology, 1984, Volume: 51, Issue:6

    Topics: Animals; Collateral Circulation; Coronary Circulation; Coronary Disease; Disease Models, Animal; Dog

1984
[Anti-aggregation effect of verapamil in healthy persons and in patients after myocardial infarct].
    Vnitrni lekarstvi, 1984, Volume: 30, Issue:8

    Topics: Adult; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Verapamil

1984
[Use of verapamil in acute myocardial infarct].
    Terapevticheskii arkhiv, 1984, Volume: 56, Issue:9

    Topics: Adult; Aged; Creatine Kinase; Drug Evaluation; Electrocardiography; Female; Heart Rate; Humans; Isoe

1984
[Comparative effects of obsidan and isoptin on the size of myocardial infarction].
    Kardiologiia, 1984, Volume: 24, Issue:10

    Topics: Adult; Aged; Female; Heart; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Propranolo

1984
[Use of isoptin in the acute period of myocardial infarction (its effect on hemodynamics and myocardial metabolism)].
    Kardiologiia, 1984, Volume: 24, Issue:10

    Topics: Adult; Fatty Acids, Nonesterified; Glucose; Hemodynamics; Humans; Lactates; Male; Middle Aged; Myoca

1984
Myocardial infarct size limitation. Principles, problems and possibilities.
    Giornale italiano di cardiologia, 1984, Volume: 14, Issue:11

    Topics: Allopurinol; Animals; Coronary Circulation; Dogs; Flurbiprofen; Humans; Metoprolol; Myocardial Infar

1984
Natural history of pure coronary artery spasm in patients treated medically.
    Journal of the American College of Cardiology, 1983, Volume: 2, Issue:2

    Topics: Adult; Aged; Coronary Artery Bypass; Coronary Vasospasm; Electrocardiography; Ergonovine; Female; Fo

1983
Intravenous verapamil therapy in imminent myocardial infarction.
    Clinical cardiology, 1983, Volume: 6, Issue:10

    Topics: Aged; Blood Pressure; Cardiac Output; Cardiac Volume; Coronary Angiography; Electrocardiography; Fem

1983
Triggered ventricular rhythms in 1-day-old myocardial infarction in the dog.
    Circulation research, 1983, Volume: 52, Issue:5

    Topics: Action Potentials; Animals; Automatism; Calcium; Dogs; Electric Stimulation; Endocardium; Epinephrin

1983
The beneficial effect of nicardipine compared with nifedipine and verapamil in limiting myocardial infarct size in baboons.
    Arzneimittel-Forschung, 1983, Volume: 33, Issue:6

    Topics: Animals; Calcium Channel Blockers; Female; Hemodynamics; Lidocaine; Male; Myocardial Infarction; Nic

1983
Calcium channel blocking agents. Council on scientific affairs.
    JAMA, 1983, Nov-11, Volume: 250, Issue:18

    Topics: Angina Pectoris; Animals; Arrhythmias, Cardiac; Asthma; Calcium Channel Blockers; Cardiomyopathy, Hy

1983
Effects of diltiazem on vulnerability to atrial and ventricular reentrant arrhythmias in the normal and ischemic heart.
    Arzneimittel-Forschung, 1983, Volume: 33, Issue:8

    Topics: Animals; Arrhythmias, Cardiac; Benzazepines; Coronary Disease; Diltiazem; Dogs; Electrophysiology; F

1983
Verapamil treatment of intractable ventricular arrhythmias after cardiopulmonary bypass.
    Anesthesia and analgesia, 1984, Volume: 63, Issue:4

    Topics: Angina Pectoris; Arrhythmias, Cardiac; Cardiopulmonary Bypass; Heart Arrest, Induced; Humans; Male;

1984
Blood flow to infarct and surviving myocardium: implications regarding the action of verapamil on the acutely ischemic dog heart.
    Journal of the American College of Cardiology, 1984, Volume: 3, Issue:4

    Topics: Animals; Collateral Circulation; Coronary Circulation; Dogs; Hemodynamics; Microspheres; Myocardial

1984
Polymorphous ventricular tachycardia in acute myocardial infarction.
    The American journal of cardiology, 1984, May-01, Volume: 53, Issue:9

    Topics: Aged; Cardiac Pacing, Artificial; Electric Countershock; Electrocardiography; Female; Humans; Male;

1984
[Quantitative evaluation of electrocardiographic changes in acute myocardial infarction].
    Kardiologiia, 1984, Volume: 24, Issue:5

    Topics: Cardiotonic Agents; Drug Therapy, Combination; Electrocardiography; Humans; Monitoring, Physiologic;

1984
Long-term prognosis of "variant" angina with medical treatment.
    The American journal of cardiology, 1980, Volume: 46, Issue:2

    Topics: Adult; Aged; Angina Pectoris; Angina Pectoris, Variant; Arrhythmias, Cardiac; Arteriosclerosis; Coro

1980
Effects of antiplatelet and calcium antagonist drugs on infarct size in rats.
    Acta cardiologica, 1980, Volume: 35, Issue:6

    Topics: Acute Disease; Animals; Aspirin; Blood Platelets; Calcium; Creatine Kinase; Isoproterenol; Lysine; M

1980
Verapamil in the long-term treatment of angina pectoris.
    Clinical and experimental pharmacology & physiology. Supplement, 1982, Volume: 6

    Topics: Angina Pectoris; Bradycardia; Calcium Channel Blockers; Constipation; Coronary Disease; Dose-Respons

1982
Calcium channel blockers.
    American family physician, 1983, Volume: 27, Issue:2

    Topics: Angina Pectoris; Angina Pectoris, Variant; Arrhythmias, Cardiac; Calcium Channel Blockers; Diltiazem

1983
Protection of infarcting myocardium by slow channel inhibitors. Comparative effects of verapamil, nifedipine, and diltiazem in the coronary-ligated, isolated working rat heart.
    Circulation research, 1983, Volume: 52, Issue:2 Pt 2

    Topics: Animals; Benzazepines; Calcium Channel Blockers; Cardiac Pacing, Artificial; Coronary Circulation; D

1983
Sustained limitation of myocardial necrosis 24 hours after coronary artery occlusion: verapamil infusion in dogs with small myocardial infarcts.
    The American journal of cardiology, 1983, May-01, Volume: 51, Issue:8

    Topics: Animals; Coronary Circulation; Coronary Disease; Dogs; Female; Hemodynamics; Male; Myocardial Infarc

1983
Multiform accelerated idioventricular rhythm in acute myocardial infarction: electrocardiographic characteristics and response to verapamil.
    The American journal of cardiology, 1983, Volume: 52, Issue:1

    Topics: Adult; Aged; Arrhythmias, Cardiac; Bundle-Branch Block; Electrocardiography; Female; Humans; Injecti

1983
[Morphological bases of the effect of verapamil on the heart in experimental acute coronary failure].
    Vrachebnoe delo, 1983, Issue:5

    Topics: Acute Disease; Animals; Coronary Disease; Drug Evaluation, Preclinical; Heart; Myocardial Infarction

1983
[Effects of verapamil on the normal and ischemic heart].
    Masui. The Japanese journal of anesthesiology, 1983, Volume: 32, Issue:4

    Topics: Anesthesia; Animals; Coronary Circulation; Dogs; Hemodynamics; Myocardial Infarction; Verapamil

1983
Autoradiographic method for measuring the ischemic myocardium at risk: effects of verapamil on infarct size aftr experimental coronary artery occlusion.
    Proceedings of the National Academy of Sciences of the United States of America, 1980, Volume: 77, Issue:10

    Topics: Albumins; Animals; Autoradiography; Coronary Disease; Disease Models, Animal; Dogs; Myocardial Infar

1980
Observations on the experimental reduction of infarct size and on the delayed consequences of transient myocardial ischemia.
    Acta medica Scandinavica. Supplementum, 1981, Volume: 651

    Topics: Animals; Captopril; Dogs; Fluorocarbons; Flurbiprofen; Myocardial Infarction; Myocardium; Necrosis;

1981
Symposium on Cardiovascular Disease and Calcium Antagonists. Introduction.
    The American journal of cardiology, 1982, Feb-18, Volume: 49, Issue:3

    Topics: Angina Pectoris; Animals; Arrhythmias, Cardiac; Calcium Channel Blockers; Diltiazem; Humans; Myocard

1982
Clinical characteristics of patients with variant angina complicated by myocardial infarction or death within 1 month.
    The American journal of cardiology, 1982, Volume: 49, Issue:4

    Topics: Adult; Angina Pectoris, Variant; Coronary Disease; Coronary Vasospasm; Death, Sudden; Diltiazem; Ele

1982
Method for evaluating the effects of antiarrhythmic drugs on ventricular tachycardias with different electrophysiologic characteristics and different mechanisms in the infarcted canine heart.
    The American journal of cardiology, 1982, Apr-01, Volume: 49, Issue:5

    Topics: Animals; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Dogs; Electrophysiology; Female; Isopro

1982
Influence of the extent of the zone at risk on the effectiveness of drugs in reducing infarct size.
    Circulation, 1982, Volume: 66, Issue:1

    Topics: Animals; Autoradiography; Calcium Channel Blockers; Collateral Circulation; Coronary Circulation; Di

1982
Coronary vascular reactivity after acute myocardial ischemia.
    Science (New York, N.Y.), 1982, Nov-05, Volume: 218, Issue:4572

    Topics: Animals; Coronary Circulation; Coronary Disease; Dogs; Endothelium; Male; Muscle, Smooth, Vascular;

1982
Initiation of ventricular tachycardia by supraventricular beats.
    Cardiology, 1982, Volume: 69, Issue:4

    Topics: Adult; Aged; Atrioventricular Node; Bundle-Branch Block; Cardiac Pacing, Artificial; Child; Child, P

1982
Electrophysiologic effects of verapamil on cells bordering healed myocardial infarction in the cat.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1982, Volume: 171, Issue:3

    Topics: Action Potentials; Animals; Cats; Electrophysiology; Heart; Heart Ventricles; Myocardial Infarction;

1982
[Verapamil in the acute phase of myocardial infarct].
    Bollettino della Societa italiana di cardiologia, 1981, Volume: 26, Issue:12

    Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Necrosis; Nitropr

1981
[Protection of the ischemic myocardium: experiences with verapamil].
    Bollettino della Societa italiana di cardiologia, 1981, Volume: 26, Issue:12

    Topics: Aged; Humans; Middle Aged; Myocardial Infarction; Verapamil

1981
[Importance of the size of the ischemic area on the beneficial effects of drugs capable of protecting the ischemic myocardium].
    Arquivos brasileiros de cardiologia, 1982, Volume: 39, Issue:5

    Topics: Animals; Blood Pressure; Dogs; Gallopamil; Heart Rate; Myocardial Infarction; Myocardium; Verapamil

1982
Effect of verapamil on ST-segment elevation evaluated by the orthogonal leads of the Frank vector system in patients with acute myocardial infarction.
    Arzneimittel-Forschung, 1980, Volume: 30, Issue:11

    Topics: Adult; Aged; Blood Pressure; Electrocardiography; Female; Heart Rate; Humans; Male; Middle Aged; Myo

1980
Influence of severity of ventricular dysfunction on hemodynamic responses to intravenously administered verapamil in ischemic heart disease.
    The American journal of cardiology, 1981, Volume: 47, Issue:4

    Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Coronary Disease; Heart Ventricles; Hemodynamics; Huma

1981
[The X, Y and Z orthogonal leads of the Frank vectorial system. An alternative to the precordial mapping of the ST segment in evaluation of ischemic damage in acute myocardial infarct].
    Minerva cardioangiologica, 1980, Volume: 28, Issue:6

    Topics: Acute Disease; Adult; Aged; Electrocardiography; Female; Humans; Isosorbide Dinitrate; Male; Middle

1980
Effect of verapamil (isoptin) on experimental myocardial infarction in rhesus monkeys.
    The Indian journal of medical research, 1981, Volume: 73

    Topics: Animals; Macaca mulatta; Myocardial Infarction; Myocardium; Verapamil

1981
Calcium antagonists.
    European heart journal, 1980, Volume: 1, Issue:3

    Topics: Angina Pectoris; Calcium Channel Blockers; Cell Membrane; Diltiazem; Heart; Humans; Hypertension; Mu

1980
[Reduction in the size of a myocardial infarct with the use of verapamil].
    Arquivos brasileiros de cardiologia, 1981, Volume: 36 Suppl 1

    Topics: Animals; Dogs; Female; Male; Myocardial Infarction; Myocardium; Verapamil

1981
[Use of verapamil in the treatment of pain in acute myocardial infarction].
    Arquivos brasileiros de cardiologia, 1981, Volume: 36 Suppl 1

    Topics: Adult; Aged; Angina Pectoris; Female; Hemodynamics; Humans; Infusions, Parenteral; Male; Middle Aged

1981
[Treatment of acute myocardial infarction with verapamil. Hemodynamic effects and electrical changes studied by body surface maps (author's transl)].
    Giornale italiano di cardiologia, 1981, Volume: 11, Issue:9

    Topics: Aged; Electrocardiography; Electrophysiology; Heart; Hemodynamics; Humans; Male; Middle Aged; Myocar

1981
[Incidence of arrhythmias in acute myocardial infarct treated with verapamil, digitalis and a verapamil-digitalis combination].
    Bollettino della Societa italiana di cardiologia, 1981, Volume: 26, Issue:9

    Topics: Arrhythmias, Cardiac; Digitalis Glycosides; Drug Therapy, Combination; Female; Humans; Male; Myocard

1981
[Effects of D-600 (methoxy-verapamil) on mortality and infarction size after coronary occlusion in rats].
    Arquivos brasileiros de cardiologia, 1981, Volume: 37, Issue:2

    Topics: Animals; Gallopamil; Myocardial Contraction; Myocardial Infarction; Myocardium; Prognosis; Rats; Rat

1981
[Verapamil in acute myocardial infarct. Hemodynamic effects and electrical changes studied by means of electromaps of the chest].
    Bollettino della Societa italiana di cardiologia, 1981, Volume: 26, Issue:11

    Topics: Acute Disease; Electrocardiography; Humans; Myocardial Infarction; Verapamil

1981
Verapamil therapy.
    American heart journal, 1980, Volume: 100, Issue:2

    Topics: Aged; Female; Humans; Myocardial Infarction; Verapamil

1980
Verapamil and myocardial infarct size.
    The American journal of cardiology, 1980, Volume: 46, Issue:2

    Topics: Myocardial Infarction; Verapamil

1980
Sustained ventricular tachycardia in recent canine myocardial infarction.
    Circulation, 1980, Volume: 62, Issue:5

    Topics: Animals; Coronary Vessels; Dogs; Electrophysiology; Heart Rate; Ligation; Myocardial Infarction; Rec

1980
Experimental myocardial infarction in rhesus monkeys. Verapamil pretreatment in the reduction of infarct size.
    Advances in myocardiology, 1980, Volume: 2

    Topics: Administration, Oral; Animals; Female; Injections, Intravenous; Macaca mulatta; Male; Myocardial Inf

1980
Differing electrophysiologic effects of slow response inhibiting agents manganese and verapamil on ischemic, infarcted and normal tissue in situ.
    The Journal of pharmacology and experimental therapeutics, 1980, Volume: 215, Issue:2

    Topics: Animals; Arrhythmias, Cardiac; Coronary Disease; Dogs; Heart Conduction System; Manganese; Myocardia

1980
Assessment of pharmacological treatment of myocardial infarction by phosphorus-31 NMR with surface coils.
    Science (New York, N.Y.), 1981, Jan-09, Volume: 211, Issue:4478

    Topics: Animals; Chlorpromazine; Coronary Circulation; Disease Models, Animal; Magnetic Resonance Spectrosco

1981
Actions of verapamil on Purkinje fibers from normal and infarcted heart tissues.
    The Journal of pharmacology and experimental therapeutics, 1981, Volume: 216, Issue:2

    Topics: Animals; Cell Membrane Permeability; Disease Models, Animal; Dogs; Female; Heart Conduction System;

1981
Experimental infarction studies.
    Clinical and investigative medicine. Medecine clinique et experimentale, 1980, Volume: 3, Issue:1-2

    Topics: Animals; Chlorpromazine; Dogs; Heart Rate; Ibuprofen; Morphine; Myocardial Infarction; Myocardium; P

1980
Acute hypertensive crises.
    Clinical and investigative medicine. Medecine clinique et experimentale, 1980, Volume: 3, Issue:1-2

    Topics: Acute Disease; Adult; Aged; Clonidine; Diazoxide; Heart Block; Humans; Hypertension; Injections, Int

1980
Effects of intravenously administered verapamil on hemodynamic variables and ventricular function in acute myocardial infarction.
    Clinical and investigative medicine. Medecine clinique et experimentale, 1980, Volume: 3, Issue:1-2

    Topics: Animals; Blood Pressure; Coronary Disease; Dogs; Heart; Humans; Male; Middle Aged; Myocardial Infarc

1980
Protection of reperfused ischemic pig myocardium by nexopamil, a new combined Ca2+ and serotonin antagonist.
    Journal of cardiovascular pharmacology, 1994, Volume: 23, Issue:6

    Topics: Animals; Blood Platelets; Calcium Channel Blockers; Creatine Kinase; Diastole; Epoprostenol; Female;

1994
Streptokinase-induced transient aggravation of myocardial injury.
    International journal of cardiology, 1995, Jun-30, Volume: 50, Issue:2

    Topics: Adult; Aged; Anti-Arrhythmia Agents; Blood Pressure; Coronary Circulation; Drug Therapy, Combination

1995
Infarct size-limiting properties of Ro 40-5967, a novel nondihydropyridine calcium channel, in anesthetized rats: comparison with verapamil.
    Journal of cardiovascular pharmacology, 1995, Volume: 25, Issue:4

    Topics: Anesthesia; Animals; Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Heart Rate; Hemodynam

1995
[Myocardial viability in acute myocardial infarction and verapamil].
    Cardiologia (Rome, Italy), 1994, Volume: 39, Issue:12 Suppl 1

    Topics: Double-Blind Method; Heart Ventricles; Humans; Multicenter Studies as Topic; Myocardial Infarction;

1994
Effects of catecholamines on the residual sodium channel dependent slow conduction in guinea pig ventricular muscles under normoxia and hypoxia.
    Cardiovascular research, 1995, Volume: 29, Issue:1

    Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Calcium Channels; Catecholamines; Dose-Response Re

1995
[Myocardial reperfusion injury with coronary thrombolytic therapy--clinical and experimental studies].
    Japanese circulation journal, 1993, Volume: 57 Suppl 4

    Topics: Animals; Calcium; Dogs; Humans; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Ne

1993
The novel calcium antagonist Ro 40-5967 limits myocardial infarct size in the dog.
    Cardiovascular research, 1994, Volume: 28, Issue:10

    Topics: Animals; Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Dogs; Female; Heart; Heart Rate;

1994
Secondary prevention with calcium antagonists after a myocardial infarction.
    Archives of internal medicine, 1993, Oct-11, Volume: 153, Issue:19

    Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Humans; Myocardial Infarction; Recurrence; Ve

1993
[Comments on the contribution by G. F. Hauf and H. Roskamm. Heart failure in coronary heart disease].
    Der Internist, 1994, Volume: 35, Issue:2

    Topics: Diltiazem; Heart Failure; Humans; Myocardial Infarction; Survival Rate; Verapamil

1994
Are all calcium antagonists equally effective for reducing reinfarction rate?
    The American journal of cardiology, 1993, Oct-01, Volume: 72, Issue:11

    Topics: Adult; Aged; Diltiazem; Humans; Hypertension; Middle Aged; Myocardial Infarction; Proportional Hazar

1993
Verapamil prevents sudden death in patients with increased heart size after an acute myocardial infarction.
    Cardiovascular drugs and therapy, 1993, Volume: 7, Issue:3

    Topics: Cardiomegaly; Clinical Trials as Topic; Death, Sudden, Cardiac; Female; Humans; Male; Myocardial Inf

1993
[Long-term treatment with calcium antagonists: advantageous effects and risks].
    Nederlands tijdschrift voor geneeskunde, 1995, Dec-30, Volume: 139, Issue:52

    Topics: Calcium Channel Blockers; Controlled Clinical Trials as Topic; Humans; Hypertension; Myocardial Infa

1995
[Effects of verapamil on left ventricular diastolic dysfunction].
    Zhonghua nei ke za zhi, 1995, Volume: 34, Issue:6

    Topics: Adolescent; Adult; Aged; Calcium Channel Blockers; Cardiac Catheterization; Cardiomyopathy, Hypertro

1995
Verapamil following uncomplicated myocardial infarction: promising, but not proven.
    The American journal of cardiology, 1996, Feb-15, Volume: 77, Issue:5

    Topics: Calcium Channel Blockers; Clinical Trials as Topic; Humans; Myocardial Infarction; Survival Rate; Ve

1996
Sex related differences in short and long-term prognosis after acute myocardial infarction: 10 year follow up of 3073 patients in database of first Danish Verapamil Infarction Trial.
    BMJ (Clinical research ed.), 1996, Jul-20, Volume: 313, Issue:7050

    Topics: Aged; Cause of Death; Denmark; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infa

1996
Is a combination of verapamil and an ACE-inhibitor the optimal solution in ischaemic heart failure?
    Cardiologia (Rome, Italy), 1995, Volume: 40, Issue:12 Suppl 1

    Topics: Angiotensin-Converting Enzyme Inhibitors; Arrhythmias, Cardiac; Calcium Channel Blockers; Clinical T

1995
[Myocardial protection during extracorporeal circulation. Preliminary results with different techniques].
    Acta bio-medica de L'Ateneo parmense : organo della Societa di medicina e scienze naturali di Parma, 1995, Volume: 66, Issue:5

    Topics: Cardiac Surgical Procedures; Cardiotonic Agents; Extracorporeal Circulation; Heart; Humans; Myocardi

1995
Calcium antagonists and prevention of ventricular fibrillation induced by transient or persistent ischemia.
    Japanese heart journal, 1997, Volume: 38, Issue:2

    Topics: Analysis of Variance; Angina Pectoris; Animals; Calcium Channel Blockers; Coronary Disease; Electrop

1997
[Comparative evaluation of the effect of dimebon, obzidan, finoptin, and cordarone on the functional state of the ischemic focus and the size of necrosis zone during experimental myocardial infarction].
    Biulleten' eksperimental'noi biologii i meditsiny, 1996, Volume: 122, Issue:12

    Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Cats; Histamine H1 Antagonists; Indoles; Myocardial Inf

1996
Outcome with calcium channel antagonists after myocardial infarction: a community-based study.
    Journal of the American College of Cardiology, 1998, Volume: 31, Issue:1

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Calcium Channel Blockers; Cohort Studies; Diltiazem; Femal

1998
Use of calcium antagonists in post-myocardial infarction patients.
    Journal of the American College of Cardiology, 1998, Volume: 31, Issue:1

    Topics: Calcium Channel Blockers; Case-Control Studies; Humans; Myocardial Infarction; Nifedipine; Verapamil

1998
KATP channels are common mediators of ischemic and calcium preconditioning in rabbits.
    The American journal of physiology, 1998, Volume: 274, Issue:4

    Topics: Adenosine Triphosphate; Animals; Calcium; Calcium Channel Blockers; Calcium Gluconate; Female; Hemod

1998
Effects of verapamil on indexes of heart rate variability after acute myocardial infarction.
    The American journal of cardiology, 1998, May-01, Volume: 81, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Autonomic Nervous System; Diabetes Complications; Diabetes Mellitus;

1998
[The objective assessment of treatment efficacy in microfocal myocardial infarct using paired stress tests].
    Likars'ka sprava, 1998, Issue:6

    Topics: Acebutolol; Adrenergic beta-Antagonists; Calcium Channel Blockers; Cardiac Pacing, Artificial; Dilti

1998
Unique cardioprotective action of the new calcium antagonist mibefradil.
    Circulation, 1999, Jan-19, Volume: 99, Issue:2

    Topics: Amlodipine; Animals; Benzimidazoles; Calcium Channel Blockers; Glyburide; Heart; Heart Rate; Heart V

1999
Effects of long-acting versus short-acting calcium channel blockers among older survivors of acute myocardial infarction.
    Journal of the American Geriatrics Society, 1999, Volume: 47, Issue:5

    Topics: Aged; Calcium Channel Blockers; Dihydropyridines; Diltiazem; Female; Humans; Male; Myocardial Infarc

1999
Angina pectoris, myocardial infarction and verapamil.
    Journal of the American College of Cardiology, 1999, Volume: 34, Issue:3

    Topics: Angina, Unstable; Calcium Channel Blockers; Heart Failure; Humans; Myocardial Infarction; Randomized

1999
Early treatment with verapamil or diltiazem in patients with acute myocardial infarction: safety and possible beneficial effects.
    Cardiovascular drugs and therapy, 1999, Volume: 13, Issue:4

    Topics: Acute Disease; Calcium Channel Blockers; Diltiazem; Female; Humans; Male; Middle Aged; Myocardial In

1999
Calcium channel blockers and mortality in elderly patients with myocardial infarction.
    Archives of internal medicine, 1999, Oct-25, Volume: 159, Issue:19

    Topics: Aged; Aged, 80 and over; Amlodipine; Bepridil; Calcium Channel Blockers; Diltiazem; Female; Humans;

1999
A 42-year-old man with recurrent myocardial infarction and normal appearing coronary arteries.
    International journal of cardiology, 1999, May-15, Volume: 69, Issue:2

    Topics: Adult; Aspirin; Coronary Thrombosis; Humans; Male; Microvascular Angina; Myocardial Infarction; Plat

1999
Differential effects of mibefradil, verapamil, and amlodipine on myocardial function and intracellular Ca(2+) handling in rats with chronic myocardial infarction.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 291, Issue:3

    Topics: Adrenergic beta-Agonists; Aequorin; Amlodipine; Animals; Calcium; Calcium Channel Blockers; Chronic

1999
Cardioprotective effect of magnesium chloride in experimental acute myocardial infarction.
    Indian journal of experimental biology, 1999, Volume: 37, Issue:2

    Topics: Animals; Calcium Channel Blockers; Cardiovascular Agents; Creatine Kinase; Female; Isoproterenol; Ma

1999
Spontaneous and diffuse coronary artery spasm unresponsive to conventional intracoronary pharmacological therapy: a case report.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2000, Volume: 49, Issue:2

    Topics: Adenosine; Adult; Coronary Angiography; Coronary Vasospasm; Coronary Vessels; Diagnosis, Differentia

2000
[Prognosis after late versus early nonfatal myocardial infarction].
    Ugeskrift for laeger, 2000, Feb-07, Volume: 162, Issue:6

    Topics: Adult; Aged; Denmark; Female; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Vasodilat

2000
A simplified method of harvesting and dilating the radial artery achieves acceptable clinical outcomes.
    The Australian and New Zealand journal of surgery, 2000, Volume: 70, Issue:5

    Topics: Aged; Angioplasty, Balloon, Coronary; Calcium Channel Blockers; Coronary Artery Bypass; Critical Car

2000
Abnormalities in Ca(i)handling in myocytes that survive in the infarcted heart are not just due to alterations in repolarization.
    Journal of molecular and cellular cardiology, 2000, Volume: 32, Issue:8

    Topics: Animals; Caffeine; Calcium; Calcium Channel Blockers; Cells, Cultured; Central Nervous System Stimul

2000
Altered E-C coupling in rat ventricular myocytes from failing hearts 6 wk after MI.
    American journal of physiology. Heart and circulatory physiology, 2000, Volume: 279, Issue:2

    Topics: Animals; Cells, Cultured; Cesium; Heart; Heart Failure; Heart Ventricles; Male; Membrane Potentials;

2000
Calcium channel blockade limits cardiac remodeling and improves cardiac function in myocardial infarction-induced heart failure in rats.
    Journal of cardiovascular pharmacology, 2001, Volume: 37, Issue:1

    Topics: Amlodipine; Animals; Calcium Channel Blockers; Heart Failure; Hemodynamics; Hypertrophy, Left Ventri

2001
Cardiac effects of the extract and active components of radix stephaniae tetrandrae. II. Myocardial infarct, arrhythmias, coronary arterial flow and heart rate in the isolated perfused rat heart.
    Life sciences, 2001, May-11, Volume: 68, Issue:25

    Topics: Alkaloids; Animals; Arrhythmias, Cardiac; Benzylisoquinolines; Calcium Channel Blockers; Coronary Ci

2001
Electroplegia: an alternative to blood cardioplegia for arresting the heart during conventional (on-pump) cardiac operation.
    The Annals of thoracic surgery, 2001, Volume: 72, Issue:3

    Topics: Acetylcholine; Animals; Anti-Arrhythmia Agents; Blood; Blood Pressure; Body Water; Cardiac Surgical

2001
Prior calcium channel blockade and short-term survival following acute myocardial infarction.
    Cardiovascular drugs and therapy, 2001, Volume: 15, Issue:6

    Topics: Adrenergic beta-Antagonists; Australia; Calcium Channel Blockers; Diltiazem; Drug Interactions; Fema

2001
Last performance with VIAGRA: post-mortem identification of sildenafil and its metabolites in biological specimens including hair sample.
    Forensic science international, 2002, Mar-28, Volume: 126, Issue:1

    Topics: Adult; Autopsy; Bromazepam; Cause of Death; Chromatography, Liquid; Death, Sudden, Cardiac; Drug Int

2002
[Treatment of no-reflow phenomenon with intracoronary verapamil after primary stent deployment during myocardial infarction].
    Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology, 2001, Volume: 1, Issue:3

    Topics: Coronary Angiography; Electrocardiography; Female; Humans; Intraoperative Complications; Middle Aged

2001
Letter: First aid in acute myocardial infarction.
    British medical journal, 1976, Mar-20, Volume: 1, Issue:6011

    Topics: Adrenergic beta-Antagonists; First Aid; Humans; Myocardial Infarction; Posture; Respiration; Verapam

1976
[Drug therapy of tachyarrhythmias (author's transl)].
    Klinische Wochenschrift, 1978, Feb-15, Volume: 56, Issue:4

    Topics: Action Potentials; Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Aprind

1978
[Controlled rehabilitation of patients with a recent myocardial infarction (author's transl)].
    Giornale italiano di cardiologia, 1978, Volume: 8, Issue:7

    Topics: Acute Disease; Adrenergic beta-Antagonists; Adult; Aged; Digitalis Glycosides; Female; Follow-Up Stu

1978
Effects of verapamil in ventricular premature beats of acute myocardial infarction.
    Acta cardiologica, 1978, Volume: 33, Issue:1

    Topics: Aged; Calcium; Cardiac Complexes, Premature; Heart Ventricles; Humans; Middle Aged; Myocardial Infar

1978
[Theoretical suppositions and clinical use of verapamil in the treatment of ventricular extrasystole in acute myocardial infarct].
    Bollettino della Societa italiana di cardiologia, 1978, Volume: 23, Issue:2

    Topics: Acute Disease; Adult; Cardiac Complexes, Premature; Humans; Male; Middle Aged; Myocardial Infarction

1978
[Protective effect of verapamil on the damage caused by coronary insufficiency. Experimental research].
    Bollettino della Societa italiana di cardiologia, 1978, Volume: 23, Issue:10

    Topics: Animals; Calcium; Coronary Circulation; Mitochondria, Heart; Myocardial Infarction; Myocardium; Necr

1978
Reentrant ventricular arrhythmias in the late myocardial infarction period. 7. Effect of verapamil and D-600 and the role of the "slow channel".
    Circulation, 1979, Volume: 60, Issue:3

    Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Coronary Disease; Dogs; Electrocardiography; Gallo

1979
Effects of verapamil on ventricular premature beats of acute myocardial infarction.
    American heart journal, 1979, Volume: 98, Issue:6

    Topics: Arrhythmias, Cardiac; Heart Ventricles; Humans; Myocardial Infarction; Verapamil

1979
[The comparative studies of hemodynamic effects of verapamil and propranolol in patients with acute myocardial infarction (author's transl)].
    Kokyu to junkan. Respiration & circulation, 1979, Volume: 27, Issue:10

    Topics: Adult; Aged; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Propranolol; Ve

1979
[Acute myocardial infarction as a possible consequence of abrupt withdrawal of verapamil].
    Ugeskrift for laeger, 1979, Oct-15, Volume: 141, Issue:42

    Topics: Humans; Male; Middle Aged; Myocardial Infarction; Verapamil

1979
[Intravenous verapamil in the treatment of acute coronary insufficiency].
    Arquivos brasileiros de cardiologia, 1979, Volume: 32, Issue:4

    Topics: Acute Disease; Adult; Aged; Angina Pectoris; Coronary Disease; Female; Humans; Male; Middle Aged; My

1979
[Preventive effectiveness of verapamil in ventricular fibrillation in the first 24 hours after myocardial infarct].
    Bollettino della Societa italiana di cardiologia, 1979, Volume: 24, Issue:3

    Topics: Acute Disease; Adult; Aged; Female; Humans; Lidocaine; Male; Middle Aged; Myocardial Infarction; Ven

1979
[Effects of acute infusion of verampil on the ST segment elevation measured with the Frank orthogonal leads in patients with acute myocardial infarct].
    Giornale italiano di cardiologia, 1979, Volume: 9, Issue:12

    Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Myocardial Infarction; Vectorcardiography; Verapamil

1979
[The role of calcium in the pathogenesis of experimental infarct induced with isoproterenol in the rat. Preliminary findings. I].
    Minerva cardioangiologica, 1979, Volume: 27, Issue:12

    Topics: Animals; Calcium; Isoproterenol; Male; Myocardial Infarction; Rats; Verapamil

1979
[Pharmacological protection of the cardiac mucle in experimental infarct. II. Effects of verapamil].
    Minerva cardioangiologica, 1979, Volume: 27, Issue:12

    Topics: Animals; Calcium; Male; Myocardial Infarction; Myocardium; Necrosis; Rats; Verapamil

1979
Verapamil in the management of supraventricular tachyarrhythmias occurring after a recent myocardial infarction.
    Circulation, 1978, Volume: 57, Issue:4

    Topics: Blood Pressure; Electrocardiography; Female; Heart Rate; Humans; Male; Middle Aged; Myocardial Infar

1978
[Use of modified cardioplegic solution for prevention of ventricular fibrillation in the acute stage of experimental myocardial infarct].
    Kardiologiia, 1978, Volume: 18, Issue:5

    Topics: Acute Disease; Animals; Dogs; Drug Evaluation; Injections, Intravenous; Myocardial Infarction; Solut

1978
Verapamil and sudden death.
    The American journal of cardiology, 1978, Volume: 42, Issue:3

    Topics: Arrhythmias, Cardiac; Death, Sudden; Humans; Injections, Intravenous; Myocardial Infarction; Ventric

1978
Antiarrhythmic effect of verapamil.
    The American journal of cardiology, 1978, Volume: 42, Issue:4

    Topics: Animals; Arrhythmias, Cardiac; Dogs; Drug Evaluation; Drug Evaluation, Preclinical; Humans; Myocardi

1978
Effect of verapamil on the transmural energy metabolism in the isoproterenol-induced myocardial lesion.
    Japanese heart journal, 1978, Volume: 19, Issue:6

    Topics: Adenosine Triphosphate; Animals; Calcium; Energy Metabolism; Heart; Isoproterenol; Lactates; Male; M

1978
[Calcium inhibitors in the early rehabilitation of patients with myocardial infarct].
    Bollettino della Societa italiana di cardiologia, 1978, Issue:1 Suppl

    Topics: Calcium; Exercise Test; Heart; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Nifed

1978
Verapamil after MI.
    Circulation, 1979, Volume: 59, Issue:1

    Topics: Arrhythmias, Cardiac; Drug Evaluation; Humans; Infusions, Parenteral; Myocardial Infarction; Verapam

1979
Cellular electrophysiology of human myocardial infarction. 1. Abnormalities of cellular activation.
    Circulation, 1979, Volume: 59, Issue:2

    Topics: Action Potentials; Adult; Aged; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Chronic Disease; H

1979
Reduction in infarct size following experimental coronary occlusion by administration of verapamil.
    Recent advances in studies on cardiac structure and metabolism, 1975, Volume: 10

    Topics: Animals; Blood Pressure; Cardiac Output; Coronary Circulation; Coronary Disease; Disease Models, Ani

1975
Lack of protection of ischemic myocardium by verapamil in conscious dogs.
    European journal of pharmacology, 1977, Apr-21, Volume: 42, Issue:4

    Topics: Animals; Blood Pressure; Coronary Circulation; Creatine Kinase; Dogs; Heart Rate; Myocardial Infarct

1977
[The antiarrhythmic effects of verapamil in acute myocardial infarction. Considerations on the possible action mechanism (author's transl)].
    Giornale italiano di cardiologia, 1977, Volume: 7, Issue:10

    Topics: Acute Disease; Aged; Arrhythmias, Cardiac; Drug Evaluation; Humans; Middle Aged; Myocardial Infarcti

1977
[Key-role of intracellular calcium overload in acute necrosis of the myocardium. Cardioprotection with verapamil].
    Minerva medica, 1975, May-23, Volume: 66, Issue:38

    Topics: Adenosine Triphosphate; Animals; Calcium; Catecholamines; Dihydrotachysterol; Fludrocortisone; Heart

1975
[Clinical results with verapamil in the treatment of acute coronary insufficiency].
    Minerva medica, 1975, May-26, Volume: 66, Issue:39

    Topics: Acute Disease; Angina Pectoris; Humans; Myocardial Infarction; Verapamil

1975
Effects of verapamil on infarct size following experimental coronary occlusion.
    Cardiovascular research, 1975, Volume: 9, Issue:4

    Topics: Animals; Blood Pressure; Cardiac Output; Dogs; Electrocardiography; Female; Heart Rate; Ligation; Ma

1975
[Proceedings: The effect of verapramil (isoptin) on the hemodynamics and size of the acute myocardial infarct].
    Zeitschrift fur Kardiologie, 1975, Volume: Suppl 2

    Topics: Blood Pressure; Cardiac Output; Creatine Kinase; Heart Failure; Heart Rate; Hemodynamics; Humans; My

1975
[Treatment of arrhythmia in general practice].
    Wiener medizinische Wochenschrift (1946), 1975, Nov-14, Volume: 125, Issue:46

    Topics: Ajmaline; Anti-Arrhythmia Agents; Aprindine; Arrhythmia, Sinus; Arrhythmias, Cardiac; Bradycardia; H

1975
[Clinical and hemodynamic evaluation of the use of verapamil in stenocardia].
    Bollettino della Societa italiana di cardiologia, 1975, Volume: 20, Issue:4

    Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Female; Heart Rate; Hemodynamics; Humans; Male; Middle

1975
Efficacy of verapamil against ventricular arrhythmias induced by programmed electrical stimulation in the late myocardial infarction phase in dogs.
    The Journal of pharmacy and pharmacology, 1992, Volume: 44, Issue:4

    Topics: Animals; Anti-Arrhythmia Agents; Dogs; Electric Stimulation; Electrocardiography; Electrophysiology;

1992
[Dynamic changes in the histamine and serotonin levels of acute myocardial infarct patients treated with strepodecase, finoptin and alpha-tocopherol acetate].
    Terapevticheskii arkhiv, 1992, Volume: 64, Issue:8

    Topics: Adult; Aged; alpha-Tocopherol; Drug Evaluation; Drug Therapy, Combination; Heparin; Histamine; Human

1992
Protective and anti-arrhythmic effects of dauricine and verapamil on acute myocardial infarction in anesthetized dogs.
    Zhongguo yao li xue bao = Acta pharmacologica Sinica, 1992, Volume: 13, Issue:3

    Topics: Alkaloids; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzylisoquinolines; Creatine Kina

1992
Global depletion of myocardial norepinephrine and ATP after left coronary artery occlusion in rats.
    Zhongguo yao li xue bao = Acta pharmacologica Sinica, 1992, Volume: 13, Issue:4

    Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Epinephrine; Female

1992
Cardioprotective effect of cromakalim (potassium channel opener) in isoproterenol induced myocardial infarction in rats.
    Indian journal of experimental biology, 1992, Volume: 30, Issue:7

    Topics: Animals; Aspartate Aminotransferases; Benzopyrans; Blood Coagulation; Cromakalim; Female; Glycogen;

1992
Incidence of adverse events during treatment with verapamil for suspected acute myocardial infarction.
    The American journal of cardiology, 1992, Dec-15, Volume: 70, Issue:20

    Topics: Bradycardia; Contraindications; Female; Heart Failure; Humans; Incidence; Male; Middle Aged; Myocard

1992
Ro 40-5967, a novel calcium channel antagonist, protects against ventricular fibrillation.
    European journal of pharmacology, 1992, Dec-15, Volume: 229, Issue:2-3

    Topics: Animals; Benzimidazoles; Binding Sites; Calcium Channel Blockers; Coronary Circulation; Diltiazem; D

1992
[A new indication for verapamil--secondary prevention after myocardial infarction].
    Lakartidningen, 1992, Jun-24, Volume: 89, Issue:26-27

    Topics: Humans; Myocardial Infarction; Recurrence; Verapamil

1992
Detecting fabrication of data in a multicenter collaborative animal study.
    Controlled clinical trials, 1991, Volume: 12, Issue:6

    Topics: Animals; Data Interpretation, Statistical; Disease Models, Animal; Dogs; Ibuprofen; Multicenter Stud

1991
Effect of calcium channel blocking agents on infarct size after ischaemia-reperfusion in anaesthetised pigs: relationship between cardioprotection and cardiodepression.
    Journal of cardiovascular pharmacology, 1991, Volume: 17, Issue:5

    Topics: Animals; Aspirin; Coronary Vessels; Depression, Chemical; Heart; Hemodynamics; Injections, Intra-Art

1991
Problems related to infarct size measurements in the rat heart.
    Acta anatomica, 1991, Volume: 142, Issue:4

    Topics: Animals; Autoradiography; Female; Fluorescence; Heart; Microscopy, Electron; Microspheres; Myocardia

1991
Evaluation of the protective effect of verapamil on reperfusion injury by 111In anticardiac myosin antibody in canine myocardial infarction.
    Annals of nuclear medicine, 1991, Volume: 5, Issue:3

    Topics: Animals; Dogs; Evaluation Studies as Topic; Indium Radioisotopes; Myocardial Infarction; Myocardial

1991
[Effects of verapamil and nitroglycerin on experimental occlusion- reperfusion-induced myocardial infarction in rabbits].
    Kardiologiia, 1991, Volume: 31, Issue:1

    Topics: Animals; Coronary Vessels; Disease Models, Animal; Drug Evaluation, Preclinical; Ligation; Male; Myo

1991
Three-year mortality in patients suspected of acute myocardial infarction with and without confirmed diagnosis. The Danish Study Group on Verapamil in Myocardial Infarction.
    American heart journal, 1991, Volume: 122, Issue:5

    Topics: Age Factors; Coronary Disease; Denmark; Humans; Myocardial Infarction; Prospective Studies; Sex Fact

1991
The structurally novel Ca2+ channel blocker Ro 40-5967, which binds to the [3H] desmethoxyverapamil receptor, is devoid of the negative inotropic effects of verapamil in normal and failing rat hearts.
    Cardiovascular drugs and therapy, 1990, Volume: 4, Issue:3

    Topics: Animals; Benzimidazoles; Calcium Channel Blockers; Calcium Channels; Coronary Circulation; Depressio

1990
Prinzmetal angina. Multifocal ischemia, recurrent AV block, and bradycardia with patent coronary arteries responsive to verapamil.
    Journal of electrocardiology, 1991, Volume: 24, Issue:2

    Topics: Angina Pectoris, Variant; Bradycardia; Coronary Angiography; Diagnosis, Differential; Electrocardiog

1991
Does verapamil limit myocardial infarct size in a heart deficient in xanthine oxidase?
    Clinical and experimental pharmacology & physiology, 1990, Volume: 17, Issue:11

    Topics: Animals; Blood Pressure; Male; Myocardial Infarction; Myocardium; Rabbits; Time Factors; Verapamil;

1990
Myocardial protection by verapamil and reperfusion following coronary occlusion.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 1990, Volume: 23, Issue:3-4

    Topics: Animals; Blood Pressure; Dogs; Heart Rate; Myocardial Infarction; Myocardial Reperfusion; Myocardial

1990
[Therapy of perioperative myocardial damage in aortocoronary venous bypass surgery].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1990, Jun-15, Volume: 45, Issue:11

    Topics: Cardiac Output, Low; Coronary Artery Bypass; Coronary Disease; Dopamine; Electrocardiography; Epinep

1990
[The use of verapamil for correcting the hemodynamic disorders in the acute period of a myocardial infarct].
    Vrachebnoe delo, 1990, Issue:9

    Topics: Adult; Drug Evaluation; Drug Therapy, Combination; Female; Hemodynamics; Humans; Male; Middle Aged;

1990
[Study of anti-ischemic action of carnitine chloride and its effects on the effectiveness of antianginal agents].
    Kardiologiia, 1990, Volume: 30, Issue:10

    Topics: Animals; Carnitine; Cats; Clinical Enzyme Tests; Drug Therapy, Combination; Myocardial Infarction; M

1990
[Changes in the indicators of intracardiac hemodynamics in patients with post-infarction cardiosclerosis under the action of verapamil].
    Kardiologiia, 1990, Volume: 30, Issue:8

    Topics: Cardiomegaly; Coronary Disease; Heart; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contracti

1990
[Electrophysiologic study of ischemic ventricular arrhythmia].
    Zhonghua xin xue guan bing za zhi, 1990, Volume: 18, Issue:2

    Topics: Animals; Dogs; Electrophysiology; Female; Heart; Humans; Lidocaine; Male; Myocardial Infarction; Tac

1990
Pharmacologic modifications of reperfusion arrhythmias in the dog in vivo: possible relation to limitation of the extent of infarction.
    International journal of cardiology, 1990, Volume: 28, Issue:3

    Topics: Animals; Arrhythmias, Cardiac; Butylated Hydroxytoluene; Dogs; Drug Therapy, Combination; Electrocar

1990
"Cardioprotection"--not all calcium antagonists are created equal.
    The American journal of cardiology, 1990, Oct-01, Volume: 66, Issue:10

    Topics: Calcium Channel Blockers; Humans; Myocardial Infarction; Recurrence; Verapamil

1990
[Effect of verapamil on myocardial infarct size estimated by serial 201-thallium single-photon emission tomography].
    Kokyu to junkan. Respiration & circulation, 1990, Volume: 38, Issue:7

    Topics: Drug Evaluation; Heart; Humans; Myocardial Infarction; Myocardium; Thallium Radioisotopes; Thromboly

1990
Effects of (-), (+/- ), and (+) verapamil on coronary occlusion-induced mortality and infarct size.
    Journal of cardiovascular pharmacology, 1987, Volume: 10, Issue:3

    Topics: Animals; Arrhythmias, Cardiac; Coronary Disease; Male; Myocardial Infarction; Rats; Rats, Inbred Str

1987
Effect of digoxin on the extent of injury and the severity of arrhythmias during acute myocardial ischemia and infarction in the dog.
    Journal of cardiovascular pharmacology, 1988, Volume: 11, Issue:2

    Topics: Animals; Arrhythmias, Cardiac; Coronary Disease; Digoxin; Dogs; Electrocardiography; Heart Rate; Hea

1988
[Efficacy of verapamil in the prevention of ventricular fibrillation in the acute phase of myocardial infarction].
    Archives des maladies du coeur et des vaisseaux, 1988, Volume: 81, Issue:7

    Topics: Cardiac Complexes, Premature; Female; Humans; Infusions, Intravenous; Injections, Intravenous; Male;

1988
[Diagnosis and prevention of myocardial reperfusion injury in experimental myocardial infarction].
    Kardiologiia, 1988, Volume: 28, Issue:12

    Topics: Animals; Butylated Hydroxytoluene; Calcium Channel Blockers; Cardiac Complexes, Premature; Constrict

1988
Influence of allopurinol plus verapamil treatment on myocardial tissue necrosis during permanent coronary occlusion in canine hearts with small infarcts.
    Journal of cardiovascular pharmacology, 1989, Volume: 14, Issue:1

    Topics: Allopurinol; Animals; Calcium; Coronary Circulation; Dogs; Free Radicals; Hemodynamics; Male; Myocar

1989
[Therapy of acute myocardial infarct].
    Deutsche medizinische Wochenschrift (1946), 1985, May-10, Volume: 110, Issue:19

    Topics: Acidosis; Analgesics; Atropine; Bicarbonates; Bradycardia; Cardiac Complexes, Premature; Critical Ca

1985
[Combination therapy with isosorbide dinitrate and verapamil in patients with coronary heart disease and hypertension: effect on blood pressure, ischemia and left ventricular function].
    Zeitschrift fur Kardiologie, 1989, Volume: 78 Suppl 2

    Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Cardiac Output; Coronary Circulation; Coronary Disease

1989
[Reperfusion syndrome during thrombolytic therapy of myocardial infarct].
    Kardiologiia, 1989, Volume: 29, Issue:11

    Topics: Arrhythmias, Cardiac; Female; Fibrinolytic Agents; Hemodynamics; Humans; Male; Mexiletine; Middle Ag

1989
[Effects of tetrodotoxin and verapamil on abnormal ventricular activity at the late stage of experimental myocardial infarction in dogs].
    Kardiologiia, 1989, Volume: 29, Issue:5

    Topics: Animals; Dogs; Drug Synergism; Drug Therapy, Combination; Female; Heart Block; Heart Ventricles; Mal

1989
Chronic infarction decreases maximum cardiac work and sensitivity of heart to extracellular calcium.
    The American journal of physiology, 1985, Volume: 249, Issue:1 Pt 2

    Topics: Adenosine Triphosphate; Adrenergic beta-Agonists; Animals; Blood Pressure; Calcium; Creatine Kinase;

1985
The use of beta-adrenergic blocking agents, i.v. nitrates and calcium channel blocking agents following acute myocardial infarction.
    Chest, 1988, Volume: 93, Issue:1 Suppl

    Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Humans; Infusions, Intravenous; Metoprolol; M

1988
[Acute coronary occlusion during transluminal angioplasty: role of coronary thrombosis].
    Giornale italiano di cardiologia, 1988, Volume: 18, Issue:6

    Topics: Aged; Angiography; Angioplasty, Balloon; Coronary Angiography; Coronary Disease; Coronary Thrombosis

1988
Comparison of different pharmacological interventions on enzymatic parameters during acute myocardial infarction.
    Clinical biochemistry, 1987, Volume: 20, Issue:6

    Topics: Adult; Aged; Clinical Enzyme Tests; Creatine Kinase; Dipyridamole; Female; Heart; Heparin; Humans; I

1987
Myocardial salvage with streptokinase combined with nitroglycerine and verapamil in acute myocardial infarction.
    International journal of cardiology, 1988, Volume: 21, Issue:3

    Topics: Acute Disease; Drug Therapy, Combination; Female; Heart Ventricles; Humans; Male; Middle Aged; Myoca

1988
[Effect of Typha angustata on acute experimental myocardial infarction in rabbits].
    Zhong xi yi jie he za zhi = Chinese journal of modern developments in traditional medicine, 1985, Volume: 5, Issue:5

    Topics: Animals; Medicine, Chinese Traditional; Medicine, East Asian Traditional; Microcirculation; Myocardi

1985
Recurrent sustained ventricular tachycardia solely responsive to verapamil in a patient with a remote myocardial infarction.
    Cardiology, 1988, Volume: 75, Issue:4

    Topics: Heart Ventricles; Humans; Male; Middle Aged; Myocardial Infarction; Recurrence; Tachycardia; Verapam

1988
Verapamil withdrawal as a possible cause of myocardial infarction in a hypertensive woman with a normal coronary angiogram.
    The Medical journal of Australia, 1988, Aug-15, Volume: 149, Issue:4

    Topics: Adult; Coronary Angiography; Female; Humans; Hypertension; Myocardial Infarction; Substance Withdraw

1988
Experimental and clinical investigations for the time interval from onset of symptoms to the coronary reperfusion.
    Japanese circulation journal, 1988, Volume: 52, Issue:7

    Topics: Adult; Aged; Animals; Coronary Thrombosis; Creatine Kinase; Dogs; Female; Humans; Male; Middle Aged;

1988
[Mechanisms of the anomalous activity of the Purkinje fibers in the late stage of experimental myocardial infarct in dogs].
    Biulleten' Vsesoiuznogo kardiologicheskogo nauchnogo tsentra AMN SSSR, 1988, Volume: 11, Issue:2

    Topics: Action Potentials; Animals; Calcium; Disease Models, Animal; Dogs; Electrocardiography; Heart Conduc

1988
Effects of calcium blockers on ventricular fibrillation during acute myocardial infarction.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 1988, Volume: 21, Issue:4

    Topics: Animals; Bepridil; Blood Pressure; Calcium Channel Blockers; Coronary Vessels; Dogs; Myocardial Infa

1988
Verapamil-mediated atrioventricular nodal reentrant tachycardia and the uncovering of dual-pathway AV nodal conduction.
    Journal of electrocardiology, 1988, Volume: 21, Issue:1

    Topics: Aged; Angina Pectoris; Atrioventricular Node; Electrocardiography; Heart Conduction System; Heart Ra

1988
Verapamil and tiapamil in prevention of ventricular fibrillation in pigs with coronary ligation. Comparative effects on left ventricular function.
    Circulation, 1988, Volume: 78, Issue:1

    Topics: Animals; Coronary Vessels; Female; Heart Ventricles; Hemodynamics; Ligation; Male; Myocardial Infarc

1988
[Effect of corinfar and finoptin on lipid peroxidation].
    Klinicheskaia meditsina, 1988, Volume: 66, Issue:4

    Topics: Adult; Calcium Channel Blockers; Cerebrovascular Disorders; Humans; Lipid Peroxides; Middle Aged; My

1988
Haemodynamic effects of tiapamil and verapamil in conscious rats following chronic myocardial infarction.
    Cardiology, 1988, Volume: 75, Issue:3

    Topics: Animals; Calcium Channel Blockers; Consciousness; Depression, Chemical; Hemodynamics; Male; Myocardi

1988
Comparative investigations on the antiarrhythmic and electrophysiologic effects of class I-IV antiarrhythmic agents following acute coronary artery occlusion.
    European heart journal, 1987, Volume: 8 Suppl G

    Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease; Dogs; Female; Heart Conduct

1987
[Effects of verapamil on left ventricular function in patients with myocardial infarction].
    Zhonghua xin xue guan bing za zhi, 1987, Volume: 15, Issue:6

    Topics: Adult; Aged; Blood Pressure; Female; Heart; Heart Auscultation; Heart Rate; Heart Ventricles; Humans

1987
A possible relationship between migraine and coronary artery spasm.
    Australian and New Zealand journal of medicine, 1986, Volume: 16, Issue:5

    Topics: Coronary Disease; Coronary Vasospasm; Electrocardiography; Female; Humans; Middle Aged; Migraine Dis

1986
[Effect of verapamil on hemodynamics in patients with myocardial infarction].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 1986, Oct-15, Volume: 39, Issue:20

    Topics: Adult; Aged; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Verapamil

1986
Limitation of infarct size for 24 hours by combined treatment with allopurinol plus verapamil during acute myocardial infarction in the dog.
    Circulation, 1987, Volume: 75, Issue:6 Pt 2

    Topics: Allopurinol; Animals; Coronary Circulation; Disease Models, Animal; Dogs; Drug Evaluation, Preclinic

1987
[Comparative hemodynamic effects of nifedipine, verapamil and diltiazem in cases of acute myocardial infarction].
    Zhonghua nei ke za zhi, 1986, Volume: 25, Issue:10

    Topics: Diltiazem; Hemodynamics; Humans; Middle Aged; Myocardial Infarction; Nifedipine; Verapamil

1986
[Value of using verapamil in coronary reperfusion arrhythmias].
    Cardiologia (Rome, Italy), 1987, Volume: 32, Issue:2

    Topics: Aged; Arrhythmias, Cardiac; Drug Therapy, Combination; Female; Humans; Lidocaine; Male; Middle Aged;

1987
[Myocardial infarction during tocolysis with sympathomimetics].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1987, Apr-10, Volume: 107, Issue:10-11

    Topics: Adult; Female; Fenoterol; Humans; Infant, Newborn; Myocardial Infarction; Obstetric Labor, Premature

1987
[Prevention of myocardial damage during reperfusion of the coronary artery in dogs using dibunol combined with verapamil].
    Kardiologiia, 1987, Volume: 27, Issue:7

    Topics: Animals; Antioxidants; Butylated Hydroxytoluene; Coronary Circulation; Coronary Disease; Coronary Th

1987
[Effect of dibunol and isoptin on the creatine kinase and myoglobin content of the blood serum in dogs undergoing postischemic coronary reperfusion].
    Biulleten' eksperimental'noi biologii i meditsiny, 1987, Volume: 104, Issue:10

    Topics: Animals; Antioxidants; Butylated Hydroxytoluene; Calcium Channel Blockers; Coronary Disease; Creatin

1987
Endocardial mapping of ventricular tachycardia in one-day-old myocardial infarction.
    Japanese circulation journal, 1986, Volume: 50, Issue:1

    Topics: Animals; Dogs; Electric Stimulation; Electrodes; Endocardium; Heart Conduction System; In Vitro Tech

1986
Atrioventricular junctional escape rhythm suppressed by verapamil: evidence suggesting abnormal automaticity.
    International journal of cardiology, 1986, Volume: 11, Issue:3

    Topics: Aged; Arrhythmias, Cardiac; Atrioventricular Node; Cardiac Pacing, Artificial; Electrocardiography;

1986
The effect of lidocaine compared with verapamil on the enhanced ventricular rhythm in the infarcted canine heart.
    Canadian journal of physiology and pharmacology, 1986, Volume: 64, Issue:4

    Topics: Animals; Dogs; Female; Heart; Heart Block; Heart Rate; Heart Ventricles; Lidocaine; Male; Myocardial

1986
[Effect of intracoronary streptokinase infusion and verapamil treatment on the size of the affected area in myocardial infarct patients].
    Kardiologiia, 1986, Volume: 26, Issue:8

    Topics: Coronary Angiography; Drug Evaluation; Electrocardiography; Female; Humans; Infusions, Intra-Arteria

1986
[Characteristics of the effect of verapamil on blood circulation].
    Klinicheskaia meditsina, 1986, Volume: 64, Issue:8

    Topics: Adult; Aged; Blood Circulation; Drug Evaluation; Electrocardiography; Female; Hemodynamics; Humans;

1986
Why Ca2+ antagonists will be most useful before or during early myocardial ischemia and not after infarction has been established. Danish Study Group on Verapamil in Myocardial Infarction.
    European heart journal, 1986, Volume: 7, Issue:10

    Topics: Calcium Channel Blockers; Diltiazem; Humans; Myocardial Infarction; Verapamil

1986
Role of verapamil in experimentally induced myocardial infarction in dog.
    The Journal of the Association of Physicians of India, 1986, Volume: 34, Issue:9

    Topics: Animals; Dogs; Myocardial Infarction; Myocardium; Verapamil

1986
Reperfusion after acute coronary occlusion in dogs impairs endothelium-dependent relaxation to acetylcholine and augments contractile reactivity in vitro.
    The Journal of clinical investigation, 1987, Volume: 79, Issue:1

    Topics: Acetylcholine; Animals; Coronary Circulation; Coronary Vessels; Dogs; Endothelium; Ergonovine; In Vi

1987
Animal models for protecting ischemic myocardium: results of the NHLBI Cooperative Study. Comparison of unconscious and conscious dog models.
    Circulation research, 1985, Volume: 56, Issue:5

    Topics: Anesthesia; Animal Testing Alternatives; Animals; Arterial Occlusive Diseases; Coronary Circulation;

1985
The usefulness of electrophysiological-pharmacologic studies in the long-term therapy of paroxysmal tachycardias.
    Japanese circulation journal, 1985, Volume: 49, Issue:3

    Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Cardiomyopathies; Chromatogra

1985
Verapamil in angina pectoris.
    British journal of clinical practice. Supplement, 1985, Volume: 42

    Topics: Angina Pectoris; Humans; Myocardial Infarction; Physical Exertion; Verapamil

1985
Evaluation of a rat model for assessing interventions to salvage ischaemic myocardium: effects of ibuprofen and verapamil.
    Cardiovascular research, 1985, Volume: 19, Issue:3

    Topics: Animals; Body Weight; Creatine Kinase; Disease Models, Animal; Ibuprofen; Male; Myocardial Infarctio

1985
Verapamil and nifedipine limit infarct size in the dog.
    Advances in myocardiology, 1985, Volume: 6

    Topics: Animals; Coronary Circulation; Dogs; Female; Hemodynamics; Male; Myocardial Infarction; Myocardium;

1985
[Comparative effects of three calcium antagonists (nifedipine, verapamil and diltiazem) on hemodynamics in recent myocardial infarction].
    Kokyu to junkan. Respiration & circulation, 1985, Volume: 33, Issue:2

    Topics: Aged; Calcium Channel Blockers; Diltiazem; Drug Evaluation; Echocardiography; Female; Hemodynamics;

1985
Effect of verapamil, nifedipine and diltiazem on experimental myocardial infarction in rats.
    Indian journal of experimental biology, 1985, Volume: 23, Issue:1

    Topics: Animals; Calcium Channel Blockers; Diltiazem; Female; Isoproterenol; Male; Myocardial Infarction; Ni

1985
Nicardipine in models of myocardial infarction.
    British journal of clinical pharmacology, 1985, Volume: 20 Suppl 1

    Topics: Animals; Calcium Channel Blockers; Disease Models, Animal; Dogs; Electrocardiography; Heart Conducti

1985
[Lipid peroxidation in the myocardium in experimental infarct].
    Nauchnye doklady vysshei shkoly. Biologicheskie nauki, 1985, Issue:5

    Topics: Animals; Butylated Hydroxytoluene; Catalase; Drug Evaluation, Preclinical; Glutathione Peroxidase; L

1985
Effects of verapamil and lidocaine in a canine model of sudden coronary death.
    Journal of the American College of Cardiology, 1985, Volume: 6, Issue:3

    Topics: Animals; Arrhythmias, Cardiac; Death, Sudden; Dogs; Female; Heart Conduction System; Heart Rate; Lid

1985
Effect of intracoronary verapamil on infarct size in the ischemic, reperfused canine heart: critical importance of the timing of treatment.
    The American journal of cardiology, 1985, Oct-01, Volume: 56, Issue:10

    Topics: Animals; Blood Pressure; Coronary Circulation; Dogs; Female; Heart; Heart Rate; Male; Myocardial Inf

1985
Reduction of infarct size by early use of oral propranolol and verapamil in acute myocardial infarction.
    The Journal of the Association of Physicians of India, 1985, Volume: 33, Issue:9

    Topics: Administration, Oral; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myocardial Infar

1985
[Therapy of cardiac arhythmia with verapamil].
    Arzneimittel-Forschung, 1970, Volume: 20

    Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Cardiac Compl

1970
[The treatment of heart arrhythmia with the heart sympatholytic iproveratril].
    Wiener klinische Wochenschrift, 1967, Nov-17, Volume: 79, Issue:46

    Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Com

1967
Mortality in ischaemic heart disease: a biased view point.
    The New Zealand medical journal, 1974, Jun-26, Volume: 79, Issue:518

    Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Artery Bypass; Coronary Care Units; Coronary

1974
The control of cardiac arrhythmias: discussion.
    Irish journal of medical science, 1973, Volume: 142, Issue:3 Suppl

    Topics: Arrhythmias, Cardiac; Glucose; Heart Rate; Humans; Insulin; Myocardial Infarction; Procainamide; Ver

1973
Ventricular fibrillation.
    The New England journal of medicine, 1973, Oct-04, Volume: 289, Issue:14

    Topics: Action Potentials; Cell Membrane Permeability; Electric Countershock; Heart Conduction System; Heart

1973
[Use of Isoptin in the treatment of paroxysmal tachyarrhythmia in patients with myocardial infarct].
    Klinicheskaia meditsina, 1973, Volume: 51, Issue:8

    Topics: Anti-Arrhythmia Agents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Tachycardia, Parox

1973
[Some suggestions for the treatment of myocardial infarct in the pre-hospitalization phase].
    Revue medicale de la Suisse romande, 1973, Volume: 93, Issue:12

    Topics: Allied Health Personnel; Ambulances; Angina Pectoris; Arrhythmias, Cardiac; Atropine; Droperidol; He

1973
[Verapamil treatment in myocardial infarction with relapsing ventricular tachycardia].
    Lakartidningen, 1973, Nov-28, Volume: 70, Issue:48

    Topics: Aged; Angina Pectoris; Drug Therapy, Combination; Electric Countershock; Electrocardiography; Humans

1973
[Verapamil in ischemic pain and arrhythmia].
    Duodecim; laaketieteellinen aikakauskirja, 1972, Volume: 88, Issue:20

    Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Coronary Disease; Depression, Chemical; Female;

1972
[Clinical physiopathological studies on myocardial oxygen metabolism. 3. Myocardial oxygen metabolism during administration of coronary dilators].
    Japanese circulation journal, 1971, Volume: 35, Issue:1

    Topics: Adolescent; Adult; Aged; Benzoates; Benzofurans; Coronary Disease; Coumarins; Dipyridamole; Female;

1971
[Clinical pathophysiological studies on coronary circulation. 3. The effects of so-called coronary vasodilator agents on coronary circulation in various diseases].
    Japanese circulation journal, 1971, Volume: 35, Issue:2

    Topics: Adolescent; Adult; Aged; Benzoates; Benzofurans; Blood Flow Velocity; Blood Pressure; Coronary Disea

1971
[Objective evaluation of the therapeutic activity of iproveratril].
    Minerva cardioangiologica, 1971, Volume: 19, Issue:3

    Topics: Adult; Anti-Arrhythmia Agents; Coronary Disease; Electrocardiography; Exercise Test; Heart; Humans;

1971
[Clinical evaluation of iproveratril].
    Jornal brasileiro de doencas toracicas, 1968, Volume: 4, Issue:1

    Topics: Adult; Angina Pectoris; Anti-Arrhythmia Agents; Electrocardiography; Female; Heart Diseases; Humans;

1968
[Our experiences with the beta-adrenolytic preparation Isoptin Knoll A.G].
    Casopis lekaru ceskych, 1969, Volume: 108, Issue:35

    Topics: Angina Pectoris; Anti-Arrhythmia Agents; Coronary Disease; Electrocardiography; Female; Humans; Lana

1969